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 The antibacterial properties of silver have been known for centuries; however, the 
threat of antibiotic resistant bacteria has led to renewed focus on the noble metal. Silver is 
now commonly included in a range of household and medical items to imbue them with 
bactericidal properties. Despite this, the chemical fate of the metal in mammalian or 
bacterial biological systems, is poorly understood. Through a metallomics approach, using 
techniques like X-ray absorption spectroscopy (XAS), and size-exclusion chromatography 
hyphenated inductively coupled plasma mass spectrometry (SEC-ICP-MS), results are 
presented that advance our understanding of the chemistry of these interactions.  
 
 In bacterial systems, endogenous and exogenous silver ions were found to be 
predominantly coordinated by thiolate species, likely cysteine residues. Silver in broth was 
found to be associated exclusively with moderately size species (~30 kDa). Conversely, in 
S. aureus and E. coli, silver was bound by a range of species, ranging from 20-30 kDa, to 
>1220 kDa. Silver was also nonuniformly associated with copper-bound species, 
suggesting possible cellular processing of the noble metal as nutrient copper. Colocation of 
Ag with Cu could also provide insight into the cellular distribution of silver, as copper is 
predominantly found in the extracytoplasmic space of bacteria as it is a strictly regulated 
nutrient due to potential toxicity. 
 
 Exposure of human whole blood to 2 mM AgNO3 resulted in lysis of red blood 
cells (RBCs), regardless of the isotonicity of the added solution. Despite this, within five 
minutes ~90% of silver ions were localised in the RBCs. Inside the RBCs Ag+ interacted 
predominantly with haemoglobin and no low molecular weight complexes (e.g. 
glutathione). Linear combination fitting of Ag K-edge XANES of the RBC fraction from a 
sample of human whole blood treated with AgNO3 indicated ~53% of the experimental 
spectrum could be described by a silver-haemoglobin model with the remaining percent 
explained by a silver-cysteine model. In isolated plasma the speciation of silver was found 
to strongly resemble that of solid silver chloride. Conversely, the speciation of silver in the 
plasma fraction from whole blood was found to have no contribution from the same AgCl 
model spectrum. The dominant binder of silver in human plasma was human serum 
albumin as well as higher molecular weight species.  
 
 Finally, the pore environment of UiO-66 was tailored for use as an antibacterial 
agent. In. general, inclusion of sulfur-containing functionality in the framework resulted in 
 viii 
increased silver ion uptake (relative to the parent material). While sulfhydryl-decorated 
pores were found to take up significantly more silver, the material did not release 
significant concentrations of Ag+. Allyl and alkyl thioethers were found to both increase 
silver uptake and control release. The silver-loaded materials were successfully embedded 
into polymer matrices; extending applicability as antibacterial hybrid coatings and 
providing further control over silver release. Ag XAS revealed that, when loaded with 
silver ions, the unfunctionalised UiO-66 partially reduced Ag(I) to Ag(0) in the absence of 
an added reductant. All silver-loaded UiO-66 derivatives embedded in polymer matrices 
were found to have antibacterial activity against S. aureus and E. coli. 
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Chapter One: Introduction 
1.1 Abbreviations 
AgNP   silver nanoparticle 
CSD   Cambridge Structural Database 
EXAFS  extended X-ray absorption fine structure 
ICP-MS  inductively coupled plasma mass spectrometry 
Ksp   solubility product 
MT   metallothionein 
PDB   Protein Data Bank 
SEC   size exclusion chromatography 
ROS   reactive oxygen species 
TEM   transmission electron microscopy 
XAS   X-ray absorption spectroscopy 
XANES  X-ray absorption near-edge structure 
 
1.2 Introduction 
Silver is not an essential macro- or micronutrient for any organism, nor is it 
involved in any biological process known to date. The antimicrobial properties of silver, 
however, have been known for centuries.1 Three common forms of silver include bulk 
metal, cationic (Ag+), and nanoparticles (AgNP). Of the three forms, bulk silver is known 
to have the lowest antibacterial activity due to its resistance to oxidation (E0 = +0.80 V).2 
Ionic and nanoparticulate silver are known to be active antibacterial agents, however, their 
mechanism(s) of action are still unknown. Whether nanoparticles act as Trojan 
horses/carriers for Ag+ to infiltrate the cell, the nanoparticle itself causes the antibacterial 
response, or a combination of the two is unclear.3 The mechanism by which Ag+ acts 
against bacteria is also yet to be fully understood, however, it is posited to be a dynamic, 
multimodal process where – if one avenue of attack is blocked – another mode of action is 
open to the metal ion. While the physiological effects of silver ions on bacteria are well 
documented, little is understood about the speciation, and molecular targets of silver in 
biological systems. Through metallomics techniques such as size exclusion 
chromatography hyphenated inductively coupled plasma mass spectrometry (SEC-ICP-
MS), and X-ray absorption spectroscopy (XAS) greater insight into the biochemical fate of 
silver ions in vivo can be achieved. 
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1.3 The chemistry of silver and its interactions with the building blocks of life 
An understanding of silver chemistry and how it interacts with the fundamental 
building blocks of life can provide stepping-stones to understanding its interactions with 
higher-order complex molecules in biological systems. 
 
1.3.1 Physical chemistry 
Ag+ is classified by Pearson as a ‘soft’ metal ion with preference for ‘soft’ donor 
atoms such as sulfur and, to a lesser extent, nitrogen.4 In spite of this, a review of the 
Cambridge Structural Database (CSD) reveals that a majority of silver-containing 
structures have silver-oxygen interactions, highlighting the promiscuity of the metal’s 
chemistry (Appendix 3.9.2). In structures where silver-sulfur interactions dominate, AgS2 
and AgS3 coordination spheres are common and result in linear (digonal), and trigonal 
planar geometries, respectively.5 
Both silver and copper are group 11/1B elements and Ag(I) and Cu(I) cations 
exhibit similar chemistries due to their closed shell electronic structures (d10). Cuprous ions 
exhibit a similar proclivity for soft donor atoms and linear binding geometries.6 By 
contrast, Cu(II) ions are considered ‘borderline’ hard/soft acids, preferring distorted 
octahedral and square planar geometries with oxygen or nitrogen donors.4 
While silver(I) is not a biologically essential metal ion, the cuprous and cupric 
cations are required micronutrients for both prokaryotic and eukaryotic organisms.7 
Therefore, due to the similarities in Cu(I) and Ag(I) chemistry, a knowledge of the 
biochemistry of copper can be beneficial in understanding silver in biological systems. 
 The poor aqueous solubility of salts that silver can form with common biological 
anions (like Cl-, S2-, O2-, and PO43-) is commonly thought to reduce the antibacterial effects 
of silver ions in biological systems.3 The solubility products (Ksp) of these silver salts span 
many orders of magnitude from 1.8 x 10-10 (1.93 mg per L of pure water) for AgCl to 8 x 
10-51 (0.14 mg per L of pure water) for Ag2S and have the potential to limit the 
bioavailability of silver ions by sequestering them as solids.2 Conversely, the Ksp of 
AgNO3 – a silver salt commonly administered in antibacterial studies – is often not 
reported due to its high solubility in water (~4.24 kg AgNO3 per litre of water at 25°C).8 
 
1.3.2 Amino acids and peptides 
 One of the most fundamental building blocks in biology are amino acids, of which 
there are 21 that occur naturally. Polymerisation of these diverse monomers into peptide 
chains, and proteins facilitates the complex machinations of the cell. The interaction of 
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metal ions with the side-chain groups of amino acids, resulting in (un)favourable 
conformations or providing redox activity, is part of how they carry out their biological 
function in vivo. Hence, an understanding of how Ag+ interacts with amino acids in 
isolation can, in part, give insight into its behaviour in more complex structures such as 
proteins and enzymes.  
 
 Theoretical binding energies of silver with 20 of the naturally occurring amino 
acids (stoichiometric ratios of 1:1) suggest that the basic amino acids histidine, lysine, and 
arginine (Figure 1) interact most strongly with Ag+.9-10 While the sulfur-containing amino 
acids – methionine and cysteine (Figure 1) – were ranked 5th and 14th, respectively, which 
is at odds with the experimentally observed chemistry of silver. It is likely that the 
stoichiometry used (1:1, M to L) and assumptions that binding would not be exclusively 
through the amino acid side-chains (i.e. all species would be chelated by multiple groups in 
a single amino acid molecule) resulted in these aberrant conclusions for the sulfur-
containing amino acids. Experimentally, Yan and Nan have shown that the affinity, and 
specificity, of silver for cysteine can be utilised as a probe for the detection of the amino 
acid in complex biological mixtures at low concentrations (micromolar).11 
 
 
Figure 1: The structures of selected L-amino acid. 
 
 Eight different amino acids, including derivatives thereof, have been crystallised as 
Ag+ complexes.5, 12-18 While visualisation of the behaviour of silver with these amino acids 
is undoubtedly useful, they must be viewed critically. Amino acids are highly pH-sensitive 
molecules and, unfortunately, the pHs used to crystallise such complexes are often not 
physiologically relevant (pH 7.4). Mirolo, et al. illustrated this by crystallising complexes 
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of L-histidine with Ag+ at acidic and neutral pHs.18 At neutral pH, two imidazole nitrogens 
coordinated Ag+ with a N-Ag-N bond angle of 176° (a nitrate anion balanced the charge), 
while under acidic conditions each silver cation was solely coordinated through two 
histidine carboxylate oxygens in a pseudo-linear mode (O-Ag-O bond angle range from 
110 to 136°) (Figure 2). This difference in coordination was attributed to the fact that at 




Figure 2: Pseudo-linear coordination of histidine carboxylate oxygens under acidic crystallisation conditions 
(CSD code: TIGGUN)18 
 
  In 2013 Leung, et al. published the first crystal structure of a cysteinate-silver 
complex.5 The structure reported was a coordination polymer where the cysteine sulfur 
atoms adopted a µ2 binding mode between two silver atoms, propagating a 1D chain along 
the a-axis. Two silver coordination spheres were observed in the crystal structure (AgS3 
and AgS2N) with a large range of Ag-S bond lengths (2.450 to 2.802 Å). In the same paper 
the crystal structure of a complex formed between silver and penicillamine, a derivative of 
cysteine, was reported. Each silver atom was coordinated by two penicillamine sulfurs in 
digonal binding geometry. The sulfurs bridged between two silver atoms via µ2 binding 
and long-range Ag-Ag interactions ranging from 2.954 to 3.089 Å were also observed. In 
addition to the solid phase data, solution phase characterisation of the complexes formed 
between silver and cysteine, penicillamine, and glutathione, respectively, was achieved by 
extended X-ray absorption fine structure (EXAFS), and 109Ag nuclear magnetic resonance 
(NMR) analysis. The EXAFS data for each of the three systems studied was adequately fit 
by Ag-S and Ag-Ag interactions. A high value for the Debye-Waller factor (representative 
of the disorder of the system) for the cysteine and penicillamine systems was attributed to 
large variation in Ag-S interactions; supported by the aforementioned crystal structures. 
The overall coordination spheres and bond lengths are summarised in Table 1. 
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Table 1: Summary of EXAFS parameters for solution phase complexes formed between Ag+ and cysteine, 
penicillamine, and glutathione 
Ligand Na Ag-S (Å) s2 (Å2)b N Ag-Ag (Å) s2 (Å2) 
Cysteine 2.4 2.47 0.085 0.5 2.93 0.014 
 2.3 2.47 0.081    
Penicillamine 1.8 2.40 0.072 - - - 
Glutathione 1.5 2.36 0.0034 - - - 
aCoordination number, bDebye-Waller factor 
 
While informative about the behaviour of these sulfur-containing biomolecules, all 
of the experiments were conducted at high pH (ranging from 9 to 11) and therefore cannot 
be considered representative of the behaviour of the molecules under physiological 
conditions. The XAS and NMR work was conducted at elevated pH for consistency 
between the solid- and solution-phase experiments as the cysteine/penicillamine complexes 
were crystallised under highly basic conditions.  
The interaction between silver and sulfur-containing peptides (glutathione) or small 
proteins are of particular interest as they are suspected to play important roles as metal ion 
chaperones and buffering agents in prokaryotic and eukaryotic cells.19-20 
 
1.3.3 Proteins 
 Metallothioneins (MTs) are low molecular weight (~6 kDa), cysteine-rich 
proteins/polypeptides that are ubiquitous in all forms of life.21 They traditionally exist 
intracellularly but have been found in blood plasma and cerebral fluid in higher 
organisms.22 Their high sulfur content – with cysteine in its chemically reduced form – 
imbue these species with some of the highest metal binding affinities of any biomolecule.23 
Expression of MTs have been identified to be induced by exposure of an organism to 
essential micronutrients (Cu+/Cu2+, and Zn2+ ions) as well as non-essential metals (Cd2+).24-
25 The biological role of these low MW proteins is thought to be about protection as well as 
supply. Metallothioneins are posited to bind metal ions and prevent adventitious, 
deleterious interactions with cellular components, but also to act as a buffered pool of the 
inorganic species to metallate proteins/enzymes. 
 Scheuhammer and Cherian determined that mammalian hepatic zinc and cadmium 
MTs were capable of binding up to 18 moles of Ag+ ions per mole of the protein 
(displacing the bound Zn(II) and Cd(II) clusters) and that the propensity of other metals to 
displace silver from the protein was ranked thus: Ag(I) > Cu(II) > Cd(II) > Hg(II) > 
Zn(II).26 No crystal structure of a silver-bound MT has been published to date, however, 
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Peterson, et al. reported the first solution phase 3D structure of a silver-substituted (native 
Cu(I) binding) yeast metallothionein via NMR spectroscopy.27 The MT was found to be 
devoid of defined structure in the metal-free (apo) form, but formed parallel loops upon 
exposure to Ag+; seven silver ions bound by ten cysteine residues. 
 Veronesi, et al. investigated the binding interactions of Ag(I) with a known 
mammalian copper chaperone (Atox1), as well as rabbit, and yeast MTs by XAS.6 The 
EXAFS and X-ray absorption near edge structure (XANES) revealed that Ag(I) was bound 
by two cysteine residues of the known Cu(I)-binding domain of Atox1 with silver-sulfur 
bond distances of 2.40 Å. The bonding interactions between Ag(I) and the two 
metallothioneins were similar with both species thought to have AgS3 coordination sphere 
with Ag-S distances ranging from 2.47 to 2.48 Å. 
 
 In 2017 a survey of the then 10 (now 13) silver-containing protein structures 
deposited in the Protein Data Bank (PDB) was conducted.28 Observations pertaining to 
structures which contained silver were as follows: 
• In all silver-containing structures, the metal was in the +1 oxidation state 
• The Ag(I) ions had an average coordination number of 2.3 ± 0.03 
• The most frequent coordination number was two with digonal binding geometry 
 (L-Ag-L bond angle >160°) in ~80% of structures 
• Three coordinate Ag(I) species always had a trigonal planar binding geometry 
• Four coordinate species were tetrahedral 
• No correlation was observed between the silver-ligand bond lengths and 
 coordination number 
• Silver was bound by the amino acid side chain groups in 96% of structures 
• The Ag(I) ion was never coordinated by water 
• Ag-S interactions accounted for 44% of all interactions with Ag(I) 
o Cysteine 15% with an average Ag-S bond length of 2.41(3) Å 
o Methionine 29% with an average Ag-S bond length of 2.46(3) Å 
• Ag-histidine interactions accounted for 50% of all interactions 
o Average Ag-N bond length: 2.26(3) Å 
• Ag-O interactions from aspartate (and, rarely, threonine) were the remaining 6% 
o Average Ag-O bond length: 2.32(4) Å 
Caruso also noted that protein crystal structures are susceptible to aberrant results if not 
crystallised at an appropriate pH. A silver-arginine side-chain interaction was observed in 
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one structure, but, at physiological pH, the arginine guanidino group would be protonated 
and unavailable for binding (pKa = 13.8).29 Since Caruso’s review, three additional silver-
containing protein structures have been deposited in the PDB. Silver coordination in these 
structures included linear cysteine/histidine, and cysteine/cysteine binding as well as 
trigonal pyramidal binding of the metal by two cysteine residues and an isoleucine 
hydroxyl oxygen.30-32 Additionally, a solitary structure has been deposited in the Protein 
Data Bank which shows insertion of silver into an iron/sulfide redox cluster of a bacterial 
ferredoxin (AgFe3S4) (Figure 3).33 The activity of the mis-metallated ferredoxin was 
inhibited until the silver-containing clusters were replaced with the native [Fe4S4]. 
 
 
Figure 3: Substitution of an [Fe4S4] cluster iron with silver (PDB code: 4DHV)33 
 
1.3.4 Nitrogenous bases 
 Silver ions have been shown to have an affinity for the nitrogenous bases of DNA 
with particular preference for the purine bases adenine and guanine.34 The majority of 
crystal structures reported in the CSD for complexes between silver and the nitrogenous 
bases (including relevant derivatives) are between adenine and Ag(I) (28 out of 40 
structures, Appendix 2.9.3). In these structures Ag+ can form linear complexes with the 
hydrogen bonding moieties of the nitrogenous bases (Figure 4). It has been identified that, 
when treated with sublethal silver sulfadiazine, approximately 15% of silver ions were 
associated with DNA or RNA in Pseudomonas aeruginosa.35 
 
 




1.4 Silver in bacteria 
When bacteria are treated with lethal concentrations of silver, four broad effects 
have been observed, including: 
- Disruption of the cell wall and/or membranes 
- Interaction with DNA 
- Inhibition of proteins and enzymes 
- Generation of Reactive Oxygen Species (ROS) 
As such, it has been hypothesised that Ag(I) has the ability to act in a multimodal manner 
and that if one avenue of action is blocked in the cell, by development of resistance, the 
metal ion can elicit its antibacterial effect in other ways.37 
 
1.4.1 The cell wall and membrane 
Species of bacteria can broadly be categorised as: Gram-negative, and Gram-
positive. They differ from one another by the thickness of a peptidoglycan cell wall and are 
named as such due to the discovery by Christian Gram in 1884 that certain bacteria were 
capable of retaining more crystal violet dye than others.38 
Gram-positive bacteria, such as Staphylococcus aureus (S. aureus), possess a thick 
cell wall (~15-80 nm) and are better able to retain more Gram stain. The cell wall 
envelopes the phospholipid plasma membrane of the cell (which houses important proteins 
for respiration and other processes in both groups of bacteria) and is considered the first 
line of defence for the organism. 
Gram-negative bacteria, such as Escherichia coli (E. coli), have a peptidoglycan 
layer ~2 nm thick which wraps around the cell. In addition to this, they also possess an 
external phospholipid membrane which coats the ‘cell wall’ and can be decorated with 
porins, liposaccharides and proteins. The sandwich of outer cell membrane, peptidoglycan 
layer, and inner cell membrane is referred to as the ‘periplasmic space’.38 
Park, et al. observed by transmission electron microscopy (TEM) that, when treated 
with 0.2 ppm solutions of silver nitrate, the cytoplasm of both S. aureus and E. coli shrank 
and separated from the ‘cell wall’.39 The degradation and liberation of cellular contents 
into the extracellular space resulting in cell death was visualised. 
 
1.4.2 Interaction with DNA 
Prokaryotic cells, like bacteria, do not possess a membrane-delimited nucleus for 
the storage of DNA, such as is found in eukaryotic cells; instead the genetic material is 
located in the nucleoid.38 In bacterial cells treated with silver nanoparticles, it has been 
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shown that, while the NPs were not in proximity to the nucleoid (monitored by TEM), the 
DNA of the organism had condensed and hence was unable to participate in cell 
replication.40 The authors reconciled this observation with the presumed interaction of 
Ag(I), released from the AgNPS, with DNA, causing it to condense. 
 
1.4.3 Inhibition of proteins and enzymes 
The various ways in which silver has been observed to interact with amino acids, 
peptides, and proteins has been discussed above. In isolation these interactions are 
informative about the chemistry of Ag(I) with biomolecules, however, in biological 
systems, proteins and enzymes carry out a myriad of different functions. Binding of silver 
to functionally important moieties in these biomolecules can disrupt their structure and 
functions, leading to cell death. 
 
Some enzymes utilise iron-sulfur clusters as cofactors in the active site of catalysis. 
It has been reported – both in vitro and in vivo – that soft metals, like Ag+, are able to mis-
metallate iron-sulfur clusters by substitution of iron atoms with silver atoms (Figure 3). 
For example,  fumarase A is a dehydrogenase enzyme known to be poisoned by silver in a 
similar way to the ferredoxin structure presented above.33, 41 Conversely, it was also found 
that the activity of the Fe4S4 cluster-containing NADH dehydrogenase I was not inhibited 
and the cluster remained unchanged in the presence of Ag(I) ions.41 This observation was 
rationalised by the fact that the clusters in dehydrogenase I are buried deep within the 
protein structure, possibly protecting the clusters against mis-metallation. 
Recently, silver-binding protein targets were identified in E. coli treated with toxic 
levels of silver nitrate.42 No [Fe-S] containing proteins were identified to bind silver, which 
was reconciled by the fact that such interactions may have degraded the inorganic cluster 
yielding the apo-enzyme which would not have been detectable by the hyphenated ICP-
MS methods used. However, in addition to chromatographic experiments, metabolomics 
was used to validate whether the identified silver-binding proteins were inhibited by the 
metal ion. Key enzymes in the tricarboxylic acid (TCA) cycle were found to be inhibited, 
both in vitro and in vivo, however, their respective binding substrates were not observed to 
be accumulated in the cells. The authors hypothesised that upstream [Fe-S] containing 
proteins in the TCA cycle were also inhibited, which stalled the substrate processing 
earlier than initially anticipated. 
Treatment of E. coli with lethal concentrations of silver salts increases the 
permeability of the cell membrane to protons (H+) and abolishes the proton gradient of the 
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cell.43 The movement of protons in a controlled manner across the cell membrane is an 
important step in the respiration chain. Collapse of the proton gradient causes the organism 
to increase the speed of respiration to a point where it becomes independent of the amount 
of ATP or ADP available, which ‘decouples’ the respiration chain.43 The cause of this 
breakdown of cellular machinery is suggested to be due to the metal ion binding to the 
NADH dehydrogenase (NDH) enzymes (of which E. coli is known to have at least two: 
NDH-I and -II).  
Gordon, et al. demonstrated that silver ions released from a silver coordination 
polymer used in prosthetic coatings were capable of inhibiting the growth of 
Staphylococcus epidermidis (S. epidermidis) cultures.44 They found that the silver ions 
were bound by cysteine residues of respiratory chain dehydrogenases and, after exposure 
to silver, generation of ROS was detected. 
 
1.4.4 Generation of reactive oxygen species (ROS) 
The generation of reactive oxygen species (singlet oxygen, H2O2, and O2•-) by 
bacteria is a normal part of endogenous metabolic processes in aerobic environments.45 
However, ROS are known to cause damage to cellular contents like DNA, proteins, and 
membranes.46 Bacteria have developed various mechanisms to counter the deleterious 
actions of these reactive species through the expression of scavengers such as catalases, 
peroxidoredoxins, and superoxide dismutases (SOD).47 Such species are regulated by 
sensor proteins such as SoxR and OxyR, which sense O2•- and H2O2 in the cytoplasm, 
respectively. If the natural defences of the cell are overwhelmed by the generation of ROS, 
then the organism is considered to be in a state of oxidative stress.  
 
Cysteine and methionine are particularly susceptible to damage by oxidative stress 
due to their electron-rich sulfur atoms and, in the case of cysteine, the nucleophilic nature 
of thiolates.46 Oxidation of cysteine can produce sulfenic acids which are capable of 
forming disulfide bonds (CysSSCys) with proximal cysteines, and are either irreversibly 
oxidised further to sulfinic/sulfonic acid or reacted with glutathione (GSH) to eventually 
regenerate the reduced protein in a process called glutathionylation.48 Oxidised cysteine 
residues can be reduced to the free thiol by oxidoreductases like thioredoxins (Trxs) or 
glutaredoxins (Grxs). These species are, in turn, oxidised and need to be reduced by 
thioredoxin reductase (TrxR) and glutathione reductase (Gor), respectively. Recently, 
glutaredoxin 2 (GrxB) was identified as a silver-binding target in E. coli treated with toxic 
levels of silver nitrate.42 Silver has also previously been identified to bind to this 
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oxidoreductase through two cysteine residues in the interfacial space between a GrxB 
homodimer; the metal ion adopted a pseudo-linear geometry (L-Ag-L: 136.5°, PDB code 
2MZC).49 
The oxidation of methionine by ROS can form diastereomers of methionine 
sulfoxide which can be irreversibly (but rarely) oxidised to sulfones. Oxidised methionine 
residues can be reduced by methionine sulfoxide reductase (Msrs) which are stereospecific 
and with MsrA and MsrB catalysing the reduction of the S- and R- substrates, 
respectively.50 
 Bacterial cells that have been exposed to lethal concentrations of silver ions have 
been shown to have heightened SoxR activity, suggesting that the superoxide radical anion 
may be prominent in silver-induced oxidatively stressed organisms.51 
 
1.4.5 Detoxification mechanisms in bacteria 
Bacteria have developed mechanisms to ameliorate the toxicity of metal ions 
intracellularly. A silver-resistant strain of Pseudomonas stutzeri (P. stutzeri) found in the 
soil of silver mines has been shown to form intra- and extracellular deposits of solid silver 
when exposed to Ag(I).52 The composition of these deposits was confirmed to be mixtures 
of Ag(0), and Ag2S as well as unidentified components. It is presumed that this is a source 
of the silver-resistance of the organism. The oxidative effects of such deposits would be 
more easily managed by the cell than Ag(I) ions, and the oxidative dissolution of the large 
metal deposits (100-200 nm) would be expected to be slow. 
 
In addition to sequestration of toxic Ag(I) ions, some bacteria have been shown to 
express a variety of efflux pumps, regulatory systems, and metallothioneins when exposed 
to silver. A silver-resistant strain of Salmonella isolated from a hospital burn ward 
expresses Ag(I)-specific proteins known as the sil ensemble.53 The operon silCBAEF  is 
regulated by the membrane-bound ATP kinase SilS which detects the presence of 
exogenous silver ions, and also the transcription regulatory protein, SilR, which initiates 
expression of the sil ensemble.54 SilP is a membrane-bound P-type ATPase and transports 
cytosolic Ag(I) cations into the periplasmic space. Once in the periplasmic space the 
soluble proteins, SilE and SilF, bind Ag(I) with high affinity. SilE binds Ag(I) through a 
histidine motif similar to that of the copper resistance protein PcoE.53 SilF is homologous 
to the metallochaperone CusF which forms part of the copper efflux system and binds 
Ag(I) and Cu(I) via methionine and histidine residues.55 Transport via SilE and SilF to the 
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chemiosmotic cation/proton antiporter SilCBA enables efflux of the metal ion from the 
cell.54 
 
Bacterial metallothioneins were first discovered in the 1980s with the identification 
of the BmtA family of proteins in cyanobacteria.25, 56 This family is typified by the ~6 kDa 
Zn(II) and Cd(II)-responsive protein SmtA (regulated by SmtB) which binds up to four 
zinc and/or cadmium ions through nine cysteine residues.57 In 2008 a second family of 
bacterial MTs was identified in Mycobacterium tuberculosis (MymT) that bind copper ions 
but has been shown to be expressed in the presence of silver, cadmium, zinc, and cobalt 
ions.58 Beyond this, surprisingly little is known about MTs in bacteria other than the 
identification of conserved homologues of the BmtA family of proteins in some bacterial 
strains.25 
 
1.4.6 The role and regulation of copper in bacteria 
Unlike silver, copper is a bacterial essential micronutrient that can be used as a 
cofactor in some enzymes. Its biological functionality in vivo likely stems from the two, 
readily accessible, oxidation states of copper – Cu(I) and Cu(II). The total concentration of 
copper in E. coli is estimated to be ~10 µM and is strictly regulated and almost exclusively 
localised in the periplasmic space.59-60 
 
The presence of exogenous copper is detected by the regulatory protein CueR 
which induces expression of the P-type ATPase efflux pump, CopA, as well as the 
multicopper oxidase CueO.61-62 The sensitivity of CueR to Cu(I) is as low as zeptomolar,63 
providing insight into how stringently copper is regulated in bacteria. CopA transports 
cytosolic copper into the periplasmic space where Cu(I) is oxidised to Cu(II) by CueO; the 
cupric ion is thought to be less toxic to the cell.64 CueR is also sensitive to Ag(I) and the 
presence of the metal ion induces the expression of CopA and CueO.63 The copper is 
cleared from the cytosol by these proteins and retained in the extracytoplasmic space. If the 
concentration of copper in the periplasm continues to rise (ranging from 70 to 200 µM), 
the two-component sensor CusR/CusS initiates the expression of the cusABCF operon.61 
CusA, a proton antiporter, can export various metal ions from the cell; membrane-bound 
CusB spans the periplasmic space and CusC is an outer membrane-bound protein.62 
Methionine residues located in the periplasmic domains of CusA and CusB are essential 
for their ability to transport metal ions to the extracellular space.65 CusF, an approximately 
10 kDa, soluble periplasmic protein, chaperones Cu(I) – and Ag(I) – ions between CusB 
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and CusC.66 The crystal structure of CusF shows similar binding motifs for both Ag(I) and 
Cu(I), consisting of two methionine and one histidine residue.67 Interestingly, a tryptophan 
residue appears to ‘cap’ the binding site of the metal and is thought to prevent adventitious 
redox reactions occurring between its native Cu(I) metal ion, and other periplasmic species 
during transport.  
 
Some strains of E. coli possess a secondary copper regulatory system which are 
encoded by the pcoABCDER genes, however, the mechanism of copper transport and 
efflux by this family of proteins is largely unknown.66 PcoR/PcoS are a two-component 
regulator system that induces the expression of the other five proteins upon exposure of the 
organism to copper ions. 68 PcoA – a multicopper oxidase – and PcoC are both exported to 
the periplasmic space upon expression. PcoD is thought to chaperone cytosolic copper into 
the periplasm where it is bound by PcoE. Finally, PcoB is predicted to be an outer 
membrane protein facilitating efflux of the metal ion from the cell.68-69 However, the 
putative functionality of this system in responding to Ag+ exposure is yet to be 
determined.70 
 
Much is known about systems of bacterial copper efflux, but the mechanisms of 
uptake and homeostasis are still poorly understood.71 Transport of the metal ion into the 
cell is likely a combination of active and passive processes utilising Cu-binding 
metallophores as well as membrane-bound porins.72-74 Of the copper-dependent proteins 
known, most reside in the extracytoplasmic space. The movement of nutrient copper 
within the cytoplasm is assumed to be facilitated by small, thiolate-containing molecules 
like glutathione.75 However, glutathione’s affinity for Cu+ ions is orders of magnitude 
lower than that of copper-sensing/regulatory proteins.76-77 Despite high cytoplasmic 
glutathione concentrations, and evidence that GSH may be exported to the periplasm,78 it 
has been posited that copper is only bound by the peptide in cases of high Cu stress.75 
Additionally, periplasmic extracts indicate that unidentified chaperones or low molecular 




1.5 Silver in humans 
1.5.1 Exposure and toxicity  
 Chronic exposure of humans to silver (ions or nanoparticles) can result in argyria, 
the primary symptom of which is the subdermal deposition of silver as a mixture of 
insoluble sulfides and reduced Ag(0) which gives the person a blue appearance.81-82 Few 
incidences of argyria are known, however, it is estimated that acute exposure of between 
1.4 and 40 x 104 µg/kg of soluble salts is required for the condition to be symptomatic.3 
Medical researchers suggest that the staining of the skin is not dangerous and that it is a 
purely cosmetic concern. However, consumption of the quantities of silver sufficient to 
develop argyria can also decrease beneficial flora diversity as well as perturbation of liver 
biochemistry.83-85 
 Exposure of humans to silver was traditionally a rare occurrence, however, 
heightened use of ionic and nanoparticulate silver in medical and commercial items has 
increased the rate of incidence.86 An individual can be exposure to silver by three broadly 
grouped pathways: inhalation, ingestion, and dermal exposure. Inhalation of silver-
containing aerosols or other particulates results in deposition of silver in the lungs and/or 
absorption into the blood stream. The deposition of particulate silver in the lungs has been 
identified to be dependent on both particle size and breathing force.87 Small particles (<1 
µm) can be deposited in the alveoli, thus AgNPs penetrate deeply into the lungs and can be 
in close proximity to the vascular system into which dissociated Ag+ ions can be 
incorporated and distributed around the body.88 
 Approximately 10 to 20% of silver ingested is absorbed in the gastrointestinal tract 
and distributed around the body by the vascular system; the remaining silver is excreted in 
urine and faeces.89 In mice fed with silver-doped water (500 ppm AgNO3) the highest 
concentration of silver was localised in the kidneys (1.2 x 104 µg/kg wet weight), followed 
by the spleen (8.7 x 103 µg/kg wet weight), and liver (3.9 x 103 µg/kg wet weight).90 
However, other studies suggest that silver is accumulated in the liver and could interfere 
with copper homeostasis as this is one of the dominant sites of cuproenzyme expression in 
the body.85 
 Silver can also enter the body by contact of the skin with metal salt solutions or 
medical/consumer items. Silver sulfadiazine (SSD, Figure 5) is commonly used as a 
topical ointment for the prevention of bacterial infections in burn victims.86 People treated 
with SSD or silver salts have been shown to have increased plasma and urine silver 
concentrations, suggesting that the ion is not restricted to the immediate vicinity of the 
wound site.91-92 SSD is an effective antibacterial agent with some studies even suggesting 
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that use of ionic silver can decrease wound inflammation, however, conflicting evidence in 
the literature also suggests that the ion can be toxic to host cells and delay wound healing; 
contradiction between reported in vitro and the few in vivo experiments are common.3 
 
 The cellular redundancy of mammalian organisms is one hypothesis for the 
discrepancy between silver toxicity against eukaryotic and prokaryotic organisms. 
However, the presence of biological fluids in vivo has also been demonstrated to attenuate 
the potential toxicity of silver.93 Sequestration via sedimentation as insoluble silver salts 
(chloride, sulfide, etc.) or adsorption to biomolecules in blood serum/extracellularly have 
been shown to limit the toxicity of silver.94-95 From these observations it has been 
highlighted that the speciation of silver in vivo is important to understand to try and explain 
the apparent disparities in toxicity between organisms.3, 86, 96 
 
 
Figure 5: Structure of silver sulfadiazine (SSD); used clinically for treatment of burns 
 
 Systemic effects of exposure to silver can include argyrosis of the eyes,97 
leukopenia98 and liver/kidney damage.99 Additionally, silver has been claimed to cause 
brain damage,100 seizures,101 and animal deaths.102 Mice injected with doses of various 
silver salts sufficient to kill 50% of the population (LD50) displayed signs of ataxia, 
depression of the central nervous system, and loss of ‘right reflex’.103 
 
1.5.2 Detoxification and homeostatic mechanisms 
  The antibacterial efficacy of silver has been shown to be adversely affected in vitro 
by the addition of organic matter, foetal calf serum (FCS) or serum, relative to pure 
water.94, 104-105 The cytotoxic effects of silver nitrate against fibroblasts were observed to 
decrease with increasing FCS content in the media.104 Such observations have been 
attributed to the ‘cytoprotective’ properties of biological fluids with little explanation for 
the speciation of silver in the experiments conducted. Indeed, sedimentation of silver in 
vivo as a method to mitigate the cytotoxic effects of the metal is likely the origin of the 
subdermal staining of people afflicted with argyria. 
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 Similar to bacterial systems, the uptake, transport and efflux of silver is thought to 
be orchestrated by copper homeostatic proteins.106 CTR1 is a protein responsible for the 
uptake of nutrient copper (and silver) into human cells; its inactivation leads to copper and 
iron deficiencies.107 Iron deficiencies are linked to nutrient copper as FET3 – a copper-
dependent ferroxidase – is involved in iron uptake.106 A second copper-binding protein, 
CTR2, is homologous with CTR1, however, the role of CTR2 is unclear as it has been 
shown to have a lower affinity for nutrient copper than CTR1.108 Introduction of CTR2 
into CTR1-inactive yeast cells did not appreciably restore copper uptake.109 
 P-type ATPases in eukaryotic cells are often located in the plasma or endoplasmic 
reticular membranes. Cu-ATPases such as ATP7A and ATP7B are known to export Cu(I) 
from the cytosol across the plasma membrane via hydrolysis of ATP and the charge 
balanced importation of biological monovalent ions.106 Both proteins are purported to 
transport nutrient copper into intracellular vesicles which release the metal by exocytosis. 
ATP7A is suggested to funnel copper into the blood stream for redistribution into other 
tissues or proteins, while that transported by ATP7B is exported for removal from the body 
with both efflux systems are fed by soluble copper chaperones like Atox1.62 
 All of the copper-binding proteins mentioned have been demonstrated to either 
interact with Ag+ upon exposure or be inhibited by the presence of the metal. Both CTR1 
and CTR2 can be partially or wholly inactivated by silver ions107-108 while the ATPases are 
known to efflux silver from the cells.110 ATP7A has been shown to export silver from 
Chinese hamster ovary cells and human fibroblasts.111-112 While upregulation of ATP7B 
and active efflux of Ag+ has been observed upon exposure to silver in other systems.113 
 The crystal structure of copper chaperone Atox1 with Ag+ has been deposited in the 
Protein Data Bank (PDB code: 5F0W).114 Four silver atoms were bound between two 
monomers of the chaperone. Three of the silver atoms were bound exclusively by cysteine 
residues and had pseudo-linear geometry (S-Ag-S bond angle range: 133-174°) while the 
fourth had distorted trigonal planar geometry bound by two cysteine residues and an 
isoleucine hydroxyl. The silver-cysteine bond lengths ranged from 2.29 Å to 2.66 Å while 
the silver-oxygen interaction from the isoleucine was very long at 2.87 Å. All silver atoms 
displayed Ag-Ag interactions ranging from 2.89 Å to 3.01 Å, but these interactions did not 
appear to influence the atoms geometry. 
 Solution-phase interactions between the Atox1 and silver ions have also been 
investigated by X-ray absorption spectroscopy (XAS).6 Analysis of the extended X-ray 
absorption fine structure corroborated, in part, the interactions observed in the crystal 
structure described above. Silver was found to be bound by two cysteine sulfurs with bond 
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lengths of 2.40 Å and no other interactions were present (in solution) according to the 
study. 
 
 The fate of silver in rats fed on Ag-supplemented diets for 30 days was identified to 
be the liver where it was incorporated into ceruloplasmin.85 Ag(I) disrupted the tertiary 
structure of the metalloprotein and the ceruloplasmin oxidase activity in serum fell to zero. 
In addition to this, the female rats were found to be infertile. In subsequent studies it was 
found that a prolonged period of silver supplementation in rats (6 months) resulted in 
partial restoration in Cp oxidase activity (50% relative to control group), healthy offspring 
were produced, however, copper and iron homeostatic and transport genes were 
downregulated.85 
 
1.5.3 Medical uses 
 In addition to topical ointments like silver sulfadiazine or dilute solutions of silver 
nitrate, a range of silver-containing medical devices exist; including wound dressings, 
catheters, and prostheses.92 One of the greatest differences between silver-containing 
devices is the mode of incorporation of the antibacterial metal. These processes can 
include coating with metallic silver; incorporation of AgNPs; coating with silver-
composite materials like nanocomposites, zeolites, and polymers; or surface 
modifications.37 
 Coatings of silver metal on implants and megaprostheses have demonstrated good 
in vitro antibacterial activity but poor in vivo activity.115-117 It was postulated that the 
oxidative dissolution of silver ions from the metallic surface was inefficient. Additionally, 
silver ions that are released can be quickly sequestered by biomolecules and the recipients 
of the implants had high levels of blood plasma silver.115 Conflicting evidence from 
different case studies revealed that the concentration of silver ions at the wound site of a 
silver-coated titanium megaprosthesis could reach up to 1.5 ppm, however, despite such 
high levels of silver ions, integration of the implant by the host did not appear to be 
impeded.118 The variable, uncontrolled release of silver ions has led to such implants to be 
deemed unsafe for use.3 
 Relative to bulk metallic silver, silver nanoparticles have high surface area and 
undergo oxidative dissolution to release Ag+ at a faster rate.119 Particle size effects have 
been observed for AgNPs with smaller particles (<100 nm) appearing to be more effective 
antibacterial agents. For example, 500 nm AgNPs embedded in a silicon catheter had 
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negligible activity, only stunting bacterial growth and failing to stave off infection120 
whereas smaller nanoparticles have been demonstrated to be potent bactericides.121 
 Nanocomposite materials such as TiO2-AgNPs coated on a titanium implant have 
been shown to have homogenous distribution on the surface, controlled release of silver 
ions, but did not discernibly inhibit cell ingrowth onto the implant.122-123 Coatings, 
including silver NP/tantalum nitride (TaN-Ag) composites, and silver-doped silica 
monoliths,124-125 have shown both favourable biocompatibility as well as prolonged release 
(up to 28 days, in some cases).124 
 Embedding materials in a polymer matrix or other porous material have been 
shown to display superior control of silver release while not requiring physical 
modification of the implant, and providing additional protection for the silver payload.3 
Silver ions can be diffused into porous polymer matrices by immersion in a silver solution; 
in situ reduction of Ag+ can be achieved by addition of a reductant.126-127 Hydrogels and a 
range of polymers, including polyethylene terephthalate and polyacrylamide, have been 
utilised for such purposes.128 Chitosan embedded AgNPs have been demonstrated to 
release silver for up to 90 days.129 Embedding AgNPs in polymer provides multiple 
benefits, such as preventing pacification either by biomolecules/insoluble salts or 
phagocytosis.130 The rate of diffusion of such loaded materials has been demonstrated to be 
dependent on the rate of diffusion of water into the material. Because of this it is important 
that such composites are tested in biologically relevant media. Additionally, the rate of 
diffusion of the silver has also been shown to be influenced by the crystallinity of the 
polymer matrix, and nanoparticle morphology.131 
 Silver-doped phosphate glasses are another class of material and are dependent on 
the degradation of the material to release silver into solution.132-133 In a similar vein, silver-
containing coordination polymers have been demonstrated to have antibacterial activity 
upon degradation of the framework which liberated Ag+.134 Loading of bioactive 
substances into porous frameworks (like zeolites and metal-organic frameworks) has also 
been investigated as a means of releasing the species slowly over time.135-137 
  It has been demonstrated that the release of silver from zeolites can be sustained 
for up to 20 days, and that, in general, the surface charge and pore sizes of the inorganic 
structure have appreciable impact on the antimicrobial activity of the material. However, 
zeolites are limited by a lack of scope to alter and modify the overall structure to tailor the 
material to a specific purpose.135 Conversely, porous species like metal-organic 
frameworks allow choice of metal node and organic linker which can be modified pre or 
post material synthesis. It has been shown that changing the ratio of different organic 
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linkers included in the MOF synthesis stage can allow ‘programming’ of payload release, 
changing release kinetics from the structure.138-139  
 
1.6 Research aims 
 Herein we describe research towards a more indepth understanding of silver 
chemistry in biological systems and antibacterial materials. In Chapter 2 the chemical fate 
of sublethal concentrations of silver ions in broth (exogenous) and in E. coli and S. aureus 
(endogenous) was investigated. Both endo/exogenously, the chemistry of silver ions, 
determined by XAS, was dominated by interaction with cysteine residues, and the binding 
of ions by protein species confirmed by SEC-ICP-MS. Correlation between the silver and 
copper SEC-ICP-MS traces possibly highlighted that sublethal Ag+ is treated similarly to 
nutrient copper in the bacterial cells.  
 Significant focus is given to the interaction between silver and bacteria, and the 
metal dismissed as non-toxic to mammals or humans. However, case studies and examples 
of silver cytotoxicity can be found in literature.81, 86, 92, 101-102, 140 Upon exposure, transport 
of silver ions around the body by the vascular system is likely, thus Chapter 3 focuses on 
the way in which silver ions interact with human whole blood. Silver was found to localise 
in/on red blood cells where they were predominantly coordinated by cysteine residues on 
haemoglobin and other protein species. 
 Finally, increasing concern over antibiotic resistance has led to silver being 
incorporated in a range of medical and commercial items. For the metal to be successful in 
prevention or eradication of bacterial infections, the concentration of silver ions released 
from the item needs to be at a level toxic to the bacteria over a prolonged period of time to 
prevent non-culturable stasis or reinfection. Chapter 4 investigates the inclusion of ionic 
and nanoparticulate silver into metal-organic frameworks. Tailoring the pore environments 
of the frameworks allowed control over the relative uptake of silver in each material which 




1.7.1 X-ray absorption spectroscopy 
 X-ray absorption spectroscopy (XAS) is an element specific technique that enables 
analysis of the interactions between metals/metalloids and coordinating atoms. An XAS 
spectrum is obtained through irradiation of a sample with X-rays of increasing energies. 
Once an appropriate energy is reached core electrons of the element of interest are excited 
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to a higher bound state which result in the region of an XAS spectrum known as the X-ray 
absorption near-edge structure (Figure 6). This region is sensitive to oxidation state, and 
coordination geometry of the target atom.141 Comparison of the experimental XANES 
through principal component analysis (PCA), target analysis, and linear combination 
fitting (LCF) to model XANES spectra allows empirical determination of chemical species 
present in the sample. 
 At higher energies, the excited electrons can be ejected from the atom as 
photoelectrons which give rise to the latter part of an XAS spectrum known as the 
extended X-ray absorption fine structure (Figure 6). The ejected electrons can interact 
with neighbouring atoms to produce oscillations characteristic of the coordination 




Figure 6: Ag K-edge XAS spectrum of metallic silver displaying the X-ray absorption near-edge structure 
(XANES, blue), and extended X-ray absorption fine structure (EXAFS) portions of the spectrum. 
 
 Identification of the speciation of silver in biological environments through use of 
XANES and EXAFS have been mentioned already (see above). Some of these include Ag 
L3-edge XANES analysis of silver speciation in three strains of bacteria S. aureus, E. coli, 
and L. monocytogenes which found that silver-nitrogen interactions from amino acids like 
histidine predominantly bound Ag+.142 Interactions between silver ions and 
homeostatic/transport proteins like Atox1 and rabbit/yeast metallothioneins by XAS have 
provided validation for the speciation of the metal ion with these biomolecules in solution.6 
The chemical fate of silver has also been investigated in the livers of marine mammals like 
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dolphins and whales which found that the metal was likely sequestered as both Ag2Se and 
Ag2S chemical species.143 
 
1.7.2 SEC-ICP-MS 
 Size exclusion chromatography (SEC) involves the separation of mixtures based on 
the ‘size,’ or more accurately, the hydrodynamic radius of constituents.144 The technique is 
commonly used for the separation of proteins in complex biological mixtures, either 
coupled with anionic or cationic exchange chromatography or manipulation of the pH for 
an additional dimension of separation.145 SEC columns can be manually packed or pre-
packed for purchase, but the premise of the technique is the same. The resin has well-
defined pores which are too small for large (bio)molecules to diffuse in, causing them to 
elute first while smaller species can diffuse into the resin and elute later. From large to 
small hydrodynamic radii, the molecules interact progressively more strongly with the 
column, allowing the separation of complex mixtures. Calibration of the column with 
protein standards of known molecular weights can enable calculation of the size of the 
entities eluting at each timepoint in the chromatogram.146 
 Inductively coupled plasma mass spectrometry is a technique traditionally used to 
simultaneously measure the total concentrations of metal(loid)s but provides almost no 
information on the speciation of the metals measured. Single cell ICP-MS has been shown 
to be able to identify the relative uptake of metals of interest by individual cells as opposed 
to bulk concentrations,147 and laser-ablation ICP-MS or NanoSIMS techniques can be used 
to obtain spatially resolved maps of metal localisation in cells,148-149 however, the 
techniques are only suitable for larger eukaryotic cells, at present time. ICP-MS in general 
is considered a highly sensitive technique, with low-interference analytes (like silver) 
capable of being detected at levels as low as parts per trillion. The amount of analyte 
present in a sample can be quantitatively determined by comparison against a calibration 
curve of known analyte concentrations. 
 However, when SEC is hyphenated with ICP-MS, time-resolved metal traces can 
be obtained which provide insight into the speciation of the analyte of interest based on 
size of the eluting species as well as detection of other metals or protein that eluted at a 
specific time point. 
 Size exclusion chromatography coupled with inductively coupled plasma mass 
spectrometry (SEC-ICP-MS) is not a new technique but has been underutilised, likely due 
to associated infrastructure requirements, namely an ICP-MS-adjacent high-performance 
liquid chromatography (HPLC) or peristatic pump. To the best of the authors knowledge, 
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the first paper detailing the use of SEC-ICP-MS was by Crews, et al. in 1988 in the Journal 
of Research of the National Bureau of Standard where it was used in an attempt to identify 
the speciation of trace elements in artificially digested food.150 Since the publication by 
Crews, et al. only ~40 papers have been published using the technique. Analyses include 
speciation of Br, Cu, Fe, Zn, Ru, Os, Nd, and Pt in blood plasma;151-159 Cu, Cd, I, Mn, Co, 
Se, S, and Zn in food stuffs like rice, sunflower/chia seeds, goji/açai berries, human breast 
milk, infant formula, and garlic.160-168  
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Chapter Two: Speciation of silver in S. aureus, E. coli and media 
2.1 Abbreviations 
AEX    anion exchange chromatography 
AS   Australian Synchrotron 
CSD    Cambridge Structural Database 
Cys   cysteine 
Da   Daltons 
EXAFS   extended X-ray absorption fine structure 
FT   Fourier Transform 
GSH   glutathione 
HEPES   4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HMW    high molecular weight 
HPLC    high-performance liquid chromatography 
ICP-MS   inductively coupled plasma mass spectrometry 
IU   international units 
LB    Luria Bertani 
LCF    linear combination fitting 
LMW    low molecular weight 
MIC    minimum inhibitory concentration 
NP   nanoparticles 
OD600    optical density at 600 nm 
PCA    principal component analysis 
PDB    Protein Data Bank 
ROS    reactive oxygen species 
SDS-PAGE   sodium dodecylsulfate polyacrylamide gel electrophoresis 
SEC    size exclusion chromatography 
SEM    scanning electron microscopy 
SOD   superoxide dismutase 
TEM    transmission electron microscopy 
tr    retention time 
v0    void volume 
XANES   X-ray absorption near-edge structure 
XAS    X-ray absorption spectroscopy 
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2.2 Introduction  
 The antibacterial properties of silver have been known for centuries but the 
discovery of molecular antibiotics in the early 20th century saw a decline in its use.1 Today 
silver is still used as a treatment for wounds, ulcers, and other maladies.2 However, while 
antibiotics are effective bactericidal agents, their singular modes of action enable cellular 
resistances to develop.3 Conversely, the antibacterial activity of silver has been shown to 
be multifaceted and its modes of action can be broadly grouped as such: interaction 
between Ag and the cell wall/membrane; DNA; proteins/enzymes; and generation of 
reactive oxygen species (ROS).4 Having multiple modes of action is beneficial as, if 
resistance against a single pathway was to develop, the metal can still elicit its antibacterial 
activity in other ways; however, some silver-resistant strains of bacteria have been 
identified.5-6 The down-stream impacts of silver exposure on bacteria are well documented 
(e.g. detection of ROS,7-9 cell lysis,10-11 up/down regulation of genes12-14) but little is 
known about specific intracellular molecular targets and mechanisms of the metal.15-17 
 A sizeable disparity exists between the toxic level of silver for microorganisms 
(µM levels for AgNO3), and for humans (acute toxicity estimated to require 1.4 to 40 x 104 
µg Ag/kg).4 Such a broad ‘therapeutic window’ coupled with an increase in antibiotic 
resistant bacteria has led to renewed interest in silver as an antibacterial agent. Today silver 
is included in a range of medical and commercial products to imbue them with 
antibacterial qualities.18 
 Chronic exposure of silver to humans and mammals causes a condition called 
argyria. The most apparent symptom of argyria is the deposition of silver under the skin 
giving the person a blueish appearance that can be permanent.19 Medical professionals 
suggest that the change in skin colour is purely aesthetic and poses no threat to human 
health.20 However, people afflicted with argyria can have reduced beneficial gut flora and a 
weakened immune response potentially leading to contraction of secondary infections, like 
pneumonia.21 Few cases of argyria have been reported and highlight the need to better 
understand the mode(s) of action of silver as an antibacterial agent to develop more 
targeted silver-treatments. To do so, understanding of the molecular mechanisms by which 
the metal acts as an antibacterial agent is crucial. 
 
 Bacteria can be broadly categorised as Gram-negative or Gram-positive.22 Gram-
negative bacteria, like Escherichia coli (E. coli), have inner and outer cell membranes, 
with the ‘periplasmic space’ sandwiched between. Gram-positive bacteria, like 
Staphylococcus aureus (S. aureus), have a single cell membrane which is enveloped by a 
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thick peptidoglycan cell wall and the space between the membrane and the cell wall is 
referred to as the ‘extracytoplasmic space’.22 
 Silver biochemistry has been closely linked to that of copper in biological systems. 
To date, no known biological process in any organism requires silver, however, both the 
Cu+ and Cu2+ ions are essential micronutrients for most organisms.23 The cuprous and 
cupric ions are likely utilised due to the readily accessible oxidation states and redox 
potential. Both Ag+ and Cu+ are ‘spectroscopically silent’ due to their d10 electronic 
structures and lack of distinctive interactions with light.24 The difficulty of studying these 
silent metals is likely, in part, why there are still significant gaps in knowledge about 
endogenous copper metabolic and homeostatic pathways in bacteria.25 Despite being an 
essential micronutrient, copper can also be toxic to bacterial cells through generation of 
ROS, peroxidation of cell membranes, mismetallation of proteins, and induction of protein 
misfolding and as such the metal is strictly regulated intracellularly.25 Unless bound as a 
cofactor, nutrient copper is thought to be relegated to the periplasmic/extracytoplasmic 
space of bacteria.25 In cases of copper stress both E. coli and S. aureus can express CopZ 
which chaperones cytoplasmic Cu to the inner membrane-bound efflux protein, CopA, 
which ejects the ions into the periplasm/extracytoplasmic space;26 this is largely the extent 
of understanding of copper homeostasis in S. aureus. However, for E. coli, once in the 
periplasm, multicopper oxidases (MCOs) like CueO, oxidise Cu+ to Cu2+, which is 
considered less toxic to the organism.27 If the concentration of copper ions in the periplasm 
increases too much, soluble chaperones, like CusF, bind and transport cuprous ions to 
membrane-bound cation/proton antiporters, like CusCBA, which efflux Cu+ into the 
extracellular space.28 Beyond these efflux and homeostatic proteins, little is known about 
the cellular metabolism of copper in bacteria, for example, how copper-dependent enzymes 
are metallated or the identity of low molecular weight copper-buffering molecules.25 
Cuproenzymes expressed by some strains of bacteria include nitrous oxide reductases, 
nitric reductases, [Cu, Zn]-superoxide dismutases (SOD), and haem-respiratory oxidases.29 
The latter contain cytochrome c, and quinol oxidases which are terminal enzymes in the 
respiratory chain of the organism.30  
 Copper stress in S. aureus has been shown to inhibit the cytoplasmic protein 
glyceraldehyde-3-phosphate dehydrogenase (GapA), a key enzyme in the glycolytic 
cycle.31 GapA is not a metalloprotein, but binding of Cu+ via a cysteine residue in the 
active site of the enzyme during Cu stress is thought to be a source of inhibition.31 Also 
inhibited by copper is dihydrolipoyl dehydrogenase (LpdA), a disulfide reductase, which 
catalyses electron transfer from a substrate (NADH) through intramolecular redox active 
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cysteine residues to a flavin cofactor for continuation along an electron transport chain.32-33 
Both GapA and LpdA were recently identified by Wang et al. to be silver-binding 
molecular targets in E. coli cells treated with the minimum inhibitory concentration of 
silver nitrate.34 Inhibition studies revealed that GapA retained ~50% activity when treated 
with silver in vitro.  
 
2.2.1 Research aims 
 The aim of the study presented herein is to understand the biochemical fate of 
silver ions in two clinically relevant model microorganisms (E. coli and S. aureus) exposed 
to sublethal concentrations of the metal. Identification of individual, intracellular silver-
binding targets at sublethal concentrations could improve our understanding of the toxic 
molecular mechanisms of action of the metal at higher concentrations. In addition to 
intracellular speciation, the speciation of silver ions in bacterial media was also 
investigated. To ensure only biologically relevant silver interactions were recorded, 
metallomics techniques were used, namely, X-ray absorption spectroscopy (XAS), and size 
exclusion chromatography coupled with ICP-MS (SEC-ICP-MS).  
 
2.2.2 X-ray absorption spectroscopy 
 X-ray absorption spectroscopy (XAS) is an element-specific technique used for 
speciation studies of elements larger than silicon. The technique requires little sample 
preparation meaning that the risk of analyte chemistry perturbation is reduced. A spectrum 
is obtained by irradiation of a sample over a range of energies with high intensity X-rays. 
An XAS spectrum consists of the X-ray absorption near edge structure (XANES) and the 
extended X-ray absorption fine structure (EXAFS). The XANES are sensitive to oxidation 
state and local coordination environment of the element of interest, while the EXAFS 
provide information about bond lengths, coordinating atoms and coordination number.  
 XANES analysis involves comparison of unknown experimental data against 
reference ‘model’ spectra. These comparisons allow the indentification of possible 
components of the unknown system, however, to do so requires foresight into possible 
chemistry present in the experimental sample, collection of relevant model spectra or 
access to a library of relevant data. 
 For example, analysis of the Cu K-edge XANES recently found that the oxidation 
state of copper associated with various strains of bacteria was Cu(I), regardless of the 
species of copper to which the organism was exposed.35 This is despite the fact that, under 
aerobic, atmospheric conditions, Cu(II) ion would be expected to predominate.36 37 
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 Recently, a group identified differences in the speciation of zinc at various stages 
of bacterial growth in B. subtilis and P. putida through use of high resolution XANES.38 
Traditionally, XAS techniques struggle to differentiate between coordinating atoms of 
similar atomic number (e.g. nitrogen vs. oxygen). However, the high resolution XANES 
were capable of differentiating between carboxyl and phosphoryl binding as well as 
identification of imidazole and cysteine interactions. 
 
2.2.3 Size exclusion chromatography hyphenated with ICP-MS 
 Solution ICP-MS by itself is a technique commonly used to simultaneously detect 
the concentrations of metals (as well as metalloids and sometimes non-metals) in a 
digested aqueous sample. However, when coupled with size exclusion chromatography, 
time-resolved ICP-MS allows simultaneous online detection of metal-binding species 
separated by SEC. A ‘metal trace’ is produced which can be overlaid with the size 
exclusion chromatogram to provide information about the metal-binding species in the 
sample.  
 The proteomes of most organisms are often vast lists of 1000’s of proteins, which 
can be difficult to deconvolute or analyse. Comparatively, a subset of the proteome 
(namely the metalloproteome) can be relatively smaller yet provide an appreciable amount 
of information about the fates of inorganic species in biological systems. Comparison of 
the trace of an analyte of interest against other ‘native’ metal traces can provide insight 
into the biochemical fate of the metal species of interest.39-40 SEC-ICP-MS has previously 
been used for analysis of a wide range of biological samples including analysis of a wide 
range of elements in blood plasma as well as food stuffs like rice, sunflower seeds, chia 
seeds, goji and açai berries, human breast milk, infant formula, and garlic.41-47 
 Analysis of bacterial metalloproteomes by SEC-ICP-MS is a relatively recent 
application; only a solitary published piece of work could be found.48 Within the study the 
authors exposed E. coli to a range of different sized silver nanoparticles (as well as silver 
ions) at 10, 50, and 90% of the inhibitory concentration for the organism. Treatment of the 
cells to isolate extracytoplasmic/cell wall, and cytoplasmic extracts enabled the group to 
identify that the localisation of the silver in the cell was predominantly in the extracellular 
medium (24 – 60% of total silver) or the cell wall/membrane (25 – 64% of total silver) 




2.3 Methods and procedures 
Materials 
 Protease inhibitory cocktail (Roche, cOmplete, EDTA-free); Lysostaphin (CAS 
9011-93-2; lyophilised powder from Staphylococcus staphylolyticus; protein 50-70% by 
biuret; >500 units/mg protein); silver nitrate (CAS 7761-88-8; >99%); 4-(2-hydroxyethyl)-
1-piperazinethanesulfonic acid (HEPES; CAS 7365-45-9; >99.5%); human haemoglobin 
(CAS 9008-02-0, lyophilized powder); bovine serum albumin (CAS 9048-46-8; ³98.0%); 
L-cysteine (CAS 52-90-4; 97%); L-methionine (CAS 63-68-3; ³98%); thiamine 
mononitrate (CAS 532-43-4; ³98%); L-histidine (CAS 71-00-1; ³99%); glycine (CAS 56-
40-6; ³99%); biotin (CAS 58-89-5; ³99%) were purchased from Sigma Aldrich. 
Thyroglobulin; ferritin; aldolase; conalbumin; carbonic anhydrase; ribonuclease; aprotinin; 
and ovalbumin were purchased from GE Healthcare, Life Sciences. Ultra-pure MilliQ 
water (Merck Millipore purification system) with resistivity of 18 MΩ.cm-1 was used. All 





 HEPES (100 mM) was prepared by dissolving the relevant solid in the appropriate 
volume of ultra-pure water. The pH was adjusted to 7.4 by the addition of NaOH (6M) 
(Orion Star pH Meter, Thermo Scientific). For size exclusion experiments, the mobile 
phase was passed through a 0.45 µm nylon-membrane filter before use. 
 
SEC-ICP-MS 
 The SEC-ICP-MS consisted of a high-performance liquid chromatography (HPLC) 
pump (Agilent 1200 Infinity Series, Santa Clara, CA, USA) and an inductively coupled 
plasma mass spectrometer (Agilent QQQ 8900, Santa Clara, CA, USA). A prepacked 
Agilent AdvanceBio SEC 130Å size exclusion column (7.8 x 300 mm I.D., particle size: 
2.7 µm, fractionation range: 120 – 0.1 kDa, Agilent) was used with a 100 mM HEPES 
mobile phase at a flow rate of 0.3 mL/min (column temperature: ~20°C). The void volume 
(vo) was determined experimentally by injection of bacterial cell lysate (tr = 5.79 min) 
detected by a variable wavelength detector (1200 series, VWD, Agilent) measuring 
absorbance of the effluent liquid at 280 nm. The inclusion volume (vi) was determined by 
the injection of uracil (tr = 13.74 min) detected as above. Standards used to construct a 
calibration curve included ovalbumin (4 mg/mL), carbonic anhydrase (3 mg/mL), 
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ribonuclease A (3 mg/mL), aprotinin (3 mg/mL) (GE Healthcare), and uracil (3 mg/mL) 
(Sigma). 
 
 A prepacked Agilent AdvanceBio SEC 300Å size exclusion column (300 x 7.8 mm 
I.D., particle size: 2.7 µm, fractionation range 1200 – 5 kDa) was used with a 100 mM 
HEPES mobile phase at a flow rate of 0.3 mL/min (column temperature: ~20°C). The void 
volume (vo) and inclusion volume (vi) were determined by detection of the thyroglobulin 
dimer (tr = 6.75 min), and aprotinin (tr = 15.13 min), respectively; detected by a variable 
wavelength detector (1200 series, VWD, Agilent) measuring absorbance of the column 
effluent at 280 nm. Protein standards used to construct a calibration curve were 
thyroglobulin (5 mg/mL), ferritin (0.3 mg/mL), conalbumin (3 mg/mL), ribonuclease A (3 
mg/mL), and aprotinin (3 mg/mL) (GE Healthcare). See Appendix 2.9.1 for operational 
parameters. 
 
X-ray absorption spectroscopy 
 Data collection. Silver K-edge X-ray absorption spectra were recorded on the X-
ray absorption spectroscopy (XAS) beamline at the Australian Synchrotron (AS), Victoria, 
Australia. The energy of the electron beam was 3.0 GeV with a current of ~200 mA, and 
an X-ray beam was sourced from a wiggler, monochromated by the Si(111) 
monochromator, and harmonic rejection achieved using a rhodium-coated mirror. Samples 
were positioned at ~45° to a 100-element germanium fluorescence detector which was 
placed at 90° to the incident beam. The energy ranges used for EXAFS spectra collection 
were: pre-edge region 25.3140 – 25.4941 keV (0.003 eV steps); XANES region 25.4941 – 
25.5641 keV (0.0003 eV steps); and EXAFS region 25.5641 – 25.700 keV. During data 
collection the samples were maintained at a temperature of ~ 10 K using a Cryo Industries 
(Manchester, NH, USA) cryostat. The spectrum of a silver foil, recorded in transmission 
mode downstream from the sample, was used as an internal standard to calibrate the 
energy scale for the first peak of the first derivative of the elemental silver edge (25.5156 
keV). 1 to 4 scans per sample were collected for EXAFS spectra. 
 Data analysis. Calibration, averaging, background subtraction of all spectra and 
principle component, target, and multiple linear regression analyses of XANES spectra 
were performed using the EXAFSPAK software package (G. N. George, SSRL). Single 
and multiple-scattering fits of EXAFS data were carried out using EXAFSPAK and the 
FEFF8 code.49 The model compounds for target analysis and XANES linear combination 
fitting were prepared, and spectra recorded at the AS, Victoria, Australia. 
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 Model spectra. Glassed solutions of silver nitrate with relevant amino acids, B 
vitamins, and proteins in 100 mM HEPES buffer were used to obtain model spectra for 
XANES fitting of biological samples and EXAFS analysis. The amino acid and vitamin 
samples had a molar ratio of 5:1 with a 2 mM final concentration of silver. Protein models 
had a molar ratio of 2:1 ligand to metal with a final silver concentration of 2 mM.  
 
2. Bacteria 
2.1 Cell culture 
 A single colony of Escherichia coli (E. coli) MG1655 or Staphylococcus aureus (S. 
aureus) Newman were inoculated into Luria-Bertani (LB) broth (20 mL) and incubated 
overnight (37°C, 200 rpm). 
 
2.2 Minimum inhibitory concentration (MIC) studies 
 Inoculum prepared as per 2.1 was added to fresh samples of LB broth to a starting 
optical density (OD600) of 0.04 and used as the inoculum. LB broth with silver nitrate acted 
as the positive control and broth alone acted as the negative control. Columns 1 and 12 A-
H, and row H 1-12 of the plate were unused. Into column 2 was added LB broth (100 µL), 
and silver nitrate (E. coli: 50 µL, 512 µg/mL; S. aureus: 50 µL, 128 µg/mL) in MilliQ 
water. Two-fold microdilutions were carried out to reach a minimum concentration of 0.5 
µg/mL (E. coli), and 0.125 µg/mL (S. aureus) in column 11. Column 12 was left as 
untreated with AgNO3. Columns 2-12, rows C-G were inoculated to a final OD600 of 0.01 
through addition of the above bacterial culture (50 µL). Optical densities were recorded 
every 15 min during incubation with constant shaking (BMG FLUOStar 
spectrophotometer, 37°C, 600 rpm); the MIC was read after 22 h (Appendix 2.9.2) 
 
2.3 X-ray absorption spectroscopy 
 Cell pellets and depleted broth. Fresh samples of LB broth (19 mL) were spiked 
with a stock solution of AgNO3 (1 mL, 10 mg/mL) in MilliQ water. Inoculum prepared as 
per 2.1 was added to the spiked broth to a starting optical density of 0.05 and incubated 
overnight (37°C, 200 rpm). The cultures were centrifuged (3750 g, 15 min, 8°C), 
supernatant broth removed, and the cell pellet resuspended in HEPES buffer (100 mM, 10 
mL, pH 7.4). The suspension was centrifuged (as above) and the supernatant buffer 
removed. Both the supernatant broth and the cell pellet were freeze dried (1.0 mbar, -80°C) 
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and the resultant solids loaded into Lucite holders secured with Kapton tape and stored at -
180°C until analysis. 
 Doped broth. Silver nitrate (10 or 100 mg/mL) in MilliQ water was added to LB 
broth (20 mL, final; 0.5 or 1 µg/mL, respectively). The doped broth was incubated 
overnight (37°C, 200 rpm) and freeze dried (1.0 mbar, -80°C). The resultant solid was 




 E. coli was cultured as per XAS samples (2.3), however, the cell pellet was 
suspended in HEPES (100 mM, pH 7.4, 10 mL) and the cells lysed (Cell Disruptor, 
Constant Systems Ltd., 0.4 bar, 6°C, 10 times). The resultant mixture was centrifuged 
(14,000 rpm, 15 min, 8°C) and a protease cocktail inhibitor (26 mg/mL, 600 µL) added, 
the lysate aliquoted (200 µL) and stored at -80°C. 
 S. aureus was cultured as per XAS samples (2.3), however, the cell pellet was 
suspended in HEPES (100 mM, pH 7.4, 1 mL), lysostaphin (10 units/µL, 25 µL) added, 
and the mixture incubated (37°C, 200 rpm, 1 h). The sample was centrifuged (14,000 rpm, 
15 min, 4°C), the supernatant liquid removed, a protease cocktail inhibitor (10 µg/mL) 




X-ray absorption spectroscopy 
Model XANES spectra – Interactions between Ag+ and discrete biomolecules 
 Silver K-edge XANES spectra of biologically relevant molecules and silver nitrate 
buffered at pH 7.4 displayed a range of different peak shapes dependent on the local Ag 
environment (Figure 1). The structures of some of the (bio)molecules are displayed in 
Figure 2. These data, in addition to others collected elsewhere by our research group,50 
allowed the expansion of a library of model silver K-edge XAS spectra. Comparison of 




Figure 1: Ag K-edge XANES spectra of model compounds containing silver nitrate with (a) buffer alone; 
(b) glycine, pH 7; (c) glycine, pH 8; (d) glycine, pH 10; (e) glycine, Tris, pH 7; (f) histidine; (g) thiamine; 
(h) biotin; (i) methionine; (j) cysteine; (k) bovine serum albumin (2:1 ligand to metal); (l) haemoglobin (2:1 
ligand to metal). Unless otherwise stated, all samples contained 2 mM AgNO3 and 10 mM ligand and were 




Figure 2: Structures of biologically relevant molecules used in XANES and EXAFS model spectra presented 
in Figures 1 and 6. (A) L-cysteine; (B) L-methionine; (C) L-histidine; (D) HEPES; (E) thiamine; (F) biotin. 
 
 Figure 3 shows a comparison of spectra collected from silver nitrate dissolved in 
excess buffered glycine across a range of pH values. Significant variation included that, 
with increasing pH, a shoulder near the top of the rising edge appeared (likely due to 
increasing deprotonation of glycine-NH3+ allowing nitrogen to coordinate silver). 
Additionally, an increase in the energy of a broad peak from 25,570 eV at pH 8 to more 
than 25,580 at pH 10. 
 
 
Figure 3: Superimposed Ag K-edge XANES spectra of buffered glycine/silver nitrate solutions with molar 
ratios of 5:1 glycine to silver at (b) pH 7, (c) pH 8, (d) pH 10. 
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 A shoulder feature on the rising edge similar to that observed for the glycine 
models was present in spectra of silver in solution with glycine in Tris buffer at pH 7 
(Figure 1e), and histidine in HEPES buffer at pH 7.4 (Figure 1f). Similar variation 
between the spectra of the two glycine samples at pH 7 (one buffered by HEPES, and the 
other Tris) may have been due to the presence of the primary amine of Tris coordinating 
silver, as has been seen for other heavy metals.39 Based on pKa and physiological pH, the 
percentage of deprotonated nitrogen functional groups available for coordination in both 
histidine and Tris would be: histidine imidazole (100%), histidine amine (~2%), and Tris 
(~10%). 
 Spectra of samples with sulfur-containing molecules (Figure 1g to j) did not 
display a shoulder feature. Thiamine (Figure 1g), biotin (h), and methionine (i) all possess 
thioether-like functionality that would be expected to have a strong affinity for silver. 
However, no common post-edge feature was identified for them and they each resulted in 
unique XANES spectra. The silver-cysteine spectrum (Figure 1i) displayed similar 
features to that of methionine (j), such as an initial peak atop the rising edge and a broad, 
low frequency oscillation at 25,580 eV.  
 For studies concerning silver speciation in human blood (Chapter 3) spectra of 
human haemoglobin (Hb) (Figure 1k), and bovine serum albumin (BSA) (l) in two-fold 
excess with buffered silver nitrate were recorded. The post-edge oscillations of the silver-
protein spectra were much broader and lacked strong features relative to most of the silver-
small molecule model spectra. 
 
XANES of bacterial cell pellets and broth 
 The minimum inhibitory concentration (MIC) of AgNO3 against E. coli and S. 
aureus was experimentally determined to be 1 and 2 µg/mL, respectively (Appendix 
2.9.2). Thus, samples of Luria Bertani (LB) broth were spiked to final concentrations of 
0.5 and 1 µg/mL AgNO3, inoculated with E. coli and S. aureus, respectively, and 
incubated. This allowed the organisms to grow in the presence of sublethal AgNO3 and 
when pelleted, the sample was designated as ‘growth’ cell pellets (Figure 4a and c). 
Bacterial cultures that had been allowed to grow to maturity before exposure to sublethal 
concentrations of AgNO3, incubated for a further ~16 h, and then pelletised were 
designated ‘shock’ cell pellets (Figure 4b and d).  
 
 The bacterial cell pellet spectra (Figure 4a to d) appeared visually similar bar small 
shifts in energy of the second post-edge peak annotated with a red line. However, E. coli 
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‘growth’ (Figure 4c), in addition to a higher signal-to-noise ratio, lacked a clear peak atop 
the rising edge as well as a subsequent trough. 
 
 
Figure 4: Ag K-edge XANES spectra of (a) S. aureus growth; (b) S. aureus shock; (c) E. coli growth; (d) E. 
coli shock; (e) broth 10 µg/mL; (f) broth 0.5 µg/mL; and (g) 1:1 broth/HEPES buffer. 
 
 In Figure 4, spectra (e) and (f) represent freeze-dried LB broth spiked with 10 
µg/mL, and 0.5 µg/mL AgNO3, respectively. Despite a 20-fold difference in [AgNO3] 
between the broth samples, the XANES spectra appeared similar. A freeze-dried sample of 
50:50 LB broth (10 µg/mL AgNO3) and 100 mM HEPES buffer solution – Figure 4g – 
displayed significantly different post-edge features to those of neat broth spiked with silver 
(e and f). The peak atop the rising edge increased in intensity and energy in broth:buffer 
sample, and the trough at ~25,555 eV was ~10 eV lower in energy than that of 10 µg/mL 
AgNO3 broth (Figure 4e). This would suggest a perturbation in silver speciation due to the 
presence of the buffer.  
  
 Principal component analysis (PCA) of the bacteria/broth XANES dataset, shown 
in Figure 4, determined that three components were required for the data to be adequately 
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described. Target transformation of the bacterial and broth XANES spectra against the 
model spectra, shown in Figure 1, allowed visual identification of similar spectra as well 
as calculation of residuals. Visually the model spectra of silver with cysteine, and silver 
with thiamine shared similarities with those of the bacterial/broth dataset as well as the 
lowest calculated target transform residuals (not shown). No XANES spectrum in the 
model library could account for the peak atop the rising edge of the 50:50 broth:HEPES 
(Figure 4g), however, it was still included in the dataset. Linear combination fitting (LCF) 
allowed the ratio of each model component identified above to be calculated for the 
experimental cell pellet and broth spectra (Table 1 & Figure 5). 
 
 Table 1 shows the ratio of silver-cysteine and silver-thiamine model spectra fit to 
the experimental bacterial cell pellet and broth data. Proportions of the Ag-Cys model 
spectrum fit ranged from 75 to 90% while the remaining proportion was that of the silver-
thiamine model. The largest variation observed in the LCF values was between S. aureus 
growth (75% cysteine, 25% thiamine) and S. aureus ‘shock’ (87% cysteine, 12% thiamine) 
cell pellet spectra. The ratio of cysteine fit to the E. coli growth and E. coli ‘shock’ spectra, 
and also the 0.5 µg/mL and 10 µg/mL AgNO3 broth spectra did not significantly change 
between the respective treatments of relevant samples (i.e. growth vs. shock, and 0.5 vs. 
10). 
 
Table 1: Ratio of Ag species in E. coli and S. aureus cell pellets, and broth, as estimated by linear 
combination of model XANES spectra.a 
 Ratio of component fitted   
Sample Cysteine Thiamine Ntotb Residual 
S. aureus growth 0.75(3) 0.25(3) 1.00 0.056 
S. aureus shock 0.87(3) 0.12(3) 0.99 0.117 
E. coli growth 0.85(3) 0.14(3) 0.99 0.061 
E. coli shock 0.82(3) 0.18(2) 1.00 0.047 
10 µg/mL AgNO3 broth 0.87(2) 0.11(2) 0.98 0.112 
0.5 µg/mL AgNO3 broth 0.90(4) 0.08(4) 0.98 0.135 
aValues in parentheses are the estimated standard deviation derived from the diagonal elements of the 




Figure 5: Linear combination fit of Ag K-edge XANES of (A) S. aureus growth cell pellet; (B) S. aureus 
‘shock’ cell pellet; (C) E. coli growth cell pellet; (D) E. coli ‘shock’ cell pellet; (E) 10 µg/mL AgNO3 broth; 
(F) 0.5 µg/mL AgNO3 broth. The experimental spectra (black) was fit with a linear combination fit (green) 
comprised of silver-cysteine (blue) and silver-thiamine (orange) model XANES spectra as components with 
the residual (red) shown offset. Results of linear combination analysis are shown in Table 1. 
 
EXAFS of model spectra 
 Ag K-edge EXAFS spectra were also collected for a range of biologically relevant 
molecules in buffered solutions with silver nitrate (Figure 6). Silver, sulfur, nitrogen, 
oxygen or carbon back scatterers were fit to the spectra, depending on the functional 
groups present in the molecules in the sample. Sulfur back scatterers were the dominant 
interactions in the cysteine and methionine spectra (Figure 6A and B) with Ag-S 
interactions of 2.48 and 2.56 Å, respectively. The increased bond length for methionine 
was consistent with typical silver-thioether interactions, according to a survey of the CSD 
(Chapter 3, and Appendix 3.9.2). The cysteine spectrum displayed a secondary peak at 
larger R, which was fit by an Ag-Ag interaction with a distance of 2.96 Å; conversely, no 
such interaction was visible for the methionine spectrum. Instead an asymmetry of the 
main peak was thought to be due to an unresolved peak at lower R and was adequately fit 
by a silver-nitrogen interaction at 2.36 Å. With both nitrogen and sulfur interactions in the 
coordination sphere of the silver-methionine sample, it was possible that the amino acid 
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was chelating Ag+ (Figure 7). However, were chelation to occur, the methionine molecule 
would likely be held in a sufficiently rigid orientation to allow multiple backscattering to 
occur, but no such features were observed in the EXAFS FT. However, the absence of 
backscattering in the spectrum does not preclude the presence of such a chemical species. 
 
 
Figure 6: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
buffered solutions of Ag+ in excess (A) cysteine, (B) methionine, (C) histidine, (D) HEPES, (E) thiamine, 
(F) biotin showing experimental (black) and calculated (green) data with the residual (red) shown offset. Fit 





Figure 7: Possible modes of binding between methionine and silver(I) based on the calculated EXAFS fit 
parameters in Table 2. The expected mode of coordination of a four-coordinate silver complex would be 
tetrahedral, however, this was omitted from some structures for clarity. 
 
Table 2: Parameters fit to EXAFS spectra of biologically relevant molecules with silver shown in Figure 6.a 
Ligand Scatterer CN Distance (Å) DWF (Å2) -E0 Fit error 
Cysteine S 2 2.477(5) 0.0059(3) 20(1) 0.54 
 Ag 1 2.955(7) 0.0074(4)   
Methionine N/O 2 2.36(1) 0.007(1) 14(1) 0.48 
 S 2 2.560(6) 0.0053(3)   
Histidine N 2 2.158(2) 0.0012(2) 5(1) 0.67 
 N 1 2.729 0.0033   
 C 4 3.151 0.0044   
 C 4 3.567 0.0058   
 C 4 4.163 0.0045   
 Ag-C-N-Ag 6 3.298 0.0055   
 C 4 4.074 0.0089   
HEPES N/O 2 2.221(9) 0.0066(9) 20(2) 0.71 
 N/O 1 2.56(1) 0.004(2)   
 N/O 2 3.07(1) 0.0034(8)   
 N/O 2 4.01(2) 0.005(2)   
Thiamine N 4 2.266(6) 0.0045(4) 13(1) 0.78 
 C 2 3.20(1) 0.0012(9)   
Biotin S 2 2.486(4) 0.0043(2) 14(1) 0.63 
 Ag 1 3.922(6) 0.0047(4)   
ak-ranges used for fitting each spectrum were cysteine = 1-12 Å; methionine, histidine and biotin = 1-14 Å; 
HEPES = 1-11.5 Å; thiamine = 1-13 Å with a scale factor (S02) of 0.9. DE0 = E0 – 25515 eV where E0 is the 
threshold energy. Values in parentheses are the estimated standard deviation derived from the diagonal 




 A multiple scattering fit was calculated from a crystal structure of a digonal silver-
imidazole complex51 and refined against the silver-histidine EXAFS oscillations (Figure 
6C). The fit parameters for the histidine sample in Table 2 show two imidazole nitrogen-
silver interactions with distances of 2.16 Å. All other interactions listed were not 
representative of direct bonding interactions but due to the planar, rigid nature of the 
histidine imidazole ring; they were the result of the photoelectrons emitted from the silver 
absorbing atom interacting with the other atoms in the ring, known as multiple scattering.  
 
 The EXAFS spectrum of silver nitrate in HEPES buffer (Figure 6D) was expected 
to be a representation of the coordination sphere of aqueous silver cations at pH 7. Instead 
it was observed that, ~10 min after mixing the metal salt with the buffer solution, a 
crystalline, white solid was deposited from solution. Unit cell determination of a single 
crystal extracted from the sample provided cell axes and angles identical to a Ag-HEPES 
complex reported by Bilinovich, et al.; namely, a two-dimensional framework with silver 
ions bound by all functional groups in the buffer molecule.52 Relevant structural 
parameters from the crystal structure are reported in Table 3. In light of this, immediately 
after mixing the solution of silver nitrate with buffer, it was flash frozen and presented to 
the beamline before solid was visible. However, the EXAFS fit of the AgNO3 in HEPES 
sample still displayed Ag- nitrogen/oxygen interactions at distances similar to those 
observed for the silver-HEPES crystal structure collected (Table 3). The additional, longer 
Ag-N/O components at ~3 and 4 Å may have been caused by the beginnings of crystal 
growth in the solution, prior to freezing. 
 
Table 3: Selected interatomic distances and angles for the silver-HEPES crystal structure. 
Distance (Å) Angle (°) 
Ag(1)-N(1) 2.253 N(1)-Ag(1)-N(2) 168.49 
Ag(1)-N(2) 2.273 O(1)-Ag(1)-O(2) 87.44 
Ag(1)-O(1) (OH) 2.587   
Ag(1)-O(2) (SO3) 2.686   
 
 Thiamine and biotin are the only sulfur-containing B vitamins (Figure 2E and F) 
and the XAS spectra of their interaction with silver at biological pH were recorded due to 
high levels of B vitamins in LB broth and the likely affinity of sulfur for silver. The 
EXAFS of the silver-biotin model was fit with a sulfur component at ~2.49 Å (Figure 6F), 
however, fitting the silver-thiamine EXAFS with sulfur backscatterers resulted in 
physically unrealistic fit parameters (not shown). A survey of the CSD (Appendix 2.9.3) 
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revealed that metal ions (such as Cu(I), Hg(II), and Cd(II)) were almost exclusively 
coordinated by the pyrimidine nitrogens of thiamine. In all other metal ion/thiamine-
derivative structures, the metal either did not bond (forming an overall negatively charged 
halide complex through and acting as the counterion to the positive charge of the thiazole 
nitrogen) or interacted with the hydroxyl ‘tail’. Four nitrogen backscatterers at distances of 
2.27 Å provided an adequate fit for the EXAFS spectrum of thiamine (Figure 6E, Table 
2). Additional carbon and nitrogen interactions could be fit to longer R peaks in the 
spectrum – at distances in agreement with those measured from a silver-pyrimidine crystal 
structure53 (Figure 8) – however, the fit error was only marginally reduced in doing so 
(~1% per additional component). The silver-carbon interaction at 3.20 Å was included as 





Figure 8: Distances (through space, in angstroms) of a coordinated silver atom to each atom of a pyrimidine 
ring, measured from crystal structure. CSD code: MESCAT.53 
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EXAFS of bacterial cell pellets and broth 
 Figure 9 shows the EXAFS spectra of E. coli growth and ‘shock’ cell pellets with 
fit parameters summarised in Table 4. Both spectra were adequately fit with sulfur and 
silver back scatterers. The sulfur distances varied by only 0.02 Å between the growth and 
‘shock’ samples and the silver distances were refined to be 2.94 Å for both samples. The 
large fit error of the E. coli growth EXAFS (A) was likely due to the low signal-to-noise 
ratio observed for these samples. 
 
 
Figure 9: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier transform (right panel) of (A) E. 
coli growth cell pellet, (B) E. coli ‘shock’ cell pellet showing experimental (black) and calculated (green) 
data with the residual (red) shown offset. Fit parameters reported in Table 4. 
 
Table 4: Parameters fit to Ag K-edge EXAFS spectra of pelletized, freeze-dried (A) E. coli growth and (B) 
E. coli ‘shock’.a 
Sample Scatterer CN Distance (Å) DWF (Å2) -E0 (eV) Fit error 
Growth (A) S 2 2.46(1) 0.0101(7) 20(2) 0.70 
 Ag 2 2.94(1) 0.0110(6)   
‘Shock’ (B) S 2 2.48 0.0101 20(1) 0.54 
 Ag 2 2.94 0.0079   
aThe k-range was 1-11 and 1-13.5 Å-1 for A and B, respectively, with a scale factor (S02) of 0.9. DE0 = E0 – 
25515 eV where E0 is the threshold energy. Values in parentheses are the estimated standard deviation 
derived from the diagonal elements of the covariance matric and are a measure of precision. The fit error is 
defined as [Sk6(cexp-ccalc)2/Sk6cexp2]½. 
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 The S. aureus growth Fourier Transform in Figure 10A displayed three prominent, 
resolved peaks between 2 and 3 Å. The calculated fit parameters (Table 5) revealed 
interaction of sulfur, silver, and nitrogen/oxygen backscattering atoms; a feature unique to 
the S. aureus growth cell pellet. The ‘shock’ sample FT also displayed three peaks, 
however, they were broader and more widely spaced than those observed in the growth 
sample spectrum. The peaks in the spectrum of the ‘shock’ sample were fit by a single 
sulfur interaction, as well as short and long silver interactions. The reduced intensities of 
the Ag-Ag interactions, relative to the prominent sulfur peak, were due to the dampening 
of the EXAFS oscillations at higher k-space; the oscillations became dampened at ~9 Å-1 in 
spectrum B but the oscillated of spectrum A continued until ~11 Å-1. 
 
 
Figure 10: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of (A) 
S. aureus growth, (B) S. aureus ‘shock’ showing experimental (black) and calculated (green) data with the 
residual (red) shown offset. Fit parameters reported in Table 5. 
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Table 5: Parameters fit to Ag K-edge EXAFS of pelletized, freeze-dried (A) S. aureus growth cell pellet, and 
(B) S. aureus ‘shock’ cell pellet.a 
Sample Scatterer CN Distance DWF -E0 Fit error 
Growth (A) N/O 2 2.243(6) 0.0030(4) 17(1) 0.60 
 S 1 2.544(6) 0.0035(4)   
 Ag 2 2.945(5) 0.0089(3)   
‘Shock’ (B) S 1 2.465(8) 0.0047(6) 18(1) 0.84 
 Ag 1 2.949(8) 0.0073(5)   
 Ag 2 4.05(1) 0.0086(5)   
aThe k-range was 1-11 and 1-14 Å-1 for A and B, respectively, with a scale factor (S02) of 0.9. DE0 = E0 – 
25515 eV where E0 is the threshold energy. Values in parentheses are the estimated standard deviation 
derived from the diagonal elements of the covariance matric and are a measure of precision. The fit error is 
defined as [Sk6(cexp-ccalc)2/Sk6cexp2]½. 
 
 The EXAFS oscillations of the broth sample treated with 0.5 µg/mL AgNO3 
(Figure 11A) were reduced in intensity until ~7 Å-1, which suggested strong interaction of 
the absorbing silver atom with other heavy atoms (such as another silver atom). 
Conversely, the EXAFS spectrum of 10 µg/mL AgNO3 in broth (Figure 11B) displayed 
more intense, low k undulations. This observation which was reflected in the emergence of 
a secondary low R peak at ~2 Å in the EXAFS FT of B. As such, lighter backscatters (like 





Figure 11: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
(A) 0.5 µg/mL AgNO3 Luria Bertani broth, (B) 10 µg/mL AgNO3 in Luria Bertani broth showing 
experimental (black) and calculated (green) data with the residual (red) shown offset. Fit parameters reported 
in Table 6. 
 
Table 6: Parameters fit to Ag K-edge EXAFS of Luria Bertani broth spiked with AgNO3a 
Sample Interaction CN Distance DWF -E0 Fit error 
(A) 0.5 µg/mL 
AgNO3 
S 2 2.54(2) 0.008(1) 15(2) 0.77 
Ag 2 2.93(1) 0.0060(4)   
(B) 10 µg/mL 
AgNO3 
N/O 2 2.30(2) 0.005(3) 19(2) 0.74 
S 1 2.47(4) 0.010(5)   
Ag 2 2.92(1) 0.0065(5)   
aThe k-range was 1-12 and 1-11 Å-1 for A and B, respectively, with a scale factor (S02) of 0.9. DE0 = E0 – 
25515 eV where E0 is the threshold energy. Values in parentheses are the estimated standard deviation 
derived from the diagonal elements of the covariance matric and are a measure of precision. The fit error is 




Size exclusion chromatography coupled with ICP-MS 
SEC and ICP-MS of bacterial broth 
 To follow the biochemical fate of silver in bacteria, one starting point is the 
speciation of exogenous Ag, prior to uptake by the organism. Luria Bertani broth is a 
liquid medium used for bacterial culture. It is an ‘undefined’ medium comprised of amino 
acids, low molecular weight (LMW) peptides, B vitamins, and minerals from reconstituted 
yeast extract and digested casein (tryptone). Due to its inconsistent composition, a single 
batch of LB was used for all experiments. SEC chromatograms of untreated and silver-
spiked LB broth are shown in Figure 12. No species with absorbance at 280 nm eluted at, 
or near, the void volume of the column (fractionation range: 120 to 0.1 kDa).  
 
 Absorbance of the column effluent was monitored at 280 nm for untreated broth 
(purple), broth spiked with 0.5 µg/mL AgNO3 (blue), and 10 µg/mL AgNO3 (green) 
(Figure 12). A constant injection volume (100 µL) was used allowing direct comparison 
between the absorbance traces of each sample. Residuals (dotted lines) were calculated by 
subtraction of the untreated 280 nm trace from those of the Ag-spiked broth. In the treated 
broth samples, the elution of silver-bound species (highlighted in yellow) was determined 
by fractionation (one-minute time slices) of the column effluent followed by analysis of 
each fraction by ICP-MS to identify if silver was present. The 0.5 µg/mL SEC residual 
(Figure 12) did not show significant perturbation of the broth elution profile due to 
addition of silver. Fluctuation in the 0.5 µg/mL residual at ~18.5 min (and elsewhere) was 
likely due to conformational changes of species present which would alter their elution 
times. As silver was not found to elute at high retention time it was unlikely the metal 
contributed to these changes. The 0.5 µg/mL residual showed no variation in the 280 nm 
trace occurred where silver-bound species were known to elute (between 7 and 9 minutes). 




Figure 12: Size exclusion chromatograms of Luria Bertani (LB) broth spiked to a final concentration of 10 
(green), 1 (blue), and 0 µg/mL (purple) of AgNO3 monitored at 280 nm for the detection of short chain 
peptides and amino acids. Dashed residuals were calculated by subtraction of the 0 µg/mL 280 nm trace from 
the silver-spiked 280 nm traces. The samples were fractionated into a 96-well plate with one-minute intervals 
and each fraction tested for the presence of 107Ag via ICP-MS (yellow). Column: Agilent AdvanceBio SEC 
130Å (7.8 x 300 mm I.D.; 2.7 µm particle size); temperature: ~20°C; mobile phase: 100 mM HEPES, pH 
7.4; flow rate: 0.3 mL/min; injection volume: 100 µL; detector: Agilent Infinity 1200 variable wavelength 
detector set at 280 nm. The void volume of the column (v0) and elution times of molecular weight markers 
are shown at the top of the plot in kDa. 
 
 A calibration curve constructed from the elution times and molecular weights of 
known protein standards (Appendix 2.9.4) enabled calculation of the molecular weights of 
unknown species based on elution time. However, it must be noted that calculated 
molecular weights are only accurate if solely non-specific interactions are present between 
the eluting species and the column resin.54 The MWs of the silver-bound species that 
eluted at 7.40 and 7.90 min in Figure 12 were calculated to be ~65 and 46 kDa, 
respectively, and likely represented partially digested protein as the peak in the SEC 
chromatogram was present in the absence of Ag+. Given the composition of LB broth (high 
amounts of short chain peptides and small molecules) the additional peak was likely due to 
aggregation of various smaller species; fluctuations in the higher concentration residual 
trace could indicate the source of the aggregated species. 
 
 After incubation of E. coli and S. aureus cultures in the presence of sublethal 
AgNO3, the cells were pelletized, and the supernatant broth analysed by SEC and ICP-MS. 
The elution profiles of silver-spiked broth pre and post bacterial growth were compared 
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(Figure 13). Residuals (dashed purple) were calculated by subtraction of the ‘pre growth’ 
280 nm trace (green) from the ‘post growth’ trace (blue). The residual traces highlighted 
the species taken up from the broth by the two bacterial strains during incubation. 
 
 
Figure 13: Size exclusion chromatograms of silver-spiked Luria Bertani (LB) broth pre growth (green) and 
post growth (blue) of E. coli (top) and S. aureus (bottom). Column effluent was monitored at 280 nm to 
detect short chain peptides, amino acids and UV-absorbing LMW molecules. Residuals (dashed purple) were 
calculated by subtraction of the pre-growth trace from the post-growth trace. The samples were fractionated 
into a 96-well plate with one-minute intervals and each fraction tested for the presence of 107Ag via ICP-MS 
(yellow) (Note: S. aureus ‘post’ sample had no detectable 107Ag). Column: Agilent AdvanceBio SEC 130Å 
(7.8 x 300 mm I.D.; 2.7 µm particle size); temperature: ~20°C; mobile phase: 100 mM HEPES, pH 7.4; flow 
rate: 0.3 mL/min; injection volume: 100 µL; detector: Agilent Infinity 1200 variable wavelength detector set 
at 280 nm. The void volume of the column (v0) and elution times of molecular weight markers are shown at 




 All peaks in the residuals were inverted relative to the UV traces, except for the 
peak at ~15 min in the E. coli residual. Based on how the residuals were calculated (pre- 
minus post growth UV trace), inverted peaks indicated that components of the broth were 
taken up by the bacteria, and minimal efflux of cellular detritus occurred. Significant 
uptake of the most intense peak (~18 min) by S. aureus, but not E. coli, was the largest 
difference between the post-growth broth traces. If efflux had occurred, the post-growth 
broth elution profile would be expected to appear significantly different either in elution 
profile or the relative intensities of species present. For both strains the uptake of silver-
bound species (eluted between 7 and 9 minutes) was visible as a small decrease in the 
residual between those time points. ICP-MS analysis of the S. aureus post-growth broth 
(not shown) did not detect any exogenous silver remaining in solution which would 
suggest that the bacteria were not sufficiently metal-stressed to express Cu(I)/Ag(I) efflux 
systems. Conversely, the E. coli post-growth broth still contained detectable levels of 
silver; despite E. coli being exposed to half the amount of silver that S. aureus due to their 
respective MICs. While it was possible E. coli effluxed silver from its cells, it would be 
unlikely that the majority of silver would still exist intracellularly after incubation for 
~16 h. 
 
 Size exclusion chromatograms of LB broth in which E. coli and S. aureus were 
grown in the presence and absence of AgNO3 were also recorded (Figure 14). The 
presence of sublethal silver nitrate did not appear to greatly change the elution profile of 
the post-growth broth. This would suggest that the presence of silver ions did not greatly 
affect uptake of nutrients or other exogenous species from broth. Fluctuation in the E. coli 
residual at larger elution times was likely due to shifts in elution times of the peaks at ~15 




Figure 14: Size exclusion chromatograms of Luria Bertani (LB) broth in which E. coli (top) and S. aureus 
(bottom) were treated (green) or untreated (blue) by AgNO3. Column effluent was monitored at 280 nm to 
detect short chain peptides, amino acids and UV-absorbing LMW molecules. Residuals (dashed purple) were 
calculated by subtraction of the ‘treated’ trace from the ‘untreated’ trace. Samples spiked with AgNO3 were 
fractionated into a 96-well plate with one-minute intervals and each fraction tested for the presence of 107Ag 
via ICP-MS (yellow). The fractions that contained silver (determined by ICP-MS) are highlighted (yellow). 
The void volume of the column (v0) and elution times of molecular weight markers are shown at the top of 




Hyphenated SEC and ICP-MS of E. coli and S. aureus cell lysates 
 Analysis of bacterial lysates with a low molecular weight (LMW) range column 
(fractionation range: 120 to 0.1 kDa) revealed that all silver-bound species eluted close to 
the void volume (between 6 and 8 minutes) for both strains, suggesting that the metal was 
associated with high molecular weight (HMW) species (Figure 15). The lower signal-to-
noise ratio of the S. aureus 107Ag ICP-MS data (yellow bar graph, Figure 15), relative to 
E. coli, was due to reduced cell lysis of the Gram-positive cells into buffer post silver 
treatment. For subsequent analyses S. aureus was chemically lysed with the commercially 
available lysing agent, Lysostaphin (10 IU). 
 
 
Figure 15: SEC chromatograms of E. coli (top) and S. aureus (bottom) lysate of cells grown in the presence 
of 0.5 and 1.0 µg/mL AgNO3, respectively. The presence of protein was monitored by absorbance at 280 nm 
(black). The samples were fractionated into a 96-well plate with one-minute intervals and each fraction 
tested for the presence of 107Ag via ICP-MS (yellow). Column: Agilent AdvanceBio SEC 130Å (7.8 x 300 
mm I.D.; 2.7 µm particle size); temperature: ~20°C; mobile phase: 100 mM HEPES, pH 7.4; flow rate: 0.3 
mL/min; injection volume: 100 µL; detector: Agilent Infinity 1200 variable wavelength detector set at 280 
nm. The void volume of the column (v0) and elution times of molecular weight markers are shown at the top 
of the plot in kDa. 
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 E. coli lysate passed over a high molecular weight fractionating column 
(fractionation range: 1200 to 5 kDa) resulted in better resolved 107Ag ICP-MS and 280 nm 
traces (Figure 16, top). Integration of the area under the silver trace revealed that 87% of 
detected silver in the sample eluted between 8 and 11 minutes with the major silver peak at 
9.27 min; 6% was eluted at the void volume (Table 7). The molecular weights of the 
silver-bound species were calculated (Table 8) using a calibration curve constructed from 
the elution times and molecular weights of known protein standards (Appendix 2.9.4). In 
addition to silver, multiple biologically relevant metals (Mn, Fe, Co, Ni, Zn, Cu) were 
simultaneously monitored during the experiment and all silver-bound species in the E. coli 
lysate were found to coelute with copper-bound species. However, the non-uniformity of 
the coelution of 107Ag and 65Cu peaks could represent incorporation of Ag+ into Cu(I)-
specific cellular Cu(I) metabolic pathways. 
 The 107Ag traces of S. aureus lysate (Figure 16, bottom) displayed a more diverse 
elution profile than that of E. coli; multiple non-baseline resolved silver peaks were 
observed between 5 and 13 minutes. The percentage of silver eluted between various time 
ranges of the chromatogram (determined by integration of eluted peaks) is shown in Table 
7, and the calculated molecular weights of discrete 107Ag peaks are shown in Table 8. 
 
 Similarities between the 107Ag and 65Cu traces of the S. aureus lysate were more 
prominent than for E. coli; clear mirroring of the traces was observed between 9.5 and 12.5 
minutes. The only point where silver did not coelute with copper was the shoulder peak at 
~8 minutes; while the count rate of the copper trace was elevated relative to background 




Figure 16: SEC-ICP-MS chromatograms of lysed E. coli (top) and S. aureus (bottom) cells grown in the 
presence of 0.5 and 1.0 µg/mL AgNO3, respectively. The presence of protein was monitored by absorbance 
of the column effluent at 280 nm (black). Multiple ICP-MS metal traces were measured simultaneously; 
107Ag (blue) and 65Cu (green) traces are shown. Column: Agilent AdvanceBio SEC 300Å (7.8 x 300 mm 
I.D.; 2.7 µm particle size); temperature: ~20°C; mobile phase: 100 mM HEPES, pH 7.4; flow rate: 0.3 
mL/min; injection volume: 100 µL; detector: Agilent Infinity 1200 variable wavelength detector set at 280 
nm, and Agilent QQQ 8900 ICP-MS. The void volume of the column (v0) and retention times of molecular 
weight markers are shown at the top of the plot in kDa. 
 
Table 7: Time ranges and percentage of total silver calculated by integration under the 107 Ag ICP-MS trace 
for E. coli and S. aureus lysate chromatograms in Figure 16 
Organism Time range [min] % silver 
E. coli 6 – 7 6 
8 – 10.5 87 
S. aureus 5.5 – 7 38 
7 – 9.5 24 
9.5 – 12.5 35 
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Table 8: Molecular weights of discrete peaks observed in the 107Ag ICP-MS traces for E. coli and S. aureus 
lysates, calculated from a calibration curve created from the elution times and MWs of known protein 
standards 
Organism Elution time [min] Calculated MW [kDa] 




S. aureus Void volume ³1220 







Gel electrophoresis of SEC fractions 
 The bacterial lysates were again passed over the high molecular weight SEC 
column and fractionated into a 96-well plate for subsequent analysis. The SEC-ICP-MS 
traces reported above (Figure 16) facilitated identification of silver-containing fractions 
which were subjected to SDS-PAGE conditions, stained with Coomassie blue, and imaged 
(Figure 17). 
 E. coli SEC fractions known to contain silver were loaded into lanes 2-4 and S. 
aureus silver-containing fractions loaded into lanes 6-10. The difference in protein 
concentration between the two organisms was visibly apparent as the intensity of stained 
bands are related to the concentration of protein present. For example, more protein was 
present in the S. aureus SEC fractions (lanes 6-10) and were stained darker relative to 
those of E. coli (lanes 2-5). The difference in protein concentration was a result of 
chemical vs. mechanical lysis. S. aureus cells were lysed with a chemical specific for lysis 
of the organism (Lysostaphin) which resulted in a high concentration of protein in the 
lysate buffer solution passed over the column (~3 mg/mL, as estimated by absorbance at 
280 nm relative to a blank). However, E. coli cells were mechanically lysed, which 
required suspension of the unlysed cells in ~10 mL of buffer, diluting the protein 
concentration of the lysate (~0.3 mg/mL relative to blank). 
 
 
Figure 17: Image of a stained (Coomassie Brilliant Blue) SDS PAGE gel used to further separate E. coli 
(lanes 2-4) and S. aureus (lanes 6-10) lysate SEC fractions that were identified as containing silver from 
SEC-ICP-MS chromatograms.  
 
 The number of bands visible in the S. aureus lanes showed that, at each time point 
of the SEC-ICP-MS chromatograms shown in Figure 16, many protein species eluted 
frustrating attempts to identify specific silver-bound proteins. This was unsurprising as the 
elution profile of the chromatograms between ~5 and 20 minutes represented the entire 
9 1 2 3 4 5 6 7 8 10 
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bacterial proteome of both organisms (containing thousands of proteins). Further 
identification of silver-bound species was attempted by blotting of gels (like that displayed 
in Figure 17) onto polymer membranes and analysis by X-ray fluorescence microscopy 
(XFM).55 However, the level of silver (and all other biologically relevant metals) was 
found to be below the detection limit of the technique (data not shown). 
 
Summary of key results 
 Linear combination fitting of the Ag K-edge XANES spectra of E. coli and S. 
aureus cell pellets, whether growth or shock treatments, calculated consistently high 
contributions from the silver-cysteine (Ag-Cys) model spectrum (75 – 90%) with the 
remaining percentage coming from a silver-thiamine model spectrum. The EXAFS 
spectrum of the silver-cysteine model was fit with sulfur and silver backscattering 
interactions at 2.48 and 2.96 Å, respectively. Coordination spheres similar to Ag-Cys were 
successfully fit to all E. coli and S. aureus experimental spectra. The Ag-S distances 
ranged from 2.46 – 2.54 Å and Ag-Ag distances were 2.94 Å, corroborating the LCF 
results which indicated silver/cysteine-like interactions were present. However, the small 
percentage of silver-thiamine model spectrum fit to all bacterial spectra did not appear to 
be substantiated by the EXAFS analysis, as only the S. aureus growth sample was fit with 
N/O interactions. The proportion of the thiamine spectrum fitted to all experimental spectra 
was so low that the already dampened features of the silver-thiamine XANES were almost 
completely obscured, bar minor oscillations. While pyrimidine-containing molecules are 
prominent in cellular biochemistry,56 it was likely that the fitting of the thiamine model 
spectrum was not a true component but merely added amplitude to the fit of the cysteine 
model spectrum. 
 
 Size exclusion chromatography hyphenated ICP-MS of Ag-treated E. coli and S. 
aureus lysates revealed that all silver in the system was associated with high to medium 
molecular weight species (>1220 to 22 kDa). In both organism lysates, it was found that 
silver coeluted with select peaks in the 65Cu trace. While the 107Ag elution profile of the E. 
coli lysate appeared relatively simple, with only an intense major peak and four smaller 
peaks, subsequent analysis of the SEC fractions by SDS PAGE revealed that many species 
eluted at each time point in the chromatogram. Relative to the 107Ag trace of E. coli, the S. 





X-ray absorption spectroscopy 
 Few X-ray absorption spectroscopy studies have been carried out on silver-treated 
bacteria, however, one group of researchers reported the Ag L3-edge XANES of S. aureus, 
E. coli, and L. monocytogenes exposed to Ag+.57 The researchers treated the three strains of 
bacteria with either silver nitrate or acetate (5 mM), and found that the XANES spectra of 
intracellular Ag species differed significantly from the XANES spectra of the administered 
silver salts. The group did not provide explanation for why EXAFS analysis was not 
carried out, but it was likely that low levels of silver in the cell pellets prevented adequate 
data collection. However, through use of linear combination fitting, the relative 
proportions of model XANES were fit to the experimental spectra; model spectra used 
included samples of silver with cysteine, histidine, alanine, and DL-aspartic acid. The 
dominant contributions were found to be from histidine in S. aureus and L. monocytogenes 
(47%) and alanine in E. coli (37%) while only minor contributions from the cysteine model 
were calculated across all strains of bacteria tested (10 – 24%). From their LCF analysis, 
silver-nitrogen interactions were determined to be the dominant features of silver 
speciation in bacteria, with ‘non-dominant’ Ag-S interactions also present. This was in 
stark contrast to the results reported herein which, through both XANES and EXAFS 
analysis, identified sulfur as the dominant donor atom in the Ag+ coordination sphere. In 
the previous work, the methods by which the silver model spectra were prepared for 
XANES collection were not carefully outlined; no mention was made of the buffer system 
used, solution pH, or stoichiometric metal-to-ligand ratios in the models. In addition, the 
silver-cysteine sample was prepared according to the protocol of a paper which 
investigated the gelation of silver/cysteine solutions.58 Finally, it was stated that 
compositions of the samples were validated by ‘X-ray diffraction,’ a technique often used 
for characterisation of solid-state substances; despite the standard being compared against 
an aqueous biological system. Such inconsistencies raise questions about the validity of the 
results obtained by the group, and whether biologically relevant interactions were 
recorded. 
 
 Even with appropriate model sample preparation, the silver XAS spectra of 
metal/amino acid solutions at pH 7.4 may not be representative of biologically relevant 
interactions between the Ag+ and amino acid residue sidechains in proteins. The silver-
methionine EXAFS spectrum presented here was fit with two nitrogen and two sulfur 
backscattering interactions. The nitrogen backscattering component was likely due to 
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interaction with the primary amine of methionine, in addition to the thioether sulfur. In 
protein structures the primary amine of the amino acid backbone form amide bonds with 
the carboxylic acid of a neighbouring amino acid in the sequence. While some metals have 
been shown to be bound by amide linkages (Cu2+), the functional group has been 
demonstrated to be a poor ligand for soft metals like Cu+.59 Thus, the silver-methionine 
model XAS spectrum could be considered unrepresentative of the interactions likely to 
occur between proteinaceous methionine and silver ions (unless the coordination sphere of 
the Ag+ ion happened to be S2N2, with appropriate bonding distances). A review of the 
Protein Data Bank (PDB) in 2017 revealed the most common silver-binding residues; 
histidine (50%), methionine (29%), and cysteine (15%).60 Many bacterial copper transport, 
efflux or homeostatic proteins are rich in methionine residues while being comparatively 
poor in cysteine residues. As such, it may have been the case that the high proportion of 
silver-cysteine model calculated for the bacterial cell pellet XANES in this work (74 – 
90%) could have represented a mixture of Cys and Met residue binding. A review of the 
CSD indicated an appreciable overlap between silver-cysteine and silver-methionine bond 
distances (Appendix 3.9.2). To determine whether this was the case, it would be 
informative to collect Ag K-edge XANES data of solely Ag-Sthioether interactions for 
comparison against the experimental cell pellet spectra. However, it was also possible that 
the coordination sphere of silver in bacterial cells was dominated by interactions with 
cysteine residues, given the known affinity of the amino acid for Ag+.61 Regardless, there 
is a stark contrast between the results reported herein which show binding of Ag+ to 
cysteine (and possibly methionine), and some previously reported results which suggested 
limited involvement of these amino acids. 
 In 2013 the interactions between Ag+ and the Cu+ chaperone protein, Atox1, as 
well as silver-substituted rabbit, and yeast metallothioneins were investigated by XAS.62 
Analysis of XANES (and EXAFS) identified that silver was coordinated exclusively by 
cysteine residues (an attribute for which MTs are renowned). The silver K-edge XANES 
data collected in their study (in which silver was bound by cysteine residues) bore striking 
similarities to the experimental cell pellets, and silver-cysteine model spectra reported 
herein (Figure 1). Such similarities may indicate that the chemistry of silver in bacteria 
was indeed dominated by interactions with cysteine.  
 
 The linear combination fits of all silver K-edge XANES of cell pellets and broth 
indicated a minor contribution (8–25%) from the Ag-thiamine model spectrum but the flat, 
dampened features of the thiamine spectrum raised doubts about its validity as a 
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component of the experimental XANES spectra. The thiamine model was included as 
Luria Bertani broth is known to be rich in B vitamins and, as one of the few sulfur-
containing vitamins, it was thought to have some affinity for silver ions. However, analysis 
of the thiamine EXAFS, coupled with a survey of the CSD, revealed that the most likely 
binding interaction with silver was via the aromatic pyrimidine nitrogens.  
 Intracellularly, thiamine can be utilised as a cofactor for a number of enzymes, two 
of which participate in the tricarboxylic acid cycle (TCA); pyruvate dehydrogenase 
complex (PDC), and a-ketoglutarate dehydrogenase complex (KGDHC).63 Thiamine 
deficiency has been shown to result in decreased activity of these vitamin-dependent 
enzymes of the TCA, which also contributed to significant inhibition of other non-
thiamine-dependent members of the cycle.63 In some cases, the non-thiamine-dependent 
enzymes (namely succinate dehydrogenase (SucD), and malate dehydrogenase (Mdh)) can 
be more significantly reduced in activity than the dependent enzymes. A recent 
investigation revealed SucD and Mdh as silver-binding targets in E. coli grown in the 
presence of toxic levels of silver nitrate (4 µg/mL) – see below.34 
 Pyrimidine functionality is widespread in molecular biology. Thus, if the silver ions 
interacted with the thiamine-pyrimidine in the model spectrum, the proportion fit to the 
experimental cell pellet/broth XANES could be representative of interactions with other 
pyrimidine-containing biomolecules. Possibly the most well-known pyrimidine-containing 
biomolecules are the nitrogenous bases that form part of DNA and RNA. In E. coli 
approximately 15% of accumulated silver has previously been found to be associated with 
nucleic acids (DNA/RNA).64 In the lysates of E. coli and S. aureus examined herein, the 
107Ag traces indicated some silver eluted with the void volume of the column, suggesting 
interaction with very high molecular weight species; the maximum fractionation range of 
the column used here was ~1220 kDa. A relatively small bacterial plasmid of ~35 kilo base 
pairs would exceed this fraction range (~1300 kDa) and elute with the void volume of the 
column.65 As such, interaction between silver ions and the pyrimidine/purine nitrogenous 
bases of DNA or RNA could explain the proportion of silver that eluted at the void volume 
in the SEC-ICP-MS chromatogram of E. coli and S. aureus lysates as well as the 
component of the bacterial cell pellet Ag XANES fit by the thiamine model spectrum. The 
CSD revealed that silver ions have an affinity for the purine base adenine with 28 of 40 
crystal structures of silver-nitrogenous base complexes containing solely these two 
molecules or derivatives thereof (Appendix 2.9.3).  
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 Unexpectedly, there was no indication of any silver chloride in the XANES or 
EXAFS of any bacterial samples (cell pellet or broth). Given the high concentration of 
NaCl in LB broth, it was anticipated that some AgCl would be formed. The formation of 
insoluble salts is often hypothesised to limit the antibacterial activity of silver in biological 
systems. However, in the systems studied here, it appeared that the formation of insoluble 
solids did not occur. 
 
Size exclusion chromatography ICP-MS 
Escherichia coli 
 Recently the Sun group investigated molecular mechanisms by which Ag+ acts as 
an antibacterial agent against E. coli.34 Through development of ICP-MS coupled with 
liquid chromatography (LC) and gel electrophoresis (GE) (LC-GE-ICP-MS) they 
identified 34 individual proteins to which Ag+ was bound. The proteins that were identified 
were associated with a range of cellular processes including the tricarboxylic acid cycle 
(found to be impeded by the presence of silver), the glyoxylate cycle, glycolysis, 
translation, responses to oxidative stress, and regulation of internal pH.  
 It was found that the molecular weights of the proteins identified were of moderate 
size (<50 kDa), which was partially consistent with the calculated MWs of the silver peaks 
observed in the 107Ag SEC-ICP-MS trace of E. coli lysate reported herein (198, 38, and 22 
kDa). The proteins identified by Wang et al.34 were low MW, however, there was limited 
discussion about the size of the biologically relevant species; expected to be maintained 
with the metallomics techniques used in the study presented in this thesis. For example, 
one of the proteins identified to bind Ag+ (Dps) is involved in DNA protection during 
starvation. Dps itself is a low molecular weight protein (18.7 kDa) but within the cell it 
functions as a homododecameric species with a molecular weight of ~224 kDa.66 
Similarly, two of the proteins identified to be strongly inhibited by Ag+ (by Wang et al.), 
isocitrate dehydrogenase (Idh) and malate dehydrogenase (Mdh), have nominal molecular 
weights of ~46 and 32 kDa, respectively, but both form homodimeric species 
intracellularly and have MWs of 92 and 64 kDa, respectively. However, the first 
dimension of separation of the bacterial lysates used by the Sun group involved 
manipulation of pH which would have disrupted protein-protein interactions; changing the 
pH would alter the surface environment of the protein subunits, disrupting intermolecular 
interactions, causing protein complexes to degrade.67 
 Of the 34 proteins identified by Wang et al.,34 only two are known to bind copper, 
the zinc transporter ZraP,68 and Dps, which has been implicated in the homeostasis of 
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copper as well as transport and oxidation of ferrous ions.66 However, the authors also 
acknowledged that their experiments did not provide an exhaustive list of silver-binding 
proteins in the organism. Iron-sulfur cluster-containing proteins, such as NADH 
dehydrogenases, have been demonstrated to be poisoned by silver ions, leading to 
degradation of the cluster and generation of the apo-enzyme.69 Thus, the absence of the 
copper-binding proteins identified by Wang et al does not preclude the results observed 
here. It is worth noting that the experimental design of the work published by the Sun 
group, and that of the experiments reported herein were subtly different. The work 
presented here was conducted at a concentration below the minimal inhibitory 
concentration (MIC) of silver nitrate against E. coli. The MIC was experimentally 
determined to be ~2.0 µg/mL AgNO3, and all E. coli cells were cultured in the presence of 
0.5 µg/mL silver nitrate. This ensured that cell death was not a significant factor and that 
all silver-associated species were true representations of the biochemical fate of the metal 
instead of adventitious metallation of cellular detritus. Comparitively, the work by the Sun 
group was carried out at the experimentally determined MIC50 value for E. coli (4 µg/mL) 
which would have resulted in a significant amount of silver-stress exerted on the organism 
and may have been a snapshot of a different biochemical fate for Ag+. However, in the 
study presented here, no measurements to quantify the level of metal-associated stress 
were carried out.  
 In their study, Wang et al. fidentified proteins involved in important cellular 
processes, such as the TCA cycle, pH regulation, and maintenance of cysteine-derived 
redox activity, were targeted; an observation consistent with previously reported 
antibacterial and inhibitory properties of silver.70 Additionally, the group identified that the 
enzymatic activities of succinate dehydrogenase (SucD), isocitrate lyase (AceA), and 
malate synthase (AceB) increased upon exposure to silver before decreasing. This 
phenomenon has been reported elsewhere for the decoupling of enzyme activity from 
available ATP or ADP.71-72 Analysis from Wang et al. identified the TCA to be 
significantly targeted by the Ag+ with isocitrate dehydrogenase (Idh) and malate 
dehydrogenase (Mdh) having up to 80% of their enzymatic activity inhibited by silver 
from 5 min post exposure, and for the duration of the experiment (60 min). Intracellularly 
the organism attempted to mitigate the effect of the inhibition of these enzymes in the 
oxidative branch of the tricarboxylic acid cycle by switching to the glyoxylate cycle, 
however, silver eventually inhibited that cellular process as well. 
 Nutrient copper is a double-edged sword for bacteria with it being an essential 
micronutrient but also having antibacterial activity against the organisms.73 As the 
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chemistry of silver has been likened to that of copper in the +1 oxidation state, it is likely 
that, when exposed to sublethal concentrations of AgNO3, the biochemical fate of Ag+ 
would be similar to that of endogenous Cu+. Thus, the colocalisation of the metals 
observed for the work reported here appears to be consistent with work reported elsewhere, 
namely that protein species known to bind Cu+ often also bind Ag+.62, 74-75  
 
 In 2019 a group reported on the localisation and ‘speciation’ of silver ions and 
nanoparticles in E. coli when the organism was treated with concentrations 10, 50, and 
90% of the minimal inhibitory concentration (of the NPs and silver nitrate).48 Treatment of 
the cells to isolate extracytoplasmic/cell wall, and cytoplasmic extracts enabled the group 
to identify that the localisation of the silver in the cell was predominantly in the 
extracellular medium (24 – 60% of total silver) or the cell wall/membrane (25 – 64% of 
total silver) with only a small percentage associated with the cytoplasmic extracts (6 – 15% 
of total silver). Significant gaps in bacterial copper biochemistry are known, but in vivo 
Cu(I/II) is throught to be strictly regulated and relegated to extracytoplasmic regions of the 
cell to manage the toxicity of the metal.25 As such, localisation of the majority of cell-
associated silver with the cell wall/membrane extracts of the organism is consistent with 
the observed colocalisation of silver and copper in the study presented in this thesis. 
 Despite claims of speciation analysis by Dong et al., the presented results did not 
shed significant light on the topic.48 The pore size of the column was excessive (1000 Å) 
which, at a flow rate of 0.5 mL/min, caused analysed samples to elute within 4 minutes 
with poor resolution. Additionally, there was no reference to column calibration with 
known standards for comparison with experimentally eluted species. Further to this, the 
experimental setup contained many opportunities for perturbation of analyte chemistry, 
such as the unbuffered elution solvent consisting exclusively of 2% v/v FL-70 (contains 
~1.5% Na2EDTA, NaHCO3, triethanolamine, etc.) and 2 mM Na2S2O3. As such the claims 
of the authors to be able to visualise “free” Ag+ (which is unlikely to be present in any 
case) and other microbiologically relevant silver species was dubious. 
 
 The proteome of E. coli MG1655 strain (UniProt code: UP000000625), the same 
strain used by this study and that by Wang et al.34 contains ~25 known copper-binding 
proteins; the majority of which are associated with the periplasmic space or the inner/outer 
membranes of the cell.25 While some of the copper-binding proteins are known to exist in 
the cytoplasm of the cell, they are thought to function as copper chaperones tasked with 
removal of copper from the cytoplasm to the periplasmic space, like CutC, or 
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transcriptional regulator proteins like CueR.28 Thus the observation by Wang et al. that the 
bulk of silver identified in their study was associated with cytoplasmic proteins appeared to 
be inconsistent with ours and others observations48, 64 but may have been a result of the 
concentrations of silver used (as mentioned above). It has been reported that copper stress 
in S. aureus leads to copper-binding by GapA,31 which was also identified by Wang et al. 
as a silver-binding protein. Thus, the colocalisation of silver and copper is not inconsistent 
with previous results.  
 It has, however, been observed that protein-bound copper can display significant 
lability when conducting size exclusion experiments with low molecular weight species in 
rabbit blood plasma shown to be demetallated and degraded within 30 min of blood 
collection.76 Thus, it is possible that the sample processing for the SEC experiments, albeit 
minimal, resulted in mismetallation in the lysate chromatograms. However, the presence of 
low molecular weight copper-bound species in the S. aureus and E. coli chromatograms 
(MW ranging from ~29 to 7 kDa) could be an indication that the observed phenomena in 
rabbit plasma may not be universally true. Time dependent studies in which the cell lysate 
was run immediately, and at set time points, post lysis would need to be conducted to 
identify whether cellular contents were degraded over time. 
 
 Little is known about the uptake of copper by bacteria, however, appreciably more 
is known about its efflux and homeostasis in the cell. In the proteome of the strain of E. 
coli used for this study (MG1655) there are ~25 known copper binding proteins; including 
the cus, cut, cue, and cop ensembles. CusF is a soluble, low MW Cu-chaperone that 
transports Cu+ ions in the periplasm to the CusCBA cation/proton antiporter for ejection 
from the cell, the expression of the cus operon is regulated by CusR/S. CueR regulates the 
expression of the multicopper oxidase, CueO, and the P-type ATPase exporter, CopA. 
Cytoplasmic copper is delivered to CopA by the chaperone, CopZ, where the Cu+ is 
exported to the periplasm and oxidised by CueO to the ‘less toxic’ Cu2+. 
 Several proteins that utilised nutrient copper as a cofactor are also encoded in the 
proteome of E. coli, including zinc uptake/transport proteins (ZupT), and metabolic 
proteins (RhaB, YfiH, YpdE, TynA). In Gram-negative bacteria (like E. coli) the periplasm 
between the inner and outer membranes is known to have a more oxidative redox potential 
than the cytoplasm. A result of the more oxidising environment is that surface exposed 
cysteine residues tend to be oxidised to CysSSCys and contribute to the structural integrity 
of the protein. The Dsb family of periplasmic proteins (DsbABCDG) corrects the 
formation of adventitious disulfide bonds, as well as reduces isolated cysteine residues; 
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DsbD is a known copper-binding protein.77 As mentioned above, Dps, a homododecameric 
protein involved in DNA protection during starvation, is known to bind copper and iron 




 Compared to the 107Ag trace of E. coli, the silver trace of S. aureus appeared 
appreciably more complex. Not only were more silver peaks and shoulders present in the 
chromatogram, there was also clear mirroring of the 65Cu trace in parts, strengthening the 
idea that the two metals were colocalised. Mining of the proteome of S. aureus Newman 
strain revealed only four known copper-binding proteins; the copper chaperone, CopZ (7.2 
kDa), copper efflux ATPase, CopA (87.9 kDa) (known to be present in all sequenced S. 
aureus strains),78 as well as the haem-copper oxidases quinol oxidase 1, and quinol oxidase 
2 (QoxA and B). According to the S. aureus SEC chromatogram the calculated MWs of 
Ag-bound species ranged from >1220 – 64 kDa, thus, CopZ was unlikely to be involved in 
silver binding in this system. CopA could likely be excluded from the pool of possible Ag-
binding species as it is a copper efflux protein suggesting that interaction with Ag+ would 
result in the metal’s ejection from the cell. It was found in this study that no detectable 
silver remained in the supernatant broth in which S. aureus was cultured suggesting all 
exogenous Ag+ was taken up and retained by the organism. It was unclear whether the 
concentration of silver to which S. aureus was exposed was sufficient to trigger induction 
of the copAZ operon, as it is been shown that the expression of the corresponding proteins 
is dependent on copper (and possibly silver) concentrations.78 Thus the identities of the 
silver (and copper) binding proteins are still unclear. However, within the proteome of S. 
aureus Newman (UniProt code: UP000006386) there are hundreds of entries whose 
functions and properties are yet to be elucidated and are listed as ‘uncharacterised protein’. 
It is likely that many copper-binding proteins in S. aureus are yet to be identified and 
characterised. Conversely, a similar argument regarding the lability of copper in size 
exclusion experiments (see above) could be applied to this system.  
 
 Some proteins that are known to require copper as a cofactor include nitrous oxide 
reductases, and nitrite reductases, but they have not been identified in the S. aureus or E. 
coli proteomes. However, two additional groups of cuproenzymes – superoxide reductases, 
and haem-copper oxidases – have been identified in E. coli and S. aureus. 
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 Superoxide dismutases (SOD) are an important group of proteins responsible for 
the degradation of the superoxide radical and mitigation of oxidative stress.29 Many 
different types of SODs exist in nature, including one that utilises copper and zinc as 
cofactors and is found widely in bacteria (SodC).79 SodC is a homodimer where each 
monomer binds one solvent-accessible copper atom as an active site. This protein exists in 
the extracytoplasmic space of the organism as a soluble protein in most Gram-negative 
bacteria or an anchored protein in Gram-positive bacteria.80 SodC is hypothesised to be 
metallated by the soluble periplasmic chaperone protein CueP. CueP binds one Cu(I) atom 
with high affinity in vitro through a combination of cysteine and histidine residues.81 
Additionally, CueP is suspected to act as a copper sink in the periplasm to aid copper 
tolerance.82-83 The proteome of the strain of E. coli used in the study presented here 
contains SodC and could represent one of the colocalised Cu/Ag peaks in the SEC-ICP-MS 
chromatogram of E. coli lysate. However, CueP has not been identified in the E. coli 
proteome and neither protein species have been identified in S. aureus Newman. At toxic 
concentrations of silver, were the Ag+ to inhibit the antioxidant activity of SodC in 
addition to generation of ROS, the organisms could experience significant oxidative 
damage.  
 Haem-copper oxidases (HCO) are a group of proteins that catalyse the terminal 
step of the respiratory electron transport chain via the reduction of O2 to H2O.25 All HCOs 
contain a buried mononuclear copper centre where the reduction of molecular oxygen 
occurs while some have an additional binuclear copper centre located in a soluble 
periplasmic subunit.25 The insertion of Cu into HCOs is possibly due to metallochaperones 
like the lipoprotein, Sco, which binds Cu(I) through a histidine and two cysteine residues 
in vitro.84 The proteome of the strain of S. aureus used herein (Newman, UniProt code: 
UP000006386) is known to contain two HCOs; quinol oxidase 1 (QoxA), and quinol 
oxidase 2 (QoxB). In this current study, the concentration of silver was sublethal to the 
bacteria, however, inhibition of these terminal HCOs at higher AgNO3 concentrations 
would trap electrons in the transport chain and generate reactive oxygen species. In fact, 
the HCO cytochrome BD oxidase subunit II (CydB) in E. coli was found to be a silver-
binding molecular target by Wang et al.34 
 A key difference between Ag+ and Cu+ cations is silver’s lack of accessible 
oxidation states. Under physiological conditions, copper can readily switch between the +1 
and +2 oxidation states and is thought to be included in some proteins/enzymes to facilitate 
redox activity or reactions.23 According to the Irving-Williams series, of the first-row 
transition metals, copper forms some of the most stable complexes with biomolecules.85 
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Thus it could also be expected that silver would form an even stronger complex than 
copper in biological binding sites.85 Potentially providing insight into the first cellular 
processes targeted and ‘poisoned’ by bactericidal concentrations of Ag+. 
 
 All silver detected in the study presented here was found to be associated with 
moderate to high molecular weight, likely proteinaceous, species. No low molecular 
weight metal-buffering species, such as glutathione-bound Ag+, were identified. While 
unexpected, some metals have demonstrated a preference for interaction with proteins 
while others have shown a stronger affinity for interaction with small molecules like 
glutathione. An example of this is the fate of cadmium ions, and mercury ions in red blood 
cells; Cd2+ primarily associates with cellular glutathione, while Hg2+ primarily associate 
with haemoglobin (the dominant proteins in red blood cells).39  
 From the results presented here, it would indicate that Ag+ forms more stable 
complexes with proteins, relative to glutathione or other small molecules. However, under 
atmospheric conditions, reduced GSH will readily be oxidised to GSSG and be less likely 
to interact with silver ions. To determine whether this occurred, it would be informative to 
‘fortify’ the SEC-ICP-MS elution solvent with physiologically relevant concentrations of 
glutathione to observe if the 107Ag elution profile was altered, as has been achieved 




 Through use of metallomics techniques, namely size exclusion chromatography 
hyphenated with ICP-MS, and X-ray absorption spectroscopy, greater insight into the 
speciation and chemistry of silver ions in E. coli, and S. aureus cultured in the presence of 
sublethal concentrations of AgNO3 was achieved.  
 Upon addition of micromolar concentrations of silver nitrate into Luria Bertani 
broth, XANES and EXAFS analysis revealed that the Ag+ ions were likely complexed by 
thiolate-containing species of moderate size (MW ~30-50 kDa). Despite high 
concentrations of sodium chloride in solution (5 g/L), no formation of silver chloride 
occurred; validated by linear combination fitting of Ag-broth XANES spectra.  
 Neither the XANES nor the EXAFS spectra of silver nitrate in broth changed 
appreciably when the concentration of AgNO3 was increased 20-fold. However, the SEC 
and ICP-MS chromatograms of the same Ag-broth samples displayed an additional 
shoulder feature in the region silver was known to elute. When considering both the XAS 
and SEC ICP-MS data for the silver in broth samples, it would appear that the increase in 
silver concentration caused aggregation of low molecular weight species. 
 The Ag K-edge XANES of silver ions in E. coli and S. aureus cell pellets did not 
significantly differ from exogenous silver in broth suggesting similar coordination 
environments in all samples. However, the size exclusion chromatography 107Ag ICP-MS 
trace showed that silver in both bacterial lysates was bound by high molecular weight, 
likely proteinaceous, biomolecules significantly larger in size than the species in broth. For 
this to have occurred, the silver would have to be taken up by the bacteria, possibly by 
some unidentified copper uptake mechanism or cross the cell membranes via porins/other 
uptake mechanisms. The 107Ag and 65Cu ICP-MS traces of E. coli and S. aureus lysates 
showed non-uniform colocation of silver and copper, possibly indicating incorporation of 
silver ions into other cellular processes (likely Cu(I) metabolic pathways). The partial 
colocation of silver with copper in the metalloprotein elution profile is consistent with 
previous observations of Ag exposure resulting in upregulation of, or an affinity for, Cu-
transport/homeostatic proteins. Analysis of the post-bacterial growth supernatant (SN) 
broth by SEC and ICP-MS found that the elution profile (monitored by absorbance at 280 
nm) was not significantly altered relative to samples of fresh silver-spiked broth from the 
same stock. Paired with this, the observation that the SN broth of S. aureus contained 
undetectable levels of silver ions it could be further stated that the organism did not 
identify silver ions as a toxic species to efflux from the cell; were this the case, silver 
would likely have been detectable in the SN post-growth broth. The proteome of the strain 
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of S. aureus used herein (Newman) contains only two known copper-binding proteins, 
namely the Cu-chaperone CopZ which transports Cu+ to the Cu-efflux protein CopA. 
However, the proteome of S. aureus Newman also contains hundreds of uncharacterised 
proteins. The SEC-ICP-MS chromatogram (in particular the 65Cu trace) of the organism 
lysate indicates that there are numerous unidentified Cu-metalloproteins and that this 
technique could be beneficial in isolating and further characterising these biomolecules. 
 While the silver signal in E. coli post-growth broth was reduced relative to the pre-
growth broth, the metal was still detectable after culturing the organism. As such, some of 
the silver associated with copper in the E. coli lysate SEC-ICP-MS chromatogram was 
possibly bound by components of copper efflux and homeostatic systems. The strain of E. 
coli used (MG1655) contains ~25 known Cu-binding proteins including the Cus, Cut and 
Cop copper homeostatic and efflux ensembles. Several species that use copper as a 
cofactor are also known, including proteins involved in zinc uptake (ZupT), thiol/disulfide 
interchange (DsbD), metabolism (TynA, RhaB, YpdE), and DNA protection (Dps). This 
may provide insight into how silver ions transition from a benign to toxic entity in the 
organisms as cellular processes (such as DNA replication and metabolism) have been 
shown to be inhibited or adversely effected by the noble metal. These findings represent a 
new understanding of the chemistry of silver when it is not acting as an antibacterial agent 
in Gram-positive and Gram-negative organisms. 
 
2.7 Future directions 
 If silver is incorporated into the copper metabolic pathways of bacterial Gram-
positive and Gram-negative bacteria it could provide clues regarding the initial cellular 
response of the microorganism to toxic concentrations of silver ions. While the general 
trend of colocation of silver ions with copper was observed through size exclusion 
chromatography hyphenated with ICP-MS of cell lysates, the separation provided by SEC 
alone did not allow identification of individual silver-bound molecular targets. A useful 
technique to provide a second dimension to the size-based SEC chromatogram is anion 
exchange chromatography (AEX) which can separate proteins based on their isoelectric 
points.86 
 Throughout this study all solutions were maintained at pH 7.4 by HEPES buffer. 
HEPES was chosen due to its buffering capacity at physiological pH and its demonstrated 
lack of affinity for various heavy metals, meaning it would be unlikely to perturb the 
‘natural’ chemistry of silver.87 Unfortunately, an unforeseen consequence of this buffer 
choice was that the sulfonate group of HEPES is completely deprotonated at pH 7.4. The 
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result of this was that attempts to carry out anion exchange chromatography were 
unsuccessful as HEPES molecules saturated the cationic binding sites of the column resin, 
causing all protein to elute with the void volume of the column as, presumably the 
biomolecules could not compete with the buffer for the positive binding sites. One of the 
main focuses of this project was the speciation and chemistry of silver in bacterial systems, 
and, as XAS synchrotron experiments had already been carried out in HEPES buffer, it 
was deemed unnecessary to alter a variable, such as buffer choice, mid project.  
 As such, lysis of bacterial cells into a non-anionic buffer, like Tris, would enable a 
second dimension of separation of the cellular components in addition to size exclusion. 
The added purification of the cell lysate may allow greater resolution of the localisation of 
silver, as monitored by ICP-MS which could aid the identification of individual silver-
binding molecular targets. If a sufficiently pure sample of individual or small groups of 
proteins could be attained, trypsin digestion, analysis of the resultant fragments by 
electrospray ionisation mass spectrometry, and comparison of the fragments to a proteomic 
database like MASCOT could enable identification of proteins that bind sublethal silver in 
S. aureus and E. coli; as has been achieved for gold in another bacterial system.88 Analysis 
of the binding profile of silver in bacteria cultured in the presence of silver nitrate 
concentrations ranging from sublethal to toxic could provide significant insight into the 
transition of Ag(I) from benign copper mimic to toxic antibacterial agent. This would help 
pinpoint the pathways and molecular mechanisms by which silver elicits its toxic effect 
which could aid in more targeted use of the metal. 
 As was mentioned above, there are significant gaps in the knowledge of copper 
uptake, metabolism, and homeostasis in bacterial cells. Within this study, many new 
copper binding proteins were identified in the S. aureus Newman strain as the multiple 
peaks of the 65Cu trace appeared inconsistent with the four copper-binding proteins known 
in the organisms’ proteome. Further purification of the copper-containing fractions of the 
bacterial lysates could provide a greater understanding of unknown aspects of copper 
biochemistry. For example, low molecular weight molecules like glutathione and other 
unidentified peptide/proteins have been hypothesised to act as a copper buffering pool.25 In 
the chromatograms presented herein two small, broad peaks were observed in the copper 
trace of S. aureus which could be representative of LMW buffered copper as the broadness 
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Appendix 2.9.1 Operating parameters 
Table 9: Typical operating parameters for SEC-ICP-MS experiments 
Agilent 1200 LC 
Mobile phase 100 mM HEPES, pH 7.4 
Column Agilent AdvancedBio SEC 130 or 300 Å 
Particle size 2.7 µm 
Pore size 130 or 300 Å 
Flow rate 0.3 mL/min 
Injection volume 10 – 100 µL 
Column dimensions 7.8 mm x 300 mm 
Agilent ICP-MS QQQ 8900 
RF power 1550 W 
Sample depth 10.0 mm 
Carrier gas 15.0 L/min 
Makeup gas 0.90 L/min 
Spray chamber temp 2°C 
Extracts 1, 2 -6.0 V, -250.0 V 
Omega bias, lens -150 V, 7.5 V 
Deflect, plate bias 2.0 V, -60 V 
Cell entrance, exit -70 V, -80 V 
Octopole bias, RF -18.0 V, 170 V 




Appendix 2.9.2 Experimentally determined minimum inhibitory concentrations (MIC) 
 
Figure 18: Blank-corrected growth curves of E. coli MG1655 strain, as measured by the optical density 
(OD) at 600 nm, incubated at 37°C with a range of concentrations of AgNO3 (0 µg/mL to 128 µg/mL) for 16 
hours. Time point >12 hours were discarded as the natural cell death was expected beyond this time frame. 
The minimum inhibitory concentration (MIC) was determined to be >2 µg/mL. 
 
 
Figure 19: Blank-corrected growth curves of S. aureus Newman strain, as measured by the optical density 
(OD) at 600 nm, incubated at 37°C with a range of concentrations of AgNO3 (0 µg/mL to 128 µg/mL) for 16 
hours. Time point >12 hours were discarded as the natural cell death was expected beyond this time frame. 
The minimum inhibitory concentration (MIC) was determined to be >4 µg/mL. 
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Appendix 2.9.3 Cambridge Structural Database (CSD) survey results and references 
Table 10: Survey of silver-nitrogenous bases (and relevant derivatives thereof) in CSD version 5.40 (Nov 
2018) 
CSD Code Reference Nitrogenous base 
ADAGPC Gagnon, C., et al., Inorg Chem, 1977, 16, 2469 Adenine 
EBILIM Venkatesh, V., et al., CrystEngComm, 2011, 13, 6030 
EBILOS Venkatesh, V., et al., CrystEngComm, 2011, 13, 6030 
EKAYUL Mishra, A. K., et al., Dalton Trans, 2010, 39, 10034 
EKAZAS Mishra, A. K., et al., Dalton Trans, 2010, 39, 10034 
EKAZEW Mishra, A. K., et al., Dalton Trans, 2010, 39, 10034 
EKAZIA Mishra, A. K., et al., Dalton Trans, 2010, 39, 10034 
EKAZOG Mishra, A. K., et al., Dalton Trans, 2010, 39, 10034 
FIHJOX Prajapati, R. K., et al., CrystEngComm, 2013, 15, 9316 
FIHJUD Prajapati, R. K., et al., CrystEngComm, 2013, 15, 9316 
FIHKAK Prajapati, R. K., et al., CrystEngComm, 2013, 15, 9316 
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Table 11: Survey of silver-biotin structures in CSD version 5.40 (Nov 2018) 
CSD Code Reference Interaction Bond length (Å) 






















LERDIX Altaf, M., Stoeckli-Evans, H., Acta 











LERDOD Altaf, M., Stoeckli-Evans, H., Acta 











LERDUJ Altaf, M., Stoeckli-Evans, H., Acta 









LERFAR Altaf, M., Stoeckli-Evans, H., Acta 







a Ligand chelated 
 
Table 12: Survey of silver-methionine (and derivatives thereof) structures in CSD version 5.40 (Nov 2018) 














































a Ligand chelated 
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Table 13: Survey of silver-histidine (and derivatives thereof) structures in CSD version 5.40 (Nov 2018) 




Kasuga, N. C., et al., Acta Crystallographica 































































a Ligand chelated 
Table 14: Survey of silver-cysteine (and derivatives thereof) structures in CSD version 5.40 (Nov 2018) 
CSD Code Reference Interaction Bond length 
(Å) 

































a Ligand chelated 
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Table 15: Survey of metal-thiamine (and derivatives thereof) structures in CSD version 5.40 (Nov 2018) 
CSD Code Reference Metal Interaction 
CEJHAA Cramer, R. E., et al., J Am Chem Soc, 1984, 106, 111,  Cu(I) Cu-N (LHPN)a 
Cu-Cl (x2) 
CLTMCD Cramer, R. E., et al., J Am Chem Soc, 1981, 103, 76  Cd(II) Cd-N (LHPN) 
Cd-Cl (x3) 




FURPAJ Cramer, R. E., et al., Inorg Chem, 1988, 27, 123  Pt(II) Pt-N (LHPN) 
Pt-Cl (x3) 
GETZAG Bencini, A, et al., Inorg Chim Acta, 1987, 135, 85 Zn(II) Zn-N (LHPN) 
Zn-Cl (x3) 
GETZAG01 Pengjun, L., et al., Yingyong Huaxue, 1989, 6, 40-42 Zn(II) Zn-N (LHPN) 
Zn-Cl (x3) 





HOXZID Hu, N.-H., et al., Polyhedron, 1999, 18, 2987 Cd(II) Cd-N (LHPN) 
Cd-Cl (x3) 
HOXZOJ Hu, N.-H., et al., Polyhedron, 1999, 18, 2987 Cd(II) Cd-N (LHPN) 
Cd-Br (x3) 
HOXZUP Hu, N.-H., et al., Polyhedron, 1999, 18, 2987 Hg(II) Hg-N (LHPN) 
Hg-Cl (x3) 
NOTE: dinuclear 
HOYBAY Hu, N.-H., et al., Polyhedron, 1999, 18, 2987 Hg(II) Hg-N (LHPN) 
Hg-Br (x3) 
NOTE: dinuclear 
HOYBEC Hu, N.-H., et al., Polyhedron, 1999, 18, 2987 Pt(II) Pt-N (LHPN) 
Pt-ONO 
JAHGEE Archibong, E., et al., Inorg Chim Acta, 1989, 156, 77 Cu(I) Cu-N (LHPN) 
Cu-Br (x2) 




KIBVEW Louloudi, M. et al., J Am Chem Soc, 1990, 112, 7233  Hg(II) Hg-N (LHPN) 
Hg-Cl (x3) 
LATLAT Cramer, R. E., Carrie, M. J. J. Inorg Chem, 1993, 32, 3509  Pt(II) Pt-N (LHPN) 
Pt-Cl (x2) 
Pt-S (DMSO) 
NODXUZ Hu, N.-H., Inorg Chim Acta, 2001, 325, 9 Pt(II) Pt-N (LHPN) 
Pt-ONO (x2) 
Pt-NO2  
SISHIL Aoki, K., et al., Inorg Chim Acta, 1990, 175, 247 Co(II) Co-N (LHPN) 
Co-Cl (x3) 
SISHOR Aoki, K., et al., Inorg Chim Acta, 1990, 175, 247 Zn(II) Zn-N (LHPN) 
Zn-Br (x3) 
SORXUS Malik, K.M.A., et al., J Bangladesh Chem Soc, 1990, 3, 205 Co(II) Co-N (LHPN) 
Co-Cl (x3) 
SORYAZ Malik, K.M.A., et al., J Bangladesh Chem Soc, 1990, 3, 205 Zn(II) Zn-N (LHPN) 
Zn-Cl (x3) 
SOSMES Hu, N.-H., Inorg Chim Acta, 1991, 186, 209 Mn(II) Mn-N (LHPN) 
Mn-OH2 
Mn-Cl (x2) 
Mn-O (OH tail) 
TUBJIJ Dodi, K. et al., Inorg Chem, 1996, 35, 6513  Hg(II) Hg-N (LHPN) (x2) 
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Hg-Cl (x2) 
VISCEF Aoki, K., et al., Inorg Chim Acta, 1991, 180, 117 Zn(II) Zn-N (LHPN) 
Zn-NCS (x3) 
VISCIJ Aoki, K., et al., Inorg Chim Acta, 1991, 180, 117 Cd(II) Cd-O (OH tail) 
Cd-NCS (x3) 
Cd-SCN (x2) 
YUBNAK Casas, J.S., et al., Inorg Chem, 1995, 34, 2430  Cd(II) Cd-N (LHPN) 
Cd-Cl (x3) 
Cd-O (OH tail) 
ZADCAI Casas, J.S., et al., Polyhedron, 1995, 14, 1825  Cd(II) Cd-N (LHPN) (x2) 
Cd-Cl (x4) 
ZADCAI01 Marsh, R.E., Acta Crystallographica, Section B, 1999, 55, 
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Cd(II) Cd-N (LHPN) (x2) 
Cd-Cl (x4) 
a LHPN = least hindered pyrimidine nitrogen 
Table 16: Survey of silver-porphyrin interactions in CSD version 5.40 (Nov 2018) 
CSD Code Reference 
 
Av. Ag-N (Å) 
ABOSOZ Ishii, T., et al., Inorg Chim Acta, 2001, 317, 81 2.089 
AYOHOM Liao, J.-X., et al., Acta Crystallographica Section E, 2011, 67, m1316  2.084 
BICQUZ Wong, W.-K., et al., Dalton Transactions, 1999, 615  2.094 
BOPVUY Epple, L. et al., Fullerenes, Nanotubes, Carbon Nanostructures, 2009, 67 2.088 
DOWRAI Scheidt, Y.-J., et al., Inorg Chem, 1986, 25, 795  2.092 
LICRAR Xu, Y.-J., et al., Acta Crystallographica Section E, 2007, 63, m1437  2.099 
QAKTUR Senge, M.O., et al., Tetrahedron, 2000, 56, 8927 2.087 
QOMCUR Epple, L., et al., Chem Comm, 2008, 5610 2.093 
QOMCUR Epple, L., et al., Chem Comm, 2008, 5610  2.101 
RUVHEX Jiang, W., et al., Chem Comm, 2016, 52, 1373 2.080 
TEJBAO Singh, A. K., et al., Ange Chemie, Intl Ed, 2017, 56, 8849 2.091 
TEJBAO Singh, A. K., et al., Ange Chemie, Intl Ed, 2017, 56, 8849 2.095 
TEJBES Singh, A. K., et al., Ange Chemie, Intl Ed, 2017, 56, 8849 2.025 
TEJBES Singh, A. K., et al., Ange Chemie, Intl Ed, 2017, 56, 8849 2.089 
TEJBOC Singh, A. K., et al., Ange Chemie, Intl Ed, 2017, 56, 8849 2.031 
TEJBOC Singh, A. K., et al., Ange Chemie, Intl Ed, 2017, 56, 8849 2.035 
TPSTPP Schneider, M.L., Dalton Transactions, 1972, 1093  2.063 
UPOTEZ Carlucci, L., et al., J Porphyrins Phthalocyanines, 2010, 14, 804 2.071 
UPOTID Carlucci, L., et al., J Porphyrins Phthalocyanines, 2010, 14, 804  2.080 
XIQLAN Wand, H.-H., et al., Chinese Chem Lett, 2018, 29, 1404  2.099 




Appendix 2.9.4 Size exclusion column calibration and molecular weight markers 
Table 17: SEC calibration proteins (Figure 21, blue series), molecular weights and concentrations of 







Thyroglobulin 669 5 Gel filtration HMW calibration kit (product 
ID: 28403841, GE Healthcare Life Sciences, 
US 
Ferritin 440 0.3 
Conalbumin 75 3 
Carbonic 
anhydrase 
30 3 Gel filtration LMW calibration kit (product 
ID: 28403842, GE Healthcare Life Sciences, 
US 
Ribonuclease A 13.7 3 
Aprotinin 6.5 3 
Bovine serum 
albumin (BSA) 




64.5 1 Sigma Aldrich, CAS 9048-46-8; ³98.0% 
 
 
Figure 20: Normalised size exclusion chromatograms of protein standards. Agilent AdvanceBio SEC 300Å 
column (7.8 x 300 mm I.D.; 2.7 µm particle size); temperature: ~20°C; mobile phase: 100 mM HEPES, pH 
7.4; flow rate: 0.3 mL/min; injection volume: 10 µL; detector: Agilent Infinity 1200 variable wavelength 
detector set at 280 nm. Naturally occurring thyroglobulin dimer (shoulder on low retention time edge of 
monomer peak, MW ~1338 kDa) was identified as the void volume of the column. Calibration protein 




Figure 21: Calibration curve of log10 protein standard molecular weights and retention times, as determined 
by monitoring column effluent at 280 nm. Agilent AdvanceBio SEC 300Å column (7.8 x 300 mm I.D.; 2.7 
µm particle size); temperature: ~20°C; mobile phase: 100 mM HEPES, pH 7.4; flow rate: 0.3 mL/min; 





Chapter Three: The biochemical fate of silver ions in human blood 
3.1 Abbreviations 
AS   Australian Synchrotron 
BSA   bovine serum albumin 
CSD   Cambridge Structural Database 
Cys   cysteine 
EXAFS  extended X-ray absorption fine structure 
FCS   foetal calf serum 
FT   Fourier transform 
GSH   glutathione 
Hb   haemoglobin 
HEPES  4-(2-hydroxyethyl)-1-piperazinethane sulfonic acid 
HSA   human serum albumin 
LCF   linear combination fitting 
PCA   principal component analysis 
RBC   red blood cell 
vi   inclusion volume 
vo   void volume 
WHO   World Health Organisation 
XANES  X-ray absorption near-edge structure 
XAS   X-ray absorption spectroscopy 
 
3.2 Introduction 
 Historically ‘lunar caustic’ (silver nitrate) was applied to wounds to aid healing.1 
During the First World War, silver salts were used to treat burns or wounds to ‘cleanse 
them’.2 However, the discovery of molecular antibiotics in the early 20th century led to a 
decline in use of silver. A lack of novel antibiotic drug discovery or research, coupled with 
over prescription and misuse, has seen the efficacy of these drugs waning as bacteria 
develop resistances against them.3 Rising concern over an antibacterial resistance crisis has 
seen an increase in materials for medical and commercial use which contain silver to 
imbue them with bactericidal properties.4 While silver has traditionally been viewed as 
non-toxic to humans, adverse side effects have been reported if used inappropriately.5-11 
Chronic exposure to silver leads to a condition called argyria, the primary symptom of 
which is the permanent subdermal deposition of silver as Ag(0) and sulfides which gives 
the person a blue appearance.6 Several case studies involving chronic exposure of 
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individuals to silver show a mixture of symptoms, ranging from staining of the skin (but 
otherwise asymptomatic), to weight loss, anaemia, contraction of secondary infections 
(pneumonia), and neurodegenerative conditions.9-10, 12 Mice receiving daily silver 
‘supplementation,’ displayed reduction in ceruloplasmin activity, and infertility, from 
which the mice recovered when silver dosing was stopped.13 Conversely, inclusion of 
silver in some prosthetic implants has been shown to have no adverse effects on the 
recipient while preventing bacterial infection and increasing wound healing or showing no 
adverse effects.14 To better understand the reported variability and inconsistency between 
in vivo and in vitro results, a greater understanding of the biochemical fate and speciation 
of silver in biological systems is needed. 
 Three main routes of exposure to silver exist: dermal, inhalation, and ingestion, all 
of which bring the metal in close proximity to the vascular system.15 Patients treated with 
silver-based wound dressings or implants have been shown to have elevated plasma silver 
concentrations, indicating that the metal is not localised to a wound site once used.16 
Particulate silver lodged in the lungs can undergo oxidative dissolution and the released 
silver ions absorbed into the blood stream via the alveoli.17 Finally, if ingested, 
approximately 10 to 20% of the total silver consumed is absorbed from the small intestines 
into the blood stream while the remaining amount is excreted from the body.18 As such, the 
speciation and biochemical fate of silver ions in human whole blood is important to 
understand when considering the metal’s interaction with humans. 
 Previous studies concerning the effect of silver ions in blood have found that the 
metal can lyse red blood cells (possibly by scrambling membranes and lipid peroxidation), 
disruption of KCl efflux, impede clotting and reduce cellular ATP concentrations.19-20 In 
the case of AgNPs, unless intravenously injected, only silver ions released from the 
particles are expected to be present in the vascular system. Once in the blood, it has been 
suggested that Ag+ could interact with reduced thiolates and proteinaceous species as well 
as formation of chloride salts.21-22 However, such studies were only conducted via dynamic 
light scattering techniques which provide little to no information on chemical speciation.  
 
3.2.1 Research aims 
 With increased use of silver in medical and commercial spheres, the rate of human 
exposure to the metal has increased. While only mildly toxic against mammals or humans 
the speciation of the metal within these systems is important to understand as adverse 
effects of the use of silver have been reported.5, 7-11, 23  
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 We aim to investigate the biochemical fate of silver ions in human whole blood and 
related biological fluids. Analysis of a sub-population of the whole blood proteome (the 
metalloproteome) could aid in identification of specific silver-binding targets. Localisation 
of silver in whole blood was also investigated. To ensure only biologically relevant silver 
interactions were recorded, metallomics techniques were used, namely, X-ray absorption 
spectroscopy (XAS), and size exclusion chromatography coupled with ICP-MS (SEC-ICP-
MS). Limited speciation studies regarding the interaction between silver ions and whole 
blood or mammalian biological fluids have been reported. However, other inorganic 
species in blood or relevant fluids have been investigated through use of metallomics 
techniques like X-ray absorption spectroscopy (XAS), and size exclusion chromatography 
coupled with ICP-MS or ICP-AES (SEC-ICP-MS/AES). 
 
3.2.2 X-ray absorption spectroscopy 
 While not directly related to speciation of silver in blood, an XAS study to 
investigate the speciation and distribution of silver in marine mammals indicated that Ag2S 
or Ag2Se species predominated in the animals’ livers.24 The minimal sample preparation 
required means that there is little risk of perturbation of naturally occurring species or 
introduction of processing artefacts. Another study involved the collection of hair and 
blood from citizens of a town in China which is in close proximity to a mercury mine.25 
Analysis of the Hg L3-edge of the samples revealed that while inorganic Hg2+ was the 
dominant species in hair (~92%), there was a 50:50 split between methyl mercury and 
Hg2+ in the blood.  
 The use of XAS is not limited to toxicants or heavy metals, a species of worm 
Ascidia certodes (A. ceratodes) is known to have naturally high concentrations of 
vanadium in its blood.26 Analysis of the V K-edge of two different species known to be 
closely related but geographically isolated indicated that the two organisms had 
significantly different vanadium blood chemistry. In another study by the same group on 
the same organism, sulfur K-edge XAS enabled a greater understanding of the range of 
different sulfur-containing species in the worm’s blood.27 
 Speciation of a drug or supplement is an important consideration for human health 
and the efficacy of the administered medicine. An XAS study regarding the biochemistry 
of non-toxic chromium(III) supplements, purported to have antidiabetic properties, showed 
that the Cr(III) species induced oxidative stress in the blood and was oxidised to toxic 
Cr(VI) or Cr(V) oxidation states, presenting potentially health risks.28 
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 It has also been shown by XAS that the breakdown of various vanadium(V) and 
(IV) anticancer and antidiabetic drugs in human blood result in the formation of the same 
V-containing metabolic products.29 By principal component analysis and linear 
combination fitting the vanadium metabolite was found to be in the (IV) oxidation state, 
coordinated by carbohydrate/citrate-like ligands (65-85%), as well as in the (V) oxidation 
state bound by protein (15-35%).  
 XAS can also be used to characterise the binding sites of a metal ion in a purified 
sample of protein or biomolecule, for example, Sendzik et al., identified a Cu+ binding site 
on human serum albumin (HSA).30 Analysis of the Cu K-edge EXAFS showed the Cu2+ 
was bound by the ATCUN motif and, upon reduction with ascorbate, Cu+ was bound by a 
different site consisting of two histidine residues. Long range backscattering interactions 
can sometimes be observed in the EXAFS Fourier Transform (FT) if the analyte is 
coordinated by a rigid, planar species (like a histidine imidazole). 
 The binding interactions of silver ions in proteins known to be involved in copper 
homeostasis were probed by XANES and EXAFS analysis of the Ag K-edge.31 Silver was 
found to be bound by the Cu+ binding loop of the copper chaperone Atox1, namely digonal 
binding with two cysteine residues. Also investigated was the silver coordination in rabbit 
and yeast metallothioneins, which were dominated by Ag-S interactions typical of AgS3 
geometry. 
 
3.2.3 Size exclusion chromatography hyphenated with ICP-MS 
 Size exclusion chromatography enables the separation of complex samples based 
on the components’ hydrodynamic radius, which can be correlated to molecular weight.32 
Hyphenation of SEC with a secondary analytical technique like ICP-MS or ICP-AES 
allows visualisation of metal-bound species and estimation of molecular weight. 
Simultaneous detection of multiple analytes by ICP-MS provides some deconvolution of 
eluting species in the biological sample. Regarding silver, a solitary study investigating the 
fate of Ag+ and AgNPs in E. coli by use of SEC-ICP-MS has been reported.33 However, 
speciation experiments of other inorganic analytes in whole blood or related biological 
fluids have been carried out. 
 Copper, zinc, and iron are essential micronutrients for all organisms and are 
involved in a range of biological processes. In 2009, Manley, et al., analysed healthy 
human plasma by SEC-ICP-AES and identified multiple Cu/Zn/Fe metalloproteins; 
including, ceruloplasmin, human serum albumin, and possible superoxide dismutases.34 In 
the study a peak in the iron trace was thought to correspond to the Fe storage protein 
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ferritin, but was recently confirmed to be the first identification of the haptoglobin-
haemoglobin complex35 which serves to free haemoglobin from reaching the kidneys.36 
Such findings, and identification of important plasma proteins in healthy individuals, could 
allow for non-invasive blood screening and diagnosis of diseases associated with metal-
binding plasma proteins.37 For example, a patient with Wilson’s disease will 
characteristically have low ceruloplasmin plasma levels, conversely, a person with 
hemochromatosis (an overload of iron) will typically have elevated holo transferrin 
levels.38-39 
 In addition to monitoring biologically relevant metal ions, the technique can shed 
light on important biochemical processing of toxic heavy metals in blood. Gibson et al., 
investigated the fate of Cd2+, Hg2+, CH3Hg+, and thimerosal in red blood cell lysate by 
SEC-ICP-AES.40 They identified that the majority of cadmium was associated with 
haemoglobin (Hb) (85%) with a much smaller proportion associated with reduced 
glutathione (~13%). The inverse was found to be true for Hg2+ with only 6% Hg eluting 
with Hb and 94% bound as GSH complexes, confirming previously trends reported for the 
speciation of the metals in RBCs.41-42 The biochemical fate of methyl mercury and 
thimerosal was found to be similar to mercuric ions with 5-12% associated with 
haemoglobin after 6 hours and the authors posited that the interaction between the heavy 
metal and Hb could be a source of its toxicity against mammals. Additionally, the study 
was supported by Hg L3-edge X-ray absorption spectroscopy which indicated the metal 
was predominantly bound by sulfur. 
 Combination therapy of two metal-based anticancer drugs, cisplatin (Pt) and 
NAMI-A (Ru), has been demonstrated to be more effective in treatment of lung metastasis 
than when administered alone.43 SEC-ICP-AES was used to determine, in human plasma, 
whether exposure to both drugs resulted in unfavourable or toxic metabolites.44 The 
technique also indicated that the two drugs have distinct metabolic and hydrolytic 
chemistries in plasma; cisplatin largely remained as the molecular species with a minor 
component consisting of protein bound species, conversely, NAMI-A was immediately 
hydrolysed and bound by plasma proteins (<10 min post exposure). 
 The technique can also be used to guide drug design under a similar premise to the 
above study. Harper et al., investigated the degradation products of a range of platinum-
containing complexes in the presence of glutathione spiked rabbit plasma over time which 
allowed selection of the species least susceptible to inhibition in plasma.45 
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3.3 Methods and procedures 
Materials 
 Silver nitrate (CAS 7761-88-8; >99%); 4-(2-hydroxyethyl)-1-
piperazinethanesulfonic acid (HEPES; CAS 7365-45-9; >99.5%); human haemoglobin 
(CAS 9008-02-0, lyophilized powder); bovine serum albumin (CAS 9048-46-8; ³98.0%); 
L-cysteine (CAS 52-90-4; 97%); L-methionine (CAS 63-68-3; ³98%); thiamine 
mononitrate (CAS 532-43-4; ³98%); L-histidine (CAS 71-00-1; ³99%); glycine (CAS 56-
40-6; ³99%); biotin (CAS 58-89-5; ³99%) were purchased from Sigma Aldrich. 
Thyroglobulin; ferritin; aldolase; conalbumin; carbonic anhydrase; ribonuclease; aprotinin; 
ovalbumin were purchased from GE Healthcare, Life Sciences. Ultra-pure MilliQ water 
(Merck Millipore purification system) with resistivity of 18 MΩ.cm-1 was used. All 





 HEPES (100 mM) was prepared by dissolving the relevant solid in the appropriate 
volume of ultra-pure water. The pH was adjusted to 7.4 by the addition of NaOH (6M) 
(Orion Star pH Meter, Thermo Scientific). For size exclusion experiments, the mobile 
phase was passed through a 0.45 µm nylon-membrane filter before use. 
 
SEC-ICP-MS 
 The SEC-ICP-MS was comprised of a high-performance liquid chromatography 
(HPLC) pump (Agilent 1200 Infinity Series, Santa Clara, CA, USA) and an inductively 
coupled plasma mass spectrometer (Agilent QQQ 8900, Santa Clara, CA, USA). A 
prepacked Agilent AdvanceBio SEC 300Å size exclusion column (7.8 mm x 300 I.D., 
particle size: 2.7 µm, fractionation range 1200 – 5 kDa) was used with a 100 mM HEPES 
mobile phase at a flow rate of 0.3 mL/min (column temperature: ~20°C). The void volume 
(vo) and inclusion volume (vi) were determined by the injection of thyroglobulin – which 
naturally contains the thyroglobulin dimer (tr = 6.75 min), and aprotinin (tr = 15.13 min), 
respectively; each detected by a variable wavelength detector (1200 series, VWD, Agilent) 
measuring absorbance of the column effluent at 280 nm. Protein standards used to 
construct a calibration curve were thyroglobulin (5 mg/mL), ferritin (0.3 mg/mL), 




X-ray absorption spectroscopy 
 Data collection. Silver K-edge X-ray absorption spectra were recorded on the X-
ray absorption spectroscopy (XAS) beamline at the Australian Synchrotron (AS), Victoria, 
Australia. The energy of the electron beam was 3.0 GeV with a current of ~200 mA, and 
an X-ray beam was sourced from a wiggler, monochromated by the Si(111) 
monochromator, and harmonic rejection achieved using a rhodium-coated mirror. Samples 
were positioned at ~45° to a 100-element germanium fluorescence detector which was 
placed at 90° to the incident beam. The energy ranges used for EXAFS spectra collection 
were: pre-edge region 25.3140 – 25.4941 keV (0.003 eV steps); XANES region 25.4941 – 
25.5641 keV (0.0003 eV steps); and EXAFS region 25.5641 – 25.700 keV. During data 
collection the samples were maintained at a temperature of ~ 10 K using a Cryo Industries 
(Manchester, NH, USA) cryostat. The spectrum of a silver foil, recorded in transmission 
downstream from the sample, was used as an internal standard to calibrate the energy scale 
for the first peak of the first derivative of the elemental silver edge (25.5156 keV). 1 to 4 
scans per sample were collected for EXAFS spectra. 
 Data analysis. Calibration, averaging, background subtraction of all spectra and 
principle component, target, and multiple linear regression analyses of XANES spectra 
were performed using the EXAFSPAK software package (G. N. George, SSRL). Single 
and multiple-scattering fits of EXAFS data were carried out using EXAFSPAK and the 
FEFF8 code.46 The model compounds for target analysis and XANES linear combination 
fitting were prepared, and spectra recorded at the AS, Victoria, Australia. 
Model spectra. Glassed solutions of relevant amino acids, B vitamins, and proteins in 100 
mM HEPES buffer were used to obtain model spectra for XANES fitting of biological 
samples and EXAFS analysis. The amino acid and vitamin samples had a molar ratio of 
5:1 with a 2 mM final concentration of silver. Protein models had a molar ratio of 2:1 





3.1 Blood collection 
 Whole blood donated by the author, was collected into heparin-coated Vacutainer 
tubes (Becton Dickinson), stored on ice prior to experimentation, and used within 1 h of 
collection.  
 
3.2 Silver localisation study 
 A silver nitrate stock solution (50 mM, 40 µL) was added to whole blood (960 µL) 
and incubated (37°C, 200 rpm, 60 min). The sample was centrifuged (4000 rpm, 5 min, 
4°C), the plasma and RBCs separated, and stored on ice. The procedure was carried out 
simultaneously on six samples of whole blood which differed in the time of incubation 
with silver nitrate (5, 10, 20, 30, 40, 50 min). A zero min sample was prepared by the 
addition of silver nitrate to an ice-cold sample of blood followed by immediate 
centrifugation (as above). The RBCs were lysed by diluting the sample in HEPES buffer 
(1:4). The concentration of silver in both the plasma and red blood cell fractions was 
determined by AAS. 
 
3.3 X-ray absorption spectroscopy of human blood 
 A portion of the blood collected in 3.1 was centrifuged (2000 rpm, 10 min, 4°C) 
and the supernatant plasma removed to be used as a sample of isolated plasma. A silver 
nitrate solution (50 mM) in MilliQ water was prepared in the hour preceding the 
experiment and added to whole blood (20 µL), isolated plasma, or serum to give a final 
volume of 0.5 mL, and a final Ag(I) concentration of 2.0 mM.  
 Two whole blood samples were centrifuged (2000 rpm, 10 min, 4°C) to separate 
the plasma and RBC fractions for ‘whole blood – plasma/RBC fraction’ samples. All 
samples were loaded, neat, into Lucite XAS samples holders, secured with Kapton tape, 
flash frozen to form a glass and stored at -180°C until analysis. 
 
3.4 SEC-ICP-MS 
 Whole blood (960 µL) was treated with silver nitrate (50 mM, 40 µL) and 
incubated (37°C, 200 rpm, 1 h). The sample was briefly cooled on ice, centrifuged (4,000 
rpm, 4°C, 5 min), and the plasma and RBC fractions isolated. The RBC fraction was 
diluted in HEPES buffer (1:10) and the cells lysed (BioRuptor, 8°C, 15 min). Both the 
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plasma and lysed RBCs were centrifuged (14,000 rpm, 4°C, 15 min) to remove cellular 
detritus and unlysed cells prior to SEC experiments. 
 To prepare a blood sample with low silver concentration whole blood (984 µL) was 
spiked with silver nitrate (6 mM, 16 µL) and treated as above. The plasma fraction was 
isolated and used for SEC analysis. 
 To assist the identification of haemoglobin (Hb) and human serum albumin (HSA), 
a solution of each (bovine serum albumin used in lieu of HSA) (3 mg/mL) was injected (10 
µL) onto a SEC column (300 Å, 0.3 mL/min, ~280 bar) and the UV absorbance monitored 




X-ray absorption spectroscopy  
XANES of silver in blood 
 The Ag K-edge XANES of human blood and related biological fluids spiked with 
AgNO3 are displayed in Figure 1. A range of post-edge shapes and features were observed 
which could be loosely grouped thusly: spectra (a) to (e), which displayed low intensity 
oscillations with few distinct features, and spectra (f) and (g) with intense, high-frequency 
oscillations which were consistent between the two samples. 
 
 
Figure 1: Ag K-edge XANES spectra of biological fluids incubated at 37°C with 2 mM AgNO3 for 1 hr: (a) 
human whole blood; (b) RBC fraction from whole blood; (c) plasma fraction from whole blood; (d) RBC 
lysate; (e) precipitate that formed when AgNO3 was added to (d) and subsequently isolated by centrifugation; 
(f) isolated plasma; (g) foetal calf serum. 
 
 Fresh human whole blood was spiked with silver nitrate to a final concentration of 
2 mM, and incubated at 37°C for 1 hr; the Ag K-edge XANES are displayed in Figure 1a. 
Additional samples of whole blood were treated as above and separated into plasma and 
red blood cell (RBC) fractions, Figure 1b and c, respectively. The three whole blood 
samples (a), (b), and (c) displayed similar XANES features including a change in the slope 
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of the rising edge at ~25,518 eV (seen previously for nitrogen-coordinated species 
Chapter 2), the energy of the peak atop the rising edge (25,525 eV) and a trough at 25,560 
eV. However, the first and second broad post-edge peaks at 25,545 and 25,585 eV shifted 
by -5 eV and +10 eV, respectively, between the RBC and plasma spectra. 
 To investigate possible changes in speciation of silver in processed biological 
fluids, (such as RBC lysate), relative to whole blood, the Ag K-edge XANES of RBC 
lysate spiked with AgNO3 (post-lysis) was recorded (Figure 1d). The spectra of the RBC 
fraction of whole blood (b), and RBC lysate (d) were similar, with all significant post-edge 
features (including the change in the slope of the rising edge at 25,525 eV) consistent 
between them. However, the first two post-edge peaks of the RBC lysate were moderately 
more intense than those of the RBC fraction isolated from whole blood that had been 
spiked with AgNO3. 
 The similarity of the whole blood RBC spectrum and that of the RBC lysate was 
unexpected as the addition of the silver nitrate solution to the lysate generated a significant 
amount of reddish-black precipitate. The precipitate was isolated, freeze-dried and XANES 
recorded (Figure 1e). The XANES spectrum of the precipitate was, overall, flat and 
featureless, however, a peak atop the rising edge (25,530 eV), a subsequent peak at 25,540 
eV, and a trough at 25,560 eV were discernible; all features shared by spectra (a) to (d). 
 Other processed biological fluids such as isolated plasma, and foetal calf serum 
(FCS) were also incubated with AgNO3 at 37°C for 1 hr. The Ag K-edge XANES of both 
the isolated plasma (Figure 1f) and FCS (g) had very different post-edge features 
compared to the RBC lysate/precipitate and whole blood samples. The intensity of the 
peaks in the spectrum of isolated plasma were lower in intensity than those of the FCS 
XANES. Strong post-edge oscillations continuing to high energy suggested a well-ordered 
local environment around the absorbing silver atoms, e.g. a solid/colloid. 
 
 Principal component analysis (PCA) of the blood XANES dataset presented in 
Figure 1 indicated that three to four spectral components were required for the data to be 
adequately described. Target transformation of the blood XANES spectra against a library 
of model Ag K-edge XANES spectra allowed qualitative identification of species that may 
have been present in each experimental sample. Visually, the XANES of solid silver 
chloride, aqueous silver-cysteine, silver-haemoglobin, and silver-BSA models shared 
features with those of the experimental blood dataset. The ratio of each model spectrum 
required to describe the experimental spectra was calculated by linear combination fitting 
(LCF) (Table 1 & Figure 2). 
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Figure 2: Linear combination fits of Ag K-edge XANES of biological fluids incubated at 37°C with 2 mM 
AgNO3 for 1 hr: (A) human whole blood; (B) RBC fraction from whole blood; (C) plasma fraction from 
whole blood; (D) lysed RBCs; (E) precipitate that formed when AgNO3 was added to (D) and subsequently 
isolated by centrifugation; (F) isolated plasma; (G) foetal calf serum. The experimental spectra (black) were 
fit with a linear combination fit (green) comprised of model XANES spectra of silver-BSA (dark blue), 
silver-haemoglobin (orange), solid bulk silver chloride (light blue), silver-cysteine (purple) with the residual 
(red) shown offset. Numerical results of linear combination analysis are shown in Table 1. 
 
 Silver chloride was found to be the dominant contribution in the silver-spiked 
isolated plasma and FCS XANES (Figure 2F and G), accounting for 65 and 95% of the 
experimental spectra, respectively. The second largest contribution was from BSA (27 and 
5%, respectively), while cysteine (Cys) contributed ~8% of the isolated plasma (Table 1 & 
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Figure 2). While it was evident that silver chloride was a large component of the isolated 
plasma and FCS samples, the model spectrum of bulk solid silver chloride was not a 
perfect model for the experimental spectra. Upon addition of silver nitrate to isolated 
plasma or FCS no white, flocculent precipitate was observed (which would be expected for 
precipitation of AgCl). This would suggest that the silver chloride in solution may have 
formed nanoparticles/a colloidal suspension or possibly existed as a charged polychloride 
species (e.g. AgCl2-/AgCl32-, etc.). The latter, however, would not be expected to display 
similar XANES features to that of solid AgCl as polychlorido silver would likely exist as 
discrete, water-soluble species. While the post-edge features of the plasma and FCS 
XANES shared clear similarities with that of bulk silver chloride, the intensities of the 
oscillations in the bulk AgCl XANES did not match those of the experimental samples; a 
phenomenon previously observed for nanoparticulate species vs. bulk material.47-48 
Haemoglobin (Hb) was included in the LCF of isolated plasma and FCS spectra but found 
to have negligible contributions.  
 
Table 1: Calculated ratios of Ag species in biological fluids treated with 2 mM AgNO3 and incubated for 1 
hr at 37°C, as estimated by linear combination of model XANES spectra.a 
 Ratio of component fitted   
Sample Haemoglobin BSA Cysteine Chloride Ntotb Residual 
Whole blood 0.71(7) 0.24(7) - - 0.95 0.25 
Whole blood – RBC  0.53(1) - 0.45(1) - 0.98 0.024 
Whole blood – plasma  0.34(5) 0.32(6) 0.33(4) - 0.99 0.11 
RBC lysate 0.68(2) 0.049(3) 0.27(2) - 0.99 0.021 
RBC lysate ppt. 0.32(2) - 0.43(2) 0.214(9) 0.96 0.082 
Isolated plasma - 0.27(5) 0.078(5) 0.65(2) 1.00 0.34 
Foetal calf serum - 0.051(4) - 0.95(4) 1.00 1.19 
aValues in parentheses are the estimated standard deviation derived from the diagonal elements of the 
covariance matric and are a measure of precision. bNtot is the sum of fractions. 
 
 A high contribution from haemoglobin in the whole blood LCF (Figure 2A) was 
consistent with the general trend observed for the localisation of silver in whole blood (see 
localisation study, Figure 7), which showed that ~90% of Ag was localised in the RBCs. 
All fractionated whole blood or RBC lysate/precipitate XANES (B) to (E) were found to 
have mixed contributions from haemoglobin, BSA, and cysteine-bound silver. The linear 
combination fit of the plasma fraction from whole blood was approximately a three-way 
split between the aforementioned model spectra, including haemoglobin. Haemolysis of 
erythrocytes in whole blood spiked with 2 mM AgNO3 was observed within 5 minutes of 
the addition of a solution of silver nitrate (40 µL in 960 µL of blood), regardless of 
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isotonicity. This meant that the plasma fraction of whole blood was contaminated with 
RBC cellular contents, including haemoglobin, which was identified by the LCF 
calculation, showing ~33% contribution from Ag-Hb (Table 1). 
  
 Comparison of the proportions of components fit to the RBC fraction from spiked 
whole blood and spiked RBC lysate (Table 1) showed some similarities between the two 
samples. The Ag-haemoglobin model had the largest contribution of both spectra followed 
by cysteine, and 5% BSA for the lysate. The composition of the reddish-black precipitate 
that formed upon addition of AgNO3 into RBC lysate was found to be a mixture of species 
including silver bound to cysteine, haemoglobin, and chloride.  
 
CSD survey of interactions between silver and biologically relevant moieties 
 A survey of the Cambridge Structural Database (CSD) was conducted for 
interactions between silver and biologically relevant functional groups (Table 2). Silver 
coordination spheres consisting of only one type of donor atom (i.e. only sulfur, nitrogen 
or oxygen) were surveyed for total coordination numbers of two, three, and four; the most 
common coordination numbers for silver in biological systems.49 Across all systems 
investigated (bar AgO3) an increase in total coordination number correlated with an 
increase in average bond length, however, a surprisingly broad range of bond lengths was 
observed. Additionally, the average bond lengths of sulfur (thiolate and thioether) were 
found to be longer than for silver to nitrogen, as would be expected based on atomic radii. 
However, the average Ag-carboxylate bond lengths did not follow the periodic trend. All 
interactions investigated resulted in broad bond length ranges (min. vs. max. values, Table 
2) with the breadth of Ag-O interactions being the largest (2.087 to 2.981 Å for AgO2 
coordination spheres); suggesting that silver coordination bond lengths could vary widely. 
 
 The mode values of each dataset were provided to give insight into whether the 
calculated average bond length for each coordination sphere was representative of the most 
frequently occurring bond distances; the mode of datasets with low total numbers of 
structures were excluded (e.g. AgS4 thiolate). For most of the datasets the mode agreed 
well with the calculated averages. 
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Table 2: Survey of interactions between silver and biologically relevant moieties in CSD version 5.40 (Nov 









Min. (Å) Max. (Å) Mode (Å) 
Thiolate AgS2 57 2.39 0.03 2.29 2.48 2.37 
AgS3 21 2.53 0.03 2.46 2.57 2.52 
AgS4 6 2.58 0.05 2.50 2.63 - 
Thioether AgS2 12 2.45 0.06 2.41 2.64 - 
AgS3 10 2.53 0.02 2.51 2.57 - 
AgS4 42 2.59 0.03 2.51 2.69 2.58 
Amine AgN2 110 2.18 0.08 2.05 2.51 2.14 
AgN3 29 2.30 0.04 2.23 2.43 2.29 
AgN4 44 2.37 0.10 2.15 2.48 2.40 
Carboxylate AgO2 108 2.35 0.15 2.11 2.75 2.12 
AgO3 30 2.32 0.07 2.24 2.59 2.31 





Speciation of silver with human haemoglobin and bovine serum albumin 
 Two of the most abundant proteins in human blood are haemoglobin (309 g/L in 
healthy RBCs)50 and human serum albumin (HSA) (36-53 g/L).51 Thus, understanding the 
association of silver with these proteins in isolation is useful when considering the 
speciation of silver in whole blood. Bovine serum albumin was used in lieu of HSA as the 
two proteins share a sequence similarity of 76% and are considered analogous 
biomolecules.52 The silver K-edge EXAFS spectra of BSA and Hb in buffered solutions 
with 2 mM AgNO3 are shown in Figure 3. Only a two-fold excess of protein relative to 
silver was used as this was the highest ratio achievable before protein solubility issues 
arose. The Fourier Transforms (FTs) of the BSA and Hb EXAFS displayed three resolved 
peaks centred around ~2 Å, the relative intensities of which varied between each sample. 
Additionally, the width of the most intense peak in the BSA sample was greater than for 
haemoglobin. The EXAFS oscillations (Figure 3, left panel) for BSA were not evident 
beyond 12 Å-1 while the oscillations of the Hb spectrum were present up to 14 Å-1. 
 
Figure 3: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
bovine serum albumin (BSA) (top), and human haemoglobin (bottom) in buffered solutions of silver nitrate 
(final metal to protein ratio of 1:2), showing experimental (black) and calculated (green) data with the 
residual (red) shown offset. Fit parameters are shown in Table 3. 
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 The parameters fit to the EXAFS in Figure 3 are summarised in Table 3. Both the 
haemoglobin and BSA spectra were successfully fit with S2N/O silver coordination spheres 
with short and long silver-sulfur interactions. Variation in fit error was likely due to the 
relative noise level of each spectrum, as evident in the fit residuals. The short Ag-S 
distances at 2.35 and 2.38 Å for BSA and Hb, respectively, were consistent with silver-
thiolate (cysteine) interactions observed for a number of small molecule crystal structures, 
according to a survey of the CSD (Table 2). The Ag-S distances at ~2.9 Å were longer 
than would be expected for silver-thiolate or thioether interactions, however, only sulfur 
(and chlorine) backscattering atoms provided physically realistic fit parameters and 
visually acceptable fits. While it would not be possible to differentiate between sulfur and 
chlorine backscattering atoms when fitting the EXAFS, it was unlikely to be an Ag-Cl 
interaction as care was taken to prevent introduction of chloride anions when preparing the 
samples (such as use of MilliQ water and pH adjustment of buffers with HNO3 instead of 
HCl, etc) to avoid precipitation of AgCl. As silver-thioether bonds tend to be longer than 
equivalent thiolates it was assumed that the longer Ag-S distance was due to interaction 
with methionine residues in the respective proteins. 
 A short Ag-S interaction symmetrically fit the prominent peak in the haemoglobin 
FT in Figure 3, however, the same interaction was asymmetrically fit to the BSA FT, thus 
an additional nitrogen/oxygen component at 2.24 Å was added. In the EXAFS FT of Hb a 
N/O backscatterer at 2.08 Å adequately fit the peak at ~2 Å. An Ag-N/O interaction at 2.08 
Å was shorter than would be expected for amine species (Table 2) but matched exactly the 
average Ag-N distance observed in silver-porphyrin structures (average Ag-N distance: 
2.08 ± 0.02 Å) (Appendix 2.9.3, Table 16). However, beyond the aforementioned bonding 
interaction, no evidence for the inclusion of silver in the heme porphyrin moieties of 
haemoglobin was observed (e.g. Ag-Fe interactions in the EXAFS, or multiple scattering 
interactions due to the rigid porphyrin ring). Similar short bond lengths have previously 
been reported for silver-imidazole (histidine), water, and carboxylate interactions (Table 2 
and Appendix 2.9.3). It was possible that the interaction fitted could be one, or all, of 
those mentioned as XAS data represents a weighted average of all silver environments.  
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Table 3: Parameters fit to EXAFS spectra of bovine serum albumin, and human haemoglobin in buffered 
solutions with silver nitrate shown in Figure 3. 
Sample Scatterer CN Distance DWF -E0 Fit error 
Bovine serum 
albumin 
N/O 1 2.24(2) 0.003(2) 17(1) 0.60 
S 1 2.350(9) 0.006(2)   
 S 1 2.905(8) 0.007(1)   
Human 
haemoglobin 
N/O 1 2.03(1) 0.003(1) 17(1) 0.75 
S 1 2.370(3) 0.0045(3)   
 S 1 2.93(1) 0.005(1)   
ak-ranges used for fitting each spectrum were: BSA 1-12 Å-1; Hb 1-13.8 Å-1 with scale factors (S02) of 0.9. 
DE0 = E0 – 25515 eV where E0 is the threshold energy. Values in parentheses are the estimated standard 
deviation derived from the diagonal elements of the covariance matric and are a measure of precision. The fit 
error is defined as [Sk6(cexp-ccalc)2/Sk6cexp2]½. 
 
 Differences observed between the Ag K-edge EXAFS of buffered solutions of 
BSA, and Hb with silver nitrate were likely attributable to the differences in the amino acid 
residues present in each protein. Bovine serum albumin (and HSA) has 35 cysteine 
residues in its amino acid sequence, however, only one the residues exists as reduced 
cysteine (Cys-SH); the remaining 34 form structural disulfide bonds (Cys-S-S-Cys)53 and 
are unavailable to interact with silver. As analysis of the Ag K-edge XAS identified that 
silver ions predominantly interacted with cysteine, the location of the metal on BSA could 
be pinpointed to the solitary reduced cysteine residue (Cys34) in the protein crystal 
structure (PDB code: 3V03).54 The only sulfur-containing residue in BSA within proximity 
to Cys34 is Met87; ~8.5 Å away, sulfur-atom-to-sulfur-atom. While a linear geometry was 
not feasible for silver with a total coordination number of three, summing the refined 
silver-sulfur bond lengths together with the ionic diameter (twice the Ag+ ionic radius – 1.7 
Å) resulted in a distance of ~8.7 Å; (2.91 Å + 3.4 Å + 2.35 Å = 8.66 Å); adding weight to 
the possibility that Cys34 and Met87 coordinated the silver ion. Thus, binding via the 
Cys34 and Met87 residues could account for the 2.35 and 2.91 Å Ag-S distances fit to the 
BSA Ag K-edge EXAFS spectrum (Table 3). If Ag+ ions were bound by Cys34 and 
Met87, several N/O-containing residues – glutamine (Gln33), tyrosine (Tyr84) or 
threonine (Thr83) – were present in the immediate area and available to complete the 
coordination sphere of silver which was identified here as S2N/O.  
 
 Conversely, the localisation of silver in haemoglobin was less clear. While BSA is 
a monomeric protein, human haemoglobin is tetrameric and comprises four protein 
subunits with molecular weights of ~15 kDa each. Adult humans possess two to three 
forms of haemoglobin, the dominant ‘A’ form which accounts for 97% of Hb, the A2 form, 
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and the residual F form retained from infancy; the ‘A’ form will exclusively discussed due 
to its prevalence and will simply be referred to as ‘haemoglobin’.55 Haemoglobin (‘A’ 
form) consists of two ‘a chains’ (1 Cys each), and two ‘b chains’ (2 Cys each) (all present 
as reduced Cys-SH; PDB code: 1A3N),56-57 thus, per haemoglobin tetramer, six cysteine 
residues are present; three unique Cys residues, based on symmetry. The interaction of 
silver with the different local environments surrounding each of the three non-symmetry-
related cysteine residues (Cys104, 93, and 112) would result in the EXAFS spectrum being 
a weighted average of silver coordination interactions. Thus, while the EXAFS fit 
parameters (Table 3) indicated similarities in silver coordination between the two proteins, 




EXAFS of silver in blood 
 Ag K-edge EXAFS were also collected for the blood dataset. The RBC and plasma 
fractions of whole blood were fit with sulfur back scatterers at similar distances (2.393 and 
2.373 Å, respectively). A survey of the CSD indicated that the average silver-thiolate 
distance for a silver coordination number of two was 2.39 ± 0.03 Å, thus the refined 
distances fit to the EXAFS spectra were consistent with interactions between silver and 
cysteine residues. Conversely, while both spectra were successfully fit with silver back 
scatterers, the silver-silver distances varied between the plasma and RBC fractions. Plasma 
whole blood was fit with an Ag-Ag distance of 3.29 Å while the RBC fraction spectrum 
was fit with a shorter interaction at 2.92 Å. The absence of well-defined oscillations in the 
corresponding XANES spectra for plasma and RBCs (Figure 4D and E, left panel) 
suggested that the silver in solution remained as Ag(I) (not bulk metal or nanoparticles), 
thus the silver-silver interactions were likely due to bridging by cysteine sulfur atoms 
between multiple metal centres resulting in S-Ag-S scattering. The EXAFS FT of whole 
blood (C) appeared visually similar to the FT of the RBC fraction (E) and both were fit 
with silver and sulfur backscattering atoms. However, in the whole blood spectrum two 
nitrogen/oxygen interaction was also fit at appropriate bond lengths (Table 4). 
 
 The EXAFS of isolated plasma spiked with AgNO3 (Figure 4B) was fit with a 
multiple scattering (MS) model generated from a published crystal structure of silver 
chloride.58 However, upon refinement, and rejection of components that contributed less 
than 4% of the fit, it was revealed that the spectrum was adequately described by three 
single scattering interactions (Table 4). The coordination numbers (CNs) reported for the 
FCS and isolated plasma spectra were determined by the ‘best-integer fits’ function of 





Figure 4: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
biological fluids treated with 2 mM AgNO3 and incubated at 37°C for 1 hr: (A) foetal calf serum, (B) plasma 
isolated from whole blood, (C) whole blood, (D) plasma fraction from whole blood, (E) RBC fraction from 
whole blood, and (F) RBC lysate, showing experimental (black) and calculated (green) data with the residual 
(red) shown offset. Fit parameters are shown in Table 4. Physically unrealistic peaks at distances <1.5 Å in 
the non-phase corrected FT of the EXAF spectra of C and D were filtered out and subtracted from the 
EXAFS oscillations, see Appendix 3.9.3 for unfiltered FTs. 
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Table 4: Parameters fit to EXAFS spectra of biological fluids spiked with silver shown in Figure 4.a 
Sample Scatterer CN Distance DWF -E0 Fit error 
Foetal calf serum 
(MS) 
Cl (010) 6 2.752(4) 0.0072(3) 14(1) 0.41 
Ag (020) 12 3.906(3) 0.0073(1)   
 Ag (020) 4 5.370(2) 0.0012(2)   
Isolated plasma 
(MS) 
Cl (010) 5 2.762(7) 0.0111(6) 15(1) 0.53 
Ag (020) 5 3.901(4) 0.0057(2)   
 Ag (020) 5 5.363(5) 0.0043(3)   
Whole blood N/O 2 2.212(7) 0.0061(6) 13(1) 0.42 
 S 1 2.427(4) 0.0030(2)   
 Ag 1 2.949(5) 0.0092(4)   
Plasma fraction 
from whole blood 
S 2 2.373(5) 0.0053(2) 20(1) 0.64 
Ag 1 3.294(7) 0.0065(4)   
RBC fraction 
from whole blood  
S 2 2.393(3) 0.0056(2) 19(1) 0.45 
Ag 1 2.924(3) 0.0064(2)   
RBC lysate N 1 2.14(1) 0.0047(9) 15(1) 0.49 
 S 1 2.402(4) 0.0018(2)   
 Ag 1 2.94(1) 0.014(1)   
 Ag 1 3.31(2) 0.013(1)   
ak-ranges used for fitting each spectrum were 1-13.8 Å-1 with a scale factor (S02) of 0.9. DE0 = E0 – 25515 eV 
where E0 is the threshold energy. Values in parentheses are the estimated standard deviation derived from the 





Size exclusion chromatography hyphenated with ICP-MS (SEC-ICP-MS) 
Analysis of human blood by SEC-ICP-MS 
 To further investigate the speciation of silver in human blood, size exclusion 
chromatography hyphenated with ICP-MS chromatograms of plasma and RBC lysate were 
recorded. Silver nitrate was spiked into human whole blood to a final concentration of 2 
mM, incubated for 1 hr at 37°C and separated into plasma and RBC fractions. Prior to 
passing the biological fluids over the size exclusion column the plasma was centrifuged 
(15,000 rpm, 4°C, 20 min) to remove particulate matter, while the red blood cells were 
lysed by 1:4 dilution into buffer followed by centrifugation (as above); the resultant 
chromatograms and ICP-MS traces for both fractions are shown in Figure 5. All ICP-MS 
traces were corrected by -15 seconds to account for the travel time between the UV 
detector of the HPLC and the ICP-MS; this represented 70 µL at the flow rate used for all 
samples (0.3 mL/min). 
 
 The maximum intensity of the 107Ag ICP-MS traces of the plasma and RBCs 
fractions were an order of magnitude greater than the maximum intensity of the naturally 
occurring metal ions in human blood. To allow comparison between the 107Ag, 57Fe, 65Cu, 
and 66Zn traces, their intensities were normalised as shown on the second y-axes (Figure 
5). Both stable copper isotopes (63Cu and 65Cu) were monitored simultaneously, however, 
the 65Cu trace was used for analysis due to likely interference in the 63Cu trace from 23Na-
40Ar and 23Na-40K species generated in the ICP-MS plasma.59 Elution times of BSA and 
human haemoglobin were denoted at the top of each SEC-ICP-MS plot and were 
determined by passing 1 mg/mL solutions of each protein over the column and monitoring 





Figure 5: SEC-ICP-MS chromatograms of plasma (top) and red blood cells (bottom) from a sample of 
human whole blood spiked with AgNO3 (final conc. 2 mM), incubated at 37°C for 1 hr and fractionated. 
RBCs were lysed by dilution in HEPES buffer (1:4) at pH 7.4. The presence of protein was monitored by 
absorbance of the column effluent at 280 nm (black). 107Ag (blue), 65Cu (green), 57Fe (orange), and 66Zn 
(purple) ICP-MS traces of the column effluent were recorded; all metal trace elution times were corrected by 
-15 seconds (~70 µL) to account for time taken to reach the ICP-MS. Column: Agilent AdvanceBio SEC 
300Å (7.8 x 300 mm I.D.; 2.7 µm particle size); temperature: ~20°C; mobile phase: 100 mM HEPES, pH 
7.4; flow rate: 0.3 mL/min; injection volume: 10 µL; detector: Agilent Infinity 1200 variable wavelength 
detector set at 280 nm, and Agilent QQQ 8900 ICP-MS. The void volume of the column (v0) and retention 
times of molecular weight markers are shown at the top of the plot in kDa. 
 
 A single, intense peak was observed in the 280 nm trace of RBC lysate at 10.78 
min, with which was associated elevated 57Fe and 107Ag signals (Figure 5, bottom). This 
large peak was qualitatively identified to be haemoglobin based on the colocation of the 
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intense iron peak; however, the elution time of ‘native’ Hb in the lysate was reduced 
relative to that observed for the human haemoglobin standard (tr = 11.45 min). A shoulder 
on the high retention time edge of the haemoglobin 280 nm peak (shown inset, Figure 5, 
bottom) was concomitant with a peak in the 66Zn trace (11.52 min) and likely indicated the 
elution of the zinc-bearing metalloprotein, carbonic anhydrase (CA). In RBCs the absolute 
amount of carbonic anhydrase is unclear however, it has been shown to be low relative to 
haemoglobin (~2 to 12 mg CA per g Hb)60 and the corresponding shoulder at ~11.5 min in 
the 280 nm trace was almost completely obscured by the magnitude of the Hb peak. The 
apparent offset in the 280 nm and 107Ag traces (inset Figure 5, bottom) was due to the 
tailing observed in the silver trace, likely the result of analyte/machine adsorptive effects 
caused by the high concentration of analyte present (CPS of 107Ag trace were ~17 times 
greater than 57Fe). Peaks in the 65Cu and 66Zn traces that eluted with Hb (10.78 min) could 
represent Hb-bound copper and zinc61-62 or coelution of other metalloproteins such as [Cu, 
Zn] superoxide dismutases (SOD). Low intensity, broad peaks were present at low elution 
time in the 280 nm and 107Ag traces which were likely due to the presence of remnant 
plasma in the RBC fraction. The peaks matched well with the chromatogram of plasma and 
the contamination likely resulted from not washing the RBCs prior to lysis. The additional 
peaks accounted for <5% of the total area of the plot. The RBC fraction was not washed as 
buffers used for this purpose tend to be high in halide and (bi)carbonate anions which, if 
present, have the potential to perturb silver speciation upon lysis. 
 
Table 5: Elution times and calculated molecular weights of peaks observed in the 280 nm and ICP-MS traces 
of the SEC-ICP-MS plots of plasma and RBCs treated with 2 mM AgNO3 (Figure 5). 
Fraction Elution time [min] Calculated MW [kDa] 
Plasma 6.46 1037 
6.74 878 
8.16 375 












 As mentioned above, haemolysis of RBCs occurred upon addition of 2 mM AgNO3 
to whole blood, thus the plasma fraction passed over the SEC column was contaminated 
with red blood cell contents (mostly haemoglobin) and was red in colour instead of straw 
yellow. The 2 mM concentration of Ag was chosen to provide good data for XAS 
experiments and was kept constant to enable comparison between XAS and SEC-ICP-MS 
data. The retention time of haemoglobin in the plasma fraction was in good agreement with 
the RBC lysate (10.78 min vs. 10.86 min) and again identified by the high amount of iron 
associated with the peak. Additionally, when the ICP-MS was disconnected and the 
column effluent fractionated into a 96 well plate, the fractions corresponding to the elution 
of the peak at 10.78 min were bright red while all other fractions were colourless (not 
shown). 
 
 Human blood plasma is comprised of over a thousand individual proteins,63 thus all 
peaks observed in the 280 nm trace shown in Figure 5, top were likely representative of 
coelution of multiple species. Analysis of a subsection of the proteome, namely the 
metalloproteome, can provide insight into which proteins may have been present. The 
copper transport protein, ceruloplasmin, was posited to elute at 9.00 min due to the high 
elution of copper. Iron transport proteins ferritin and transferrin likely eluted at 8.26 and 
9.94 min, respectively, based on elution of iron and molecular weight (e.g. larger proteins 
are expected to elute at lower elution time). Human serum albumin is the most abundant 
protein in plasma and a known zinc-binding protein, thus the magnitude of the 280 nm 
peak at 9.70 min as well as coelution with a peak in the 66Zn trace, suggested the presence 
of HSA. Silver was found to elute with almost all peaks observed in the UV trace with 
elution times <13 min. Notable exceptions from this observation included the peaks at 6.46 
and 6.74 min. 
 
 To investigate whether the haemolysis induced by addition of 2 mM AgNO3 altered 
the elution profile of the silver, a sample of human blood was spiked to a final 
concentration of 0.1 mM AgNO3 and the plasma fraction analysed by SEC-ICP-MS 
(Figure 6). When treated with the lower concentration of silver, even when added in non-






Figure 6: SEC-ICP-MS chromatogram of human plasma from a sample of whole blood spiked to a final 
concentration of 0.1 mM AgNO3, incubated at 37°C for 1 hr and fractionated. The presence of protein was 
monitored by absorbance of the column effluent at 280 nm (black). 107Ag (blue), 65Cu (green), 57Fe (orange), 
and 66Zn (purple) ICP-MS traces of the column effluent were recorded.; all metal trace elution times were 
corrected by -15 seconds (~70 µL) to account for time taken to reach the ICP-MS. Column: Agilent 
AdvanceBio SEC 300Å (7.8 x 300 mm I.D.; 2.7 µm particle size); temperature: ~20°C; mobile phase: 100 
mM HEPES, pH 7.4; flow rate: 0.3 mL/min; injection volume: 10 µL; detector: Agilent Infinity 1200 
variable wavelength detector set at 280 nm, and Agilent QQQ 8900 ICP-MS. The void volume of the column 
(v0) and retention times of molecular weight markers are shown at the top of the plot in kDa; BSA and Hb are 
66.5 and 64.5 kDa, respectively 
 
 When passed over the size exclusion column, the elution profile shape of plasma 
spiked with 0.1 mM AgNO3 was similar to that of the 2 mM AgNO3 sample (Figure 5, 
top) – bar the absence of the Hb peak. Most notably, however, all elution times of the 0.1 
mM AgNO3 plasma sample peaks were shifted approximately +60 seconds (Table 6). The 
cause of the observed change in elution time was unclear, however, it may have been due 
to a reduced protein load injected onto the column Hb was absent in the 0.1 mM sample 
(the same injection volume was used between the two samples). Haemoglobin was one of 
the final major proteins observed to elute from the column in the 2 mM AgNO3 plasma 
fraction, suggesting it had a stronger affinity for the column resin than the other proteins in 
the sample. If the protein loading was high, and Hb occupied a significant amount of the 
column pore volume, diffusion of the other plasma proteins into the resin pores would 
likely be impeded. As a result, they would pass through the column faster and have 
reduced elution times (relative to a sample where haemoglobin was absent); this was 
observed for the 2 and 0.1 mM AgNO3-treated plasma samples.  
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 In the absence of haemoglobin, the highest proportion of silver was found to elute 
with the dominant peak in the 280 nm trace at 10.74 min, likely to contain human serum 
albumin. The poor alignment of the UV, 107Ag, and 65Cu traces with that of the 57Fe trace 
at 10.74 min may confirm the coelution of multiple species such as transferrin (80 kDa) 
and HSA (66 kDa) based on the iron, and copper/zinc traces, respectively. 
 
Table 6: Elution times and calculated molecular weights of peaks observed in the 280 nm and ICP-MS traces 
of the SEC-ICP-MS plots of plasma from whole blood treated with 0.1 mM AgNO3 (Figure 6). 









Localisation of silver in human blood 
 The localisation of silver ions in the plasma and red blood cell fractions of human 
whole blood over time is shown in Figure 7. Each time point represents a discrete sample 
of whole blood spiked with 2 mM AgNO3 and incubated at 37°C for 5 to 60 minutes 
before centrifugation. The zero-minute time point was an ice-cooled sample of whole 
blood to which was added silver nitrate and centrifuged immediately (for 5 min). At zero 
minutes 69% of the silver was located in the RBC fraction, which increased to 94% by 30 
minutes and then decreased to 86% after 60 minutes. The plasma fraction trend mirrored 
that of the RBC fraction with a decrease in the moles of silver in the plasma from 0 to 30 
minutes followed by an increase from 30 to 60 minutes. The sum of the moles of silver in 
the plasma and RBC fractions was, on average, 1.92 ± 0.01 µmol, indicating only a small 
loss of silver during the experiment (total Ag per sample of whole blood was 2 µmol). 
 
 
Figure 7: Time-dependent localisation of silver in human whole blood. Silver in red blood cell (red) and 
plasma (blue) fractions of eight samples of human whole blood spiked with 2 mM AgNO3 (2 µmol per 
individual sample), incubated for 0 to 60 minutes at 37°C and separated into plasma and RBC fractions. The 
sum of moles in the RBC and plasma fractions at each time point is shown (black). The amount of silver was 
measured by atomic absorption spectroscopy through use of a calibration curve of known silver standards. 
 
 As has been stated above, addition of 2 mM AgNO3 to whole blood resulted in 
immediate lysis of some RBCs thus it was likely that the percentage of silver localised in 
the plasma fraction would have been even lower than that measured if lysis had not 
occurred. The decrease in moles of silver in the RBC fraction at time >30 min was possibly 
due to subsequent lysis of erythrocytes (additional to that which initially occurred) 
releasing endogenous silver into the surrounding plasma. 
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Summary of results 
 Ag K-edge XANES of human whole blood spiked with 2 mM AgNO3 were 
described by silver-Hb and silver-BSA model spectra (~70 and 30%, respectively, as 
determined by linear combination fitting); a trend corroborated by the localisation study 
which showed ~90% of the silver migrated to the red blood cell (RBC) fraction of whole 
blood. The SEC-ICP-MS 107Ag trace of lysed RBCs showed interaction between silver, 
haemoglobin (10.78 min) and carbonic anhydrase (~11.5 min). Fitting of the whole blood 
EXAFS with a S2N/OAg coordination sphere provided physically sensible fit parameters 
and shared similarities to the parameters fit to the Ag-Hb/BSA model EXAFS (S2N/O). 
 
  LCF of the plasma fraction of whole blood treated with silver calculated 
approximate one third contributions from Hb, BSA, and cysteine model spectra, 
respectively. Lysis of RBCs was observed upon exposure of whole blood to 2 mM AgNO3 
which accounted for the haemoglobin component. SEC-ICP-MS revealed that the greatest 
proportion of silver in the plasma was associated with Hb, human serum albumin (HSA), 
and other high molecular weight proteins. Similarly, at a concentration of AgNO3 where 
haemolysis was not observed (~0.1 mM) HSA was the dominant binder of Ag+. Isolation 
of the plasma fraction followed by treatment with Ag+ displayed significantly different 
speciation of silver. Both LCF and EXAFS fitting determined that solid silver chloride was 
formed; a similar result was observed for treatment of foetal calf serum (an analogous 
biological fluid). To the best of the authors’ knowledge, presented herein was the first 
metallomics study of silver speciation in human blood. However, speciation of other 





Silver in human blood plasma 
 Elsewhere it has been identified that the antibacterial properties of silver ions are 
impeded upon exposure to blood plasma.64 The hypothesis behind this observation is that 
the Ag+ ions are sequestered as solid silver chloride limiting  antibacterial properties due to 
poor aqueous solubility. Indeed, as reported here, addition of silver nitrate solution to 
isolated human blood plasma resulted in the formation of solid silver chloride (as 
determined by XAS analysis), however, this appeared to be an aberrant result. The 
speciation of silver ions in the plasma fraction of human whole blood treated with 2 mM 
AgNO3 was found to be primarily thiolate-bound from interaction with haemoglobin, 
HSA, and other unidentified plasma proteins. No contribution from a solid silver chloride 
model spectrum was found for the whole blood plasma fraction despite inclusion of the 
model in the linear combination fit analysis. Conversely, 65 and 95% contribution from the 
AgCl(s) model spectrum was found for isolated plasma and foetal calf serum, respectively. 
This disparity in speciation highlights the need to investigate the biochemical fates of 
analytes as whole systems, not simply the sum of their parts.  
 It was possible that the speciation of Ag+ in the plasma fraction of whole blood was 
perturbed due to lysis of red blood cells contaminating the plasma. However, the plasma 
fraction of a sample of whole blood treated with ~0.1 mM AgNO3 did not visually display 
signs of RBC lysis, nor was a haemoglobin peak apparent in the SEC-ICP-MS 
chromatogram, confirming decreased or complete absence of haemolysis. All detected 
Ag+, as monitored by the 107Ag ICP-MS trace, was also associated with high molecular 
weight protein species. If Ag+ was present as particulate or colloidal silver chloride, three 
things could be expected: (1) pelletisation of solid AgCl upon centrifugation of the sample 
prior to chromatographic analysis – carried out for all samples (10,000 g, 20 min, 4°C); (2) 
a significant increase in HPLC back pressure due to clogging of the column with silver 
chloride particulate when analysed; (3) elution and detection of low molecular weight-
bound Ag+ (if silver chloride colloids reached the ICP-MS). None of these observations 
occurred, indicating that formation of silver chloride in the isolated plasma sample was not 
representative of the biochemical fate of silver in whole blood. By extension, likely nor 
were the results reported elsewhere indicating a reduction in the antibacterial properties of 
silver in isolated plasma.65-66 
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 Analysis of blood plasma by similar chromatographic techniques by other allowed 
qualitative identification of plasma proteins detected by the SEC-ICP-MS traces of 
biologically relevant metal (65Cu, 66Zn, and 57Fe) reported here.35 
 Regarding the 57Fe ICP-MS trace of plasma, the two low elution time peaks (8.29, 
and 9.91 min) have previously been identified as the haptoglobin-haemoglobin complex 
(Hp-Hb, MW: ~470 kDa),35 and the iron transport protein holo-transferrin (hTf, MW: 79.7 
kDa), respectively.34 The major peak of the 65Cu trace (9.00 min) was the dominant plasma 
copper transport protein, ceruloplasmin (Cp, MW: 151 kDa) while the shoulder on the high 
elution time edge of Cp was Cu-bound albumin.34 In the 66Zn trace, the poorly defined 
peaks at elution times >9 min likely included zinc-bound entities like a2-macroglobulin 
(MW: 725 kDa) and a number of unidentified zinc metalloproteins,34 and the most intense 
peak in the 66Zn trace was likely Zn-bound albumin.67 Peaks that eluted at >10.5 min were 
presumed to be contaminants from haemolysis of RBCs as they matched well with the 
elution profile of RBC lysate and were absent in the 0.1 mM AgNO3 treated whole blood 
plasma fraction. Considering the peaks at >10.5 min likely originated from RBC cellular 
contents, the second largest peak in the 66Zn trace (11.65 min) may correspond to the zinc-
metalloprotein, carbonic anhydrase.60 The collocation of copper and zinc at 10.95 min may 
be associated with haemoglobin,61-62 however, it could also represent elution of [Cu,Zn] 
superoxide dismutases (SOD) like the extracellular sensory, homotetrameric SOD3 (MW 
130 kDa)68 or the soluble, homodimeric SOD1 (MW: 32 kDa).69  
 
Silver in red blood cells 
 Haemolysis has been reported to occur when RBCs are exposed to various metals, 
including copper,70-71 cadmium,72-73 lead,74-75 gold,76-77 and silver.20, 78 Nanomolar 
concentrations of silver nitrate can induce dose-dependent membrane scrambling, efflux of 
intracellular potassium chloride, activation of protein kinase C, and disruption of nitric 
oxide homeostasis, resulting in RBC lysis.20 Therefore, the haemolysis observed upon 
exposure of whole blood to 2 mM AgNO3 in this study was consistent with previously 
reported results and explains why, even when added as an isotonic solution, RBC lysis was 
observed. 
 
 Considering the low concentrations of silver nitrate required to induce haemolysis 
(<500 nM)20 the plasma fraction of whole blood treated with 0.1 mM AgNO3 (analysed by 
SEC-ICP-MS), was likely not devoid of RBC lysis. The absence of identifiable 
haemoglobin peaks in the 57Fe traces of the plasma fraction may have been due to the Hb 
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scavenging ability of haptoglobin, a biochemical mechanism which ensures free 
haemoglobin is not present in plasma.36 Indeed, haptoglobin itself does not naturally 
contain any iron,79 so the identification of the lowest elution time peak of the 57Fe trace as 
the Hp-Hb complex suggests that some lysis occurred but was not sufficient to overwhelm 
the natural mechanisms in whole blood. 
 
 Localisation in intact erythrocytes has been shown to occur for several heavy 
metals, however, it has not previously been reported for silver nitrate. The rapid migration 
of Hg2+ into RBCs was observed via 1H NMR studies.42 The study found that equilibration 
of mercury concentration within the RBCs was reached within less than 5 minutes post 
exposure; a result consistent with the migration of silver ions reported herein. In addition 
to the short equilibration time, RBC lysis occurred, the dominant interactions with Hg2+ 
were from Hb cysteine residues, and the metal was mainly associated with haemoglobin as 
opposed to GSH, a result that has been replicated elsewhere.40 Similarly, 1H NMR studies 
indicated that ~90% of Cd2+ ions localise within intact erythrocytes,41 however it was 
found that cadmium interacted predominantly with glutathione, a result that has been 
validated by recent size exclusion studies.40 The bulk of lead in the human body is 
eventually sequestered in bone, however, upon initial exposure, up to 99% of the blood 
lead burden is within the RBCs.74 Therefore, the rapid migration and high proportion of 
silver ions localised in the red blood cell fraction of human whole blood was consistent 
with the reported chemistry of other heavy metals. 
 
 SEC-ICP-MS analysis of the plasma and RBC fractions of silver-treated whole 
blood reported here revealed silver was exclusively bound by medium/high molecular 
weight protein species (>30 kDa). Interaction between Ag+ and high concentration blood 
proteins (like haemoglobin or human serum albumin) was expected, however, no low 
molecular weight-bound silver species were identified in the 280 nm or 107Ag traces. 
Glutathione (GSH) is present at high concentrations in RBC cytosol (~2.5 mM)80 but no 
interactions between silver ions and GSH were observed. Previous studies have identified 
that some heavy metals interact predominantly with haemoglobin or GSH (e.g. mercury, 
and cadmium, respectively), thus it may be possible that silver ions interact strongly with 
Hb, but not glutathione in RBCs.  
 A previous study has linked decreased reduced glutathione levels in plasma (as 
well as RBC cytosol) with the formation of a GS-Ag species.81 However, while a dose-
dependent decrease in GSH levels over 2 hours upon exposure to AgNO3 was apparent, 
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whether it was a result of direct interaction with Ag+ or generation of reactive oxygen 
species was not clear. Results presented here would suggest that silver ions do not interact 
directly with GSH and that discrete (GS)xAg species were not formed. 
 
 In a size exclusion metallomics study of RBC lysate, perturbation of zinc and 
phosphorous speciation (after incubation for two hours) was attributed to oxidation events 
linked to the rapid oxidation of GSH under atmospheric conditions at pH 7.4.40 To 
moderate the loss of GSH redox activity, the SEC mobile phase was fortified with 2.5 mM 
GSH (physiological RBC concentration), which mitigated the previously observed changes 
in speciation. Thus, it was possible that absence of glutathione-bound silver species in the 
SEC-ICP-MS study reported here, was due to auto-oxidation of GSH under atmospheric 
oxygen and/or generation of ROS. The experiments reported herein involved exposure of 
whole human blood to 2 mM AgNO3, incubation at 37°C for 1 hour followed by 
fractionation and lysis of RBCs. Upon lysis (which was carried out by dilution into buffer) 
the sample vials were capped immediately and kept at ~4°C until analysis (always <1 hour, 
post lysis), thus, if perturbation of GSH binding of Ag+ did occur, it was likely an artefact 
of chromatographic analysis (as reported by Gibson, et al.).40 
 
 In addition to oxidative stress possibly placed on the system by perturbation of 
GSH/GSSG ratios, there is evidence in the literature for the rapid degradation of 
metalloprotein/peptide species in blood plasma (<30 min post sample collection).34 
Degradation of Cu-bound proteins in rabbit plasma has been reported where proteins, such 
as blood coagulation factor V, were only detectable if the plasma was analysed within 30 
minutes of collection. Beyond this time, the copper signal corresponding to blood 
coagulation factor V (as well as other non-baseline separated species) disappeared 
completely. Similarly, a >50% reduction in the intensity of a low molecular weight bound 
copper species that eluted at large elution time was observed between 30 min and 1 hour.  
 Post blood collection, the whole blood sample used here was exposed to 2 mM 
AgNO3 and incubated at 37°C for one hour, therefore it is possible that low molecular 
weight proteins/peptides were degraded before analysis by SEC-ICP-MS. Were low 
molecular weight silver-bound species present in plasma or RBC lysate they would likely 
elute at high retention time. Although glutathione does not absorb strongly at 280 nm,(due 
to absence of aromatic amino acid residues) a peak in the 107Ag trace would be expected, 
however, no peak corresponding to LMW-bound silver (or any biologically relevant metal) 
was observed.  
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 The retention times of human serum albumin and haemoglobin were similar but did 
not match the protein standards of lyophilised BSA, and human haemoglobin dissolved in 
elution buffer. The standard protein samples tended to elute at larger retention times 
relative to the ‘native’ protein species, which could be due to the absence of naturally 
occurring peptides capable of binding to protein species, altering their hydrodynamic 
radii.35 
 Indeed, transient mixed-ligand metal-bound species such as GS-Hg-Hb have been 
observed in 1H NMR studies42 and such species would likely have shorter elution times 
due to the increase in size (relative to the unmodified protein). In the case of BSA, the 
discrepancy may be associated with the 24% dissimilarity in amino acid sequence relative 
to HSA which could lead to differences in their hydrodynamic radii.52 In the 2 mM AgNO3 
whole blood plasma sample HSA eluted ~10 seconds earlier than the BSA standard. 
However, HSA eluted ~60 seconds after the BSA standard in the plasma whole blood 
sample treated with 0.1 mM AgNO3. In fact, all peaks in the low concentration silver 
nitrate plasma SEC-ICP-MS chromatogram were shifted to higher elution times by ~60 
seconds. A major difference between the two plasma samples (other than [Ag+]) was the 
presence of haemoglobin and other RBC cellular contents in the 2 mM sample. Both 
samples were applied to the column as 10 µL injection volumes under identical HPLC 
running conditions, thus, the change in retention times was likely as result of the reduced 




3.6 Conclusions  
 Humans are increasingly exposed to silver through its inclusion in a vast array of 
medical and consumer items. Despite this, the biochemical fate and speciation of silver 
ions in mammals is relatively unknown. Through use of metallomics techniques, namely 
size exclusion chromatography hyphenated with ICP-MS, and X-ray absorption 
spectroscopy, greater insight into the speciation and chemistry of silver ions in human 
whole blood and relevant biological fluids was achieved. 
 Silver nitrate was found to localise within the red blood cell fraction of the human 
whole blood within five minutes, post exposure. In conjunction with this, significant lysis 
of the erythrocytes was observed. Both observations are consistent with previously 
reported effects of heavy metals on blood (like Hg2+) Once inside the RBCs silver was 
found to be predominantly associated with haemoglobin and possibly carbonic anhydrase, 
the two most abundant proteins in erythrocytes. This observation was also consistent with 
the chemistry Hg2+ ions in red blood cells, while other heavy metals, such as cadmium, 
appear to have a higher affinity for reduced glutathione in the cells, the concentration of 
which is ~2.5 mM. XANES analysis, corroborated by EXAFS fitting, revealed the silver 
coordination environment in the red blood cell fraction was dominated by sulfurous 
molecules such as cysteine, or cysteine-like ligands. The silver-methionine XAS model 
spectrum was found to be physically unrepresentative of the interactions likely to occur 
between Ag+ and proteinaceous methionine residues due to binding through the amine 
nitrogen, so the proportion of silver associated with the thioether-containing amino acid 
could not be quantified. 
 Binding of silver to human haemoglobin and bovine serum albumin was identified 
to be three-coordinate; consistent with other silver-biomolecule coordination numbers.49 
S2N/O coordination spheres fit to the EXAFS of both spectra with contributions from 
cysteine, methionine and an unidentified nitrogen/oxygen-containing residue. For BSA this 
identified the binding of silver to likely be through the sole reduced cysteine residue in the 
protein sequence, Cys34. The Ag K-edge XANES of whole blood samples could be 
described by linear combination fitting by a combination of silver-haemoglobin, BSA, and 
cysteine model spectra; no solid silver chloride component was identified. Conversely, the 
speciation of silver in ‘incomplete’ biological systems (e.g. isolated plasma) was 
determined to likely be that of colloidal silver chloride through XANES and EXAFS 
analysis. 
 At the concentration of silver used in this study, haemolysis of red blood cells was 
unavoidable. As such, the plasma fraction of silver-treated whole blood was contaminated 
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with RBC cellular contents and the prevalent binder of Ag+ in the plasma was found to be 
haemoglobin. At a lower concentration of AgNO3, in the perceived absence of haemolysis, 
the dominant binder of Ag+ in plasma was identified to be human serum albumin as well as 
other unidentified high molecular weight proteins. No low molecular weight-bound silver 
was present in any analysis of RBC lysate or plasma which suggested that does not interact 
significantly with glutathione or metallothioneins.   
 Through SEC-ICP-MS of plasma it was found that silver ions were bound by 
numerous serum proteins. Analysis of a subset of the plasma proteome, namely the 
metalloproteome, enabled some of the silver-bound species to be qualitatively identified. 
After haemoglobin, the dominant protein associated with silver was human serum albumin, 
as well as carbonic anhydrase and ceruloplasmin. The lack of toxicity of silver ions 
towards humans and mammals, especially relative to other heavy elements like mercury, 
would suggest that while silver has a wide binding profile in plasma that the coordination 
of the metal to these proteins, does not result in adverse effect on the protein function. 
 A common argument against the use of silver as an antibacterial agent is the 
sequestration of the metal as insoluble salts like silver chloride. It was found in this study 
that silver chloride only formed in ‘incomplete’ systems such as isolated plasma or foetal 
calf serum. This is consistent with previously observed studies regarding the 
supplementation of silver solutions used for antibacterial testing with broth, plasma or 
serum reducing the metal ions efficacy. However, the results presented here in indicates 
that this may not necessarily represent biologically relevant chemistries, highlighting the 
need to study biological systems as a ‘whole,’ not the sum of its parts. This was evident 
from the XAS and SEC-ICP-MS analysis that revealed no silver chloride formed in human 
whole blood treated with silver: either 2 mM or ~0.1 mM AgNO3, final concentration. 
 
3.7 Future directions 
 Throughout this study all solutions were maintained at pH 7.4 by HEPES buffer. 
HEPES was chosen due to its buffering capacity at physiological pH and demonstrated low 
affinity for various heavy metals.82 Unfortunately, an unforeseen consequence of this 
buffer choice was that the sulfonate group of the molecule would be completely 
deprotonated at the pH 7.4. A technique commonly used in conjunction with size exclusion 
chromatography is anion (or cation) exchange chromatography (AEX). This technique 
adds a second dimension of separation based on the isoelectric points (pIs) of the protein 
species present in solution. While some of the proteins could be qualitatively identified in 
the SEC-ICP-MS chromatograms of plasma and red blood cell lysate, multiple species 
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were likely eluting at any given time point of the plot. As such, the second dimension of 
separation and purification of the native proteins could allow for more accurate 
identification of the silver-binding species as well as testing by kit assays for enzymatic 
activity of some of the components of human plasma or red blood cells.35 This could be 
particularly useful for the RBC lysate sample where the sheer magnitude of the 
haemoglobin UV trace peak possibly obscured some of the less abundant intracellular 
proteins. Choice of a non-anionic buffer like Tris or bis-Tris would facilitate such analysis. 
As the purpose of the study presented herein was to determine the speciation of Ag+ in 
human blood and the XAS spectra and models were collected while in HEPES buffer, it 
was deemed inappropriate to change buffer system as the results from SEC-ICP-MS and 
XAS would not be directly comparable.  
 As was mentioned above, previous groups have identified that exposure of red 
blood cell lysate to atmospheric oxygen can lead to the degradation of glutathione via 
oxidation to GSSG.40 As both plasma and RBCs are known to have high levels of GSH, it 
was surprising that no identifiable glutathione-metal ion species were detected, either for 
silver ions or any native metal ions. As such it would be informative to see whether 
fortification of the elution buffer with physiological GSH concentrations altered the 
speciation of silver in human blood. Additionally, due to financial and time constraints an 
untreated sample of human plasma and RBC lysate was not analysed by SEC-ICP-MS. 
Comparison of the untreated plasma and RBC metal traces with those of the silver-treated 
samples would be informative to see whether significant mismetallation or degradation of 
metalloproteins occurred during treatment, incubation or chromatographic development.  
 All samples of whole blood treated with silver nitrate herein were incubated at 
37°C for 1 hours to ensure any biochemical reactions between added silver ions and the 
native biomolecules were allowed to occur. Other studies have found that copper-bound 
plasma proteins and low molecular weight species have been observed to be significantly 
degraded within 30 minutes of blood collection.34 Even halving of the incubation time with 
silver would thus lead to degradation of some of the blood components. As such a murine 
model experiment involving the addition of silver (likely as nitrate) to the animals’ food or 
water could provide better insight into the chemistry of silver in vivo. Approximately 10-
20% of silver to which mammals are exposed to orally is introduced into the vascular 
system by absorption through the small intestines. Collection of the mouse blood and 
immediate analysis by SEC-ICP-MS would ensure that the blood chemistry and chemical 
integrity is maintained as much as possible. In addition to this, were the animals humanely 
euthanised and dissected, the organs could be later analysed by either/or XAS and X-ray 
 133 
fluorescence microscopy for more speciation/localisation information. Conflicting 
evidence is present in the literature regarding the organ targets for localisation of silver 
ions. Some studies suggest the kidneys were the site of silver localisation while others 
point to the liver.13 XAS and XFM experiments coupled with bulk ICP-MS techniques for 
total metal content and SEC-ICP-MS for further speciation analysis could provide a much 
more complete understanding of the biochemical fate of silver in mammals.  
 Were some of the mice subjected to levels of silver high enough for symptomatic 
argyria to appear, detailed analysis of the subdermal silver deposits that form as a result of 
the condition could be examined by XFM and XAS, as well. While the composition of the 
deposits has been reported to contain reduced silver, and sulfide species, an unidentified 
component has also been identified.15 Mapping portions of the animals’ skin by XFM 
could allow greater understanding of the speciation of the metal deposits. 
 
 When human whole blood was treated with 2 mM silver nitrate significant lysis 
was observed. This concentration was chosen to ensure good data collection from XAS 
experiments and was maintained through the SEC-ICP-MS experiments for consistency. 
While no AgCl formation was identified from XANES of human whole blood and both the 
plasma and RBC fractions from silver-treated whole blood, what was unclear was the 
extent to which the contamination of the plasma fraction altered Ag+ speciation. When 
whole blood was treated with 0.1 mM AgNO3 no visible lysis was observed, as validated 
by the plasma SEC-ICP-MS chromatogram which showed no haemoglobin peak. While a 
concentration of 0.1 mM AgNO3 would likely be insufficient to collect EXAFS spectra, 
especially from the plasma fraction which is now known to contain <10% of the total 
added silver, collection of XANES may be possible. Analysis of the Ag K-edge XANES of 
the un-haemolysed plasma sample, in particular, would validate that silver chloride is not 
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Appendix 3.9.1 Operating parameters 
Table 7: Typical operating parameters for SEC-ICP-MS experiments 
Agilent 1200 LC 
Mobile phase 100 mM HEPES, pH 7.4 
Column Agilent AdvancedBio SEC 130 or 300 Å 
Particle size 2.7 µm 
Pore size 130 or 300 Å 
Flow rate 0.3 mL/min 
Injection volume 10 – 100 µL 
Column dimensions 7.8 mm x 300 mm 
Agilent ICP-MS QQQ 8900 
RF power 1550 W 
Sample depth 10.0 mm 
Carrier gas 15.0 L/min 
Makeup gas 0.90 L/min 
Spray chamber temp 2°C 
Extracts 1, 2 -6.0 V, -250.0 V 
Omega bias, lens -150 V, 7.5 V 
Deflect, plate bias 2.0 V, -60 V 
Cell entrance, exit -70 V, -80 V 
Octopole bias, RF -18.0 V, 170 V 




Appendix 3.9.2 Cambridge Structural Database (CSD) survey results/references 
Table 8: Survey of AgS2 THIOETHER structures in CSD version 5.40 (Nov 2018)  
CSD Code Reference Av. Ag-S (Å) 
FOFVED Kim, S., et al., Inorganica Chim Acta, 2014, 417, 171 2.440 
FOFVIH Kim, S., et al., Inorganica Chim Acta, 2014, 417, 171 2.414 
IFUWUB Bu, X.-H., et al., Cryst Growth Des, 2002, 2, 303 2.423 
KEMGOB Seo, S., et al., CrystEngComm, 2017, 19, 7185 2.420 
MEFLEP Hu, T.-L., et al., Cryst Growth Des, 2006, 6, 648 2.411 
OLOMIL Fainerman-Melnikova, M., et al., Acta Cryst E, 2003, 59, m880 2.641 
REXDUU Lee, J. Y., et al., Org Lett, 2007, 9, 493 2.495 
WEMMOS Lee, E., Shim Sung Lee, S. S., CrystEngComm, 2013, 15, 1814 2.419 
WUGLUF Brammer, L., et al., Dalton Trans, 2002, 4134 2.409 
WUGMAM Brammer, L., et al., Dalton Trans, 2002, 4134 2.437 
XAKFUL Okada, T., et al., Chem Comm, 2005, 1484 2.455 
XAYWEZ Meier, H., et al., CSD Comm, 2000 2.438 
 
Table 9: Survey of AgS3 THIOETHER structures in CSD version 5.40 (Nov 2018) 
CSD Code Reference Av. Ag-S (Å) 
ACEHOG Li, J.-R., et al., J Chem Cryst, 2004, 34, 501 2.521 
AGTRTH Domenicano, A., et al., J Chem Soc A, 1968, 866 2.548 
COJGEN Noren, B., et al., Acta Chem A Phys Inorg Chem, 1984, 38, 479 2.506 
EFAXEP Iyoshi, S., et al., Inorg Chem, 2008, 47, 3946 2.545 
FIKSAU Li, J.-R., et al., Dalton Trans, 2005, 464 2.515 
NIYLAK Siewe, A. D., et al., Inorg Chem, 2014, 53, 393 2.537 
POPKIP Awaleh, M.O., et al., J Chem Cryst, 2009, 39, 122 2.522 
UCOCAQ Brooks, N.R., et al., Dalton Trans, 2001, 2530 2.534 
ULEKUR Li, J.-R., et al., Cryst Growth Des, 2003, 3, 829 2.527 
ULELEC Li, J.-R., et al., Cryst Growth Des, 2003, 3, 829 2.566 
 
Table 10: Survey of AgS4 THIOETHER structures in CSD version 5.40 (Nov 2018) 
CSD Code Reference Av. Ag-S (Å) 
AFASEF Yamaguchi, T., et al., Acta Cryst C, 2002, 58, m213 2.564 
AQOJUN Iwatsuki, S., et al., Dalton Trans, 2016, 45, 12548 2.566 
AQOKAU Iwatsuki, S., et al., Dalton Trans, 2016, 45, 12548 2.560 
BULZOY Galindo, M.A., et al., Inorg Chem, 2009, 48, 10295 2.563 
EREXUU Park, K.-M., et al., Supramolecular Chem, 2004, 16, 51 2.620 
FIKQUM Li, J.-R., et al., Dalton Trans, 2005, 464 2.587 
FIKROH Li, J.-R., et al., Dalton Trans, 2005, 464 2.558 
FITDOB Kuppers, H.-J., et al., Angew Chem, Int Ed, 1987, 26, 575 2.603 
GUBYIM Qureshi, N., et al., Dalton Trans, 2009, 5708 2.583 
HIJKUG Drexler, H.-J., et al., Chemische Berichte, 1996, 129, 807 2.686 
HOPDOF Ishikawa, J., et al., Dalton Trans, 1999, 191 2.582 
HOPDUL Ishikawa, J., et al., Dalton Trans, 1999, 191 2.605 
ICACAQ Chen, W., et al., Acta Cryst E, 2001, 57, m213 2.629 
JAFDAY Grosu, I. G., et al., Molecules, 2015, 20, 8020 2. 552 
JEDQEO Blake, A.J., et al., Dalton Trans, 1998, 2931  
JEMKOB Blake, A.J., et al., Chem Comm, 1990, 974 2.596 
JEMKOB10 Blake, A.J., et al., Dalton Trans, 1993, 521 2.596 
KILGOD Frank, N. C., et al., Chem Euro J, 2013, 19, 14076 2.601 
LIWZIB Huang, D., et al., Chem Comm, 2008, 1305 2.511 
LIWZOH Huang, D., et al., Chem Comm, 2008, 1305 2.583 
NIYLEO Siewe, A. D., et al., Inorg Chem, 2014, 53, 393 2.566 
NOJYOA Jenkins, H.A., et al., Inorganica Chim Acta, 1996, 246, 207 2.548 
NOJYUG Jenkins, H.A., et al., Inorganica Chim Acta, 1996, 246, 207 2.571 
NOJZAN Jenkins, H.A., et al., Inorganica Chim Acta, 1996, 246, 207 2.578 
QAHPAR Pickardt, J., et al., Zeitschrift fur Naturforschung,B, 2004, 59, 1077 2.590 
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SIMKEE de Groot, B., et al., Chem Comm, 1990, 1755 2.556 
SIMKEE10 de Groot, B., et al., Inorg Chem, 1992, 31, 203 2.556 
SOLHIK de Groot, B., et al., Inorg Chem, 1991, 30, 3103 2.550 
SUHDAA Blake, A.J., et al., Dalton Trans, 1993, 521 2.611 
TAWGIH Alberto, R., et al., Inorg Chem, 1996, 35, 3420 2.605 
TAWGON Alberto, R., et al., Inorg Chem, 1996, 35, 3420 2.590 
TDECAG Hittenhausen, H., et al., Cryst Struct Comm, 1978, 7, 385 2.572 
VEBKOD Seo, J., et al., Inorg Chem, 2006, 45, 952 2.602 
VEBLEU Seo, J., et al., Inorg Chem, 2006, 45, 952 2.679 
VEDTUU Awaleh, M.O., et al., Inorg Chem, 2006, 45, 1560 2.640 
VOZNON de Groot, B., et al., Inorg Chem, 1992, 31, 203 2.618 
WAYLOX Demirhan, F., et al., Dalton Trans, 1993, 2765 2.564 
WEMMIM Lee, E., et al., CrystEngComm, 2013, 15, 1814 2.583 
XANNAB Suenaga, Y., et al., Dalton Trans, 2000, 3620 2.591 
XIXPUQ Kim, H. J. et al., New J Chem, 2008, 32, 258 2.586 
XOLNUH Bu, X.-H., et al., Inorg Chem, 2002, 41, 3477 2.604 
ZAQYUL Neve, F., et al., Chem Mater, 1995, 7, 688 2.573 
 
Table 11: Survey of AgS2 THIOLATE structures in CSD version 5.40 (Nov 2018) 
CSD Code Reference Av. Ag-S (Å) 
ADIPAF Yoshinari, N., et al., Acta Cryst E, 2006, 62, m1229 2.396 
ARAYOJ Lee, P.-S. et al., Chem Lett, 2016, 45, 740 2.421 
ARAZAW Lee, P.-S. et al., Chem Lett, 2016, 45, 740 2.436 
BEPWEB Yan, H., et al., Nature (London), 2018, 554, 505 2.378 
BEPWIF Yan, H., et al., Nature (London), 2018, 554, 505 2.382 
BIVGIY Najafabadi, B. K., et al., Dalton Trans, 2014, 43, 2104 2.370 
BIVGOE Najafabadi, B. K., et al., Dalton Trans, 2014, 43, 2104 2.363 
BIVGUK Najafabadi, B. K., et al., Dalton Trans, 2014, 43, 2104 2.371 
BIVHAR Najafabadi, B. K., et al., Dalton Trans, 2014, 43, 2104 2.401 
CAYZOR Dance, I., et al., Chem Comm, 1984, 17 2.372 
CAYZOR10 Dance, I. G., et al., Inorg Chem, 1989, 28, 1853 2.372 
CAYZUX I.Dance, et al., Chem Comm, 1984, 17 2.372 
CAYZUX10 I.G.Dance, et al., Inorg Chem, 1989, 28, 1853 2.374 
CEPKIR I.G.Dance, et al., Inorg Chem, 1983, 22, 3785 2.362 
CUTYIA S. Ahmar, et al., Angew Chem, Int Ed, 2010, 49, 4422 2.401 
DAPTUJ J. T. Sampanthar, et al., Dalton Trans, 1999, 3153 2.359 
DAPVUL J. T. Sampanthar, et al., Dalton Trans., 1999, 3153 2.359 
DENGOT N. Yoshinari, et al., Bull. Chem. Soc. Jpn., 2006, 79, 1066 2.386 
DENGUZ N. Yoshinari, et al., Bull. Chem. Soc. Jpn., 2006, 79, 1066 2.437 
ECOLIT M. Tamura, et al., Inorg Chem, 2009, 48, 8998 2.387 
ENCOAG M. J. Heeg, et al., Inorg Chem, 1980, 19, 554 2.371 
FATGAJ Y.-D. Chen, et al., Inorg Chem, 2004, 43, 7493 2.425 
FATGEN Y.-D. Chen, et al., Inorg Chem, 2004, 43, 7493 2.390 
FATNEW X. Chu, et al., Inorg Chem Front, 2017, 4, 706 2.391 
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Figure 8: Unfiltered Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right 





Chapter Four: Development of silver-containing materials for use 
as antibacterial agents 
4.1 Abbreviations 
AS   Australian Synchrotron 
ASBDC  2,5-bis(allylsulfanyl)benzene dicarboxylic acid 
BDC   1,4-benzene dicarboxylic acid 
EXAFS  extended X-ray absorption fine structure 
HAI   health care-associated infection 
LCF   linear combination fitting 
MOF   metal-organic framework 
NMR   nuclear magnetic resonance 
NP   nanoparticles 
PCL   polycaprolactone 
PSBDC  2,5-bis(propylsulfanyl)benzene dicarboxylic acid 
PXRD   powder X-ray diffraction 
SBU   secondary building unit 
SCXRD  single crystal X-ray diffraction 
XANES  X-ray absorption near-edge structure 
XAS   X-ray absorption spectroscopy 





 Health care-associated infections (HAIs) are acquired while a patient is admitted to 
a health care facility. In developed countries HAIs have been reported to impact between 5 
and 15% of hospitalised patients.1 The US Center for Disease Control and Prevention 
estimates that 1.7 million patients are affected by HAIs and that ~100,000 die as a result of 
the infection.2 In addition to the risk to human life these infections pose, the cost of 
combatting HAIs annually has been estimated to range from $28-45 billion (USD).3 An 
increase in antibiotic resistant bacteria, and a lack of novel antibiotic 
discovery/development has further compounded the problem of health care associated 
infections.4-5 
 
 The discovery of penicillin in 1928 by Alexander Flemming, and the clinical 
testing/commercialisation of the drug by Howard Florey in the 1940s enabled highly 
effective treatment/prevention of bacterial infections.6 However, while effective, molecular 
antibiotics often elicit their bactericidal activity through a singular mode of action, making 
it easier for resistances to form.7 Coupled with misuse/over-prescription, and a lack of 
novel antibacterial drug discovery an antibiotic resistance crisis is a possibility.4-5  
 The antibacterial properties of silver have been known for centuries; Persian kings 
were thought to only drink from silver vessels as it was observed that drinks stored in them 
remained fresh for longer.8 In modern day, silver is still used in the treatment of burns, 
ulcers and other wounds9 in addition to being incorporated into a myriad of different 
medical and commercial items to imbue them with antibacterial properties.10 Largely this 
is due to the high toxicity of the metal ions/nanoparticles against bacteria (µM AgNO3) as 
well as the perceived lack of toxicity against mammals and humans. The estimated acute 
lethal dose of silver for humans ranges from 1.4 to 40 x 105 µg/kg,11 and The World Health 
Organisation (WHO) has actively listed no health-based guideline for the amount of silver 
in drinking water.12 The discrepancy in toxicity between bacteria and humans is possibly 
due to the high structural and functional redundancy of multicellular organisms vs. 
prokaryotes (like bacteria); an argument that implies inherent toxicity on a cellular level. 
Additionally, humans have detoxification mechanisms such as pacification by 
sedimentation or adsorption to biomolecules. Such a broad difference in toxic levels 
provides a broad ‘therapeutic window’ for the use of silver as an antibacterial agent. 
 Silver’s efficacy as an antibacterial agent is thought to be, in part, due to a 
multifaceted attack on the organism. Four broad ways in which the metal can disrupt 
cellular processes have been identified and substantiated in literature: interaction with the 
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cell wall/membrane, DNA, inhibition of proteins/enzymes, generation of reactive oxygen 
species (ROS).13 The benefit of a multimodal mechanism is that were the organism to 
develop resistance against one pathway, silver can still elicit its antibacterial properties in 
other ways. 
 
 According to Pearson, Ag(I) is classified as a ‘soft’ cation, similar to Cu(I), and has 
preference for polarizable ‘soft’ ligands such as those containing sulfur or nitrogen.14 In 
addition to this, an affinity between silver ions and pi systems has also been observed. 
Indeed, the crystal structure of a major Cu+ homeostatic protein (CusF) crystallised in the 
presence of silver ions reveals interaction between not only coordinating methionine and 
histidine residues but cation-pi interactions with a tryptophan residue.15 Materials 
containing thioether units functionalised with pendant alkene groups have been shown to 
have increased selectivity for noble metals, like palladium.16-17  
 As the antibacterial properties of silver are well known, antibacterial assays of 
silver-containing materials/compounds are common. It has been identified that 
carboxylate-silver interactions in a structure are favourable and provide a stronger 
antibacterial response than either nitrogen or sulfur donors;18 thought to be due to weak 
Ag-O interactions facilitating release of Ag+. 
 
 Silver nanoparticles (AgNPs) also possess broad-spectrum antimicrobial properties 
against bacteria, fungi and viruses.19 However, their mode(s) of action are still unclear; 
namely, whether the NPs act as a Trojan horse from which silver ions are released or 
whether the NPs themselves are the bactericidal agent (or both). In general a decrease in 
particle size has been observed to yield greater antibacterial activity due to increased 
surface area of the particle allowing more efficient oxidative dissolution of Ag+.20 
 
 In medical instrumentation and implants, controlled release of bactericidal 
concentrations of silver are sought after.21-23 The coating of metallic silver onto implants 
has been shown to have variable leaching of silver into the wound site, presumed to be due 
to a combination of the slow rate of oxidation of bulk silver, as well as sequestration of 
silver ions that are released by biomolecules or formation of insoluble salts. Attempts to 
combat both issues have seen silver ions and/or NPs incorporated into many devices, such 
as deposition onto surfaces as ions, NPs or composite materials; silver-doped phosphate 
glasses which release their cargo as they degrade; and adhesion of polymers or porous 
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Figure 1: A schematic of MOF synthesis from a metal node and organic linker. 
 
 Metal-organic frameworks (MOFs) are crystalline, hybrid materials consisting of 
metal cluster nodes coordinated in a directional mode by organic linker molecules (Figure 
1).24 Metals such as zinc, copper, and zirconium are commonly used as ‘metal nodes’ 
while the organic linkers are often bi/trivalent carboxylic acids or nitrogen containing 
aromatic molecules.25 In the last twenty years, the MOF field has expanded greatly and 
many possible applications have been reported, including: storage/separation of gas and 
hydrocarbons,26-27 energy storage,28 sensing,29 catalysis,30 and drug delivery.31 Regarding 
medicinal drug delivery from MOFs, a wide range of applications have been investigated, 
including release/sensing of biologically-relevant gases (nitric oxide, carbon monoxide, 
hydrogen sulfide);32-34 encapsulation of drugs like ibuprofen, doxorubicin, caffeine, 
vancomycin, and silver nanoparticles;35-38 and incorporation of the bioactive component 
into the MOF structure such as the use of silver, copper or zinc in the metal cluster.39-41 
 A metal-organic framework of particular interest in this research is UiO-66 
(Universitet i Oslo-66); comprised of zirconium-based [Zr6O4(OH)4] metal nodes, or 
secondary building unit (SBU), linked by twelve 1,4-benzene dicarboxylic acids (BDC) 
(Figure 2). The connectivity of the BDC linkers with the metal nodes results in two 
different pore environments, octahedral pores (~9 Å diameter) and tetrahedral pores (~7 Å 
diameter).42 However, the synthesis of UiO-66 often requires inclusion of a modulator in 
the reaction mixture, often an organic, monotopic carboxylic acid or mineral acid (HCl). 
The role of the modulator is to impede crystal growth by competing with the BDC linker 
for coordination sites on the zirconium nodes.43 While many of the modulator molecules 




defect sites which perturb the pore distribution of the MOF;44 i.e. instead of twelve BDC 
linkers bound to the zirconium node, a mixture of BDC and modulator will be present and, 
given the modulator is a monotopic acid, provide less well-defined pore environments. 
Toxicity of zirconium against mammals is relatively low (LD50 ~4 g/kg) compared to other 
metals (LD50 Cu ~0.025 g/kg, and Zn ~0.35 g/kg)45 suggesting that adverse health effects 




Figure 2: Structures of 1,4-benzene dicarboxylic acid (BDC) (a) and derivatives; 2- (b), and 2,5- (c) 
functionalised BDC. R1 = R2; R1 = OH, NH2, SH, etc. 
 
 A benefit that metal-organic frameworks provide over other porous materials, like 
zeolites, is their ability to be tailored for specific purpose. For example, while the UiO-66 
morphology was initially discovered using the BDC linker, it has since been identified that 
structurally similar linkers, bearing different functional groups (Figure 2), can provide 
materials isostructural with UiO-66. Thus, it is possible to design a pore environment in 
the material that is favourable for a particular application (such as loading and releasing 
silver). Other modifications involve the elongation of the BDC linker by addition of a 
second phenyl core, resulting in the isoreticulated material, UiO-67, which has similar 
topology to UiO-66 but with larger pores.46  
 
 However, like most MOFs, UiO derivatives are prepared as crystalline powders, 
which, unlike composite materials, are not amenable to coating or incorporation onto 
medicinal surfaces, such as prosthetics or implants. Titanium is used for load-bearing 
implants due to its good biocompatibility, and strength, however, the metallic form of the 
transition metal has little, if any, antibacterial properties.11 In order to imbue an implant 
with antibacterial properties it needs to be modified or coated with an antibacterial agent. 
From the synthesis of silver nanoparticles in titanium oxide nanoparticles47 to hydrogels 
doped with silver ions or nanoparticles,48 a multitude of different methods to incorporate 
silver into titanium structures have been investigated. Resins have been shown to be able to 
trap AgNPs within their matrices by immersion of the material in a solution containing 
(a) (b) (c) 
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ionic silver followed by a reducing agent, which forms the NPs in situ.49 Benefits observed 
by allowing the diffusion of the ionic silver species into the material include deeper 
impregnation into the resin or polymer which, in turn, leads to a slower release of the 
synthesised NPs.11 Examples of polymers or materials previously explored for use in 
implant technology include lactose-substituted chitosan (Chitlac),50 polyacrylamide,51 
polyethylene,39 poly(L-lysine) (PLL),52 and poly(L-lactic acid) (PLLA),53 among others. It 
has been shown that the rate of release of ions or AgNPs from a polymer matrix is 
dependent on a number of factors such as the crystallinity of the matrix, concentration of 
silver, the morphology of the enveloped NPs, structural changes in the material caused by 
the inclusion of silver, as well as the strength of the interaction between silver and the 
material.11 If the silver in the material is weakly bound it is shown that the release into 
media is faster relative to that of a more strongly bound silver species.48  
 A particular polymer of interest is polycaprolactone (PCL), which has been 
approved for use by the US Food and Drug Administration (FDA).54 PCL was widely used 
in the biomaterials and drug delivery fields in the 70’s and 80’s but fell out of favour as 
other aliphatic polymers, such as polylactides and polyglycolides were developed.55 
However, with FDA approval, the reasonably inexpensive cost of production, and ease of 
use the polymer has come to the fore.54 The solubility of the polymer in non-aqueous 
solvents means that it is easier to work with (compared to other polymers) and can be 
prepared by simple solvent casting techniques.55 
 
4.2.1 Research aims 
 The aims of the work presented herein were to design and synthesise functionalised 
analogues of UiO-66 and, in doing so, determine whether uptake of silver (and controlled 
release) by the material can be manipulated to allow their use as antibacterial agents. 
Incorporation of chemical motifs known to have affinity for soft metals (like sulfur-
containing functional groups and pi systems) were explored. Ionic and nanoparticulate 
silver were loaded into the structures to probe the effect of Ag oxidation state on release of 
silver. To extend the applications of silver-loaded UiO-66 derivatives, the materials were 
embedded into PCL matrices. The speciation of the loaded silver was investigated through 
use of X-ray absorption spectroscopy (XAS), to provide insight into the chemistry of the 
loaded cargo in a material unable to be characterised by single crystal X-ray 
crystallography. As controlled release of medicinally relevant species (like silver) is highly 
sought after, the release kinetics of silver from the PCL-embedded and non-embedded 
materials into aqueous media were characterised in both bacterial broth as well as ultra-
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pure MilliQ water. Finally, the antibacterial efficacy of the materials was investigated 
against two clinically relevant strains of bacteria: Escherichia coli (E. coli), and 
Staphylococcus aureus (S. aureus). 
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4.3 Experimental and methods 
Materials 
 All chemicals were purchased from Sigma Aldrich and used as received. Where 
necessary, additional preparation of reagents, including drying of solvents, is stated and 
were carried out by literature procedures. 
 
Experimentals and methods 
 Instrumentation. NMR spectra were recorded on a Varian 500 MHz spectrometer at 
23°C using a 5 mm probe. 1H NMR spectra were referenced to either TMS (0 ppm) or 
DMSO-d6 (2.50 ppm). Infrared spectra were collected on a Perkin-Elmer Spectrum 11 
using a UATR sampling accessory. Powder X-ray diffraction data was collected using a 
Cu Kα (1.542 Å) source on a Bruker D8 Advanced X-ray powder diffractometer (parallel 
X-ray, capillary loaded) or a Co Kα (1.789 Å) Bruker D4, Endeavour X-ray power 
diffractometer. Samples run on the Bruker D8 and D4 were mounted in 0.5 mm diameter 
glass capillaries or silicon low diffraction mirrors, respectively. Data was collected 
between 2θ of 2 to 52.94, phi rotation was 20 rotations per minute and 1 second exposure 
per step for 5001 steps. Raw data was converted to .xye format and WinPlotr 2006 
software used for background subtraction. Simulated X-ray diffraction patterns were 
generated using Mercury from single crystal X-ray diffraction data. 
 
X-ray absorption spectroscopy 
 Data collection. Silver K-edge X-ray absorption spectra were recorded on the X-
ray absorption spectroscopy (XAS) beamline at the Australian Synchrotron (AS), Victoria, 
Australia. The energy of the electron beam was 3.0 GeV with a current of ~200 mA, and 
an X-ray beam was sourced from a wiggler monochromated by the Si(111) 
monochromator and harmonic rejection achieved using a rhodium-coated mirror. Samples 
were measured in transmission mode; the energy ranges used for EXAFS spectra 
collection were; pre-edge region 25.3140 – 25.4941 keV (0.003 eV steps); XANES region 
25.4941 – 25.5641 keV (0.0003 eV steps); and EXAFS region 25.5641 – 25.700 keV. 
During data collection the samples were maintained at a temperature of ~ 10 K using a 
Cryo Industries (Manchester, NH, USA) cryostat. The spectrum of a silver foil, recorded in 
transmission downstream from the sample, was used as an internal standard to calibrate the 
energy scale for the first peak of the first derivative of the elemental silver edge (25.5156 
keV); 1 to 4 scans per samples were collected for EXAFS spectra. 
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 Data analysis. Calibration, averaging, background subtraction of all spectra and 
principle component, target, and multiple linear regression analyses of XANES spectra 
were performed using the EXAFSPAK software package (G. N. George, SSRL). Single-
scattering fits of EXAFS data were carried out using EXAFSPAK and the FEFF8 code.56 
The model compounds for target analysis and XANES linear combination fitting were 
prepared, and spectra recorded at the AS, Victoria, Australia. 
 
Single crystal X-ray diffraction 
 Single crystals of AgMOF-3 or 2D [Zn(ox)2BDC-(SO3)2] material were mounted 
under paratone-N oil on a MiTeGen crystal mount, and X-ray diffraction data was 
collected at 100K on the MX2 beamline at the Australian Synchrotron using the Blue-ice 
software interface, λ=0.7108 or 0.7109 Å.57 The data sets were corrected for absorption, 
the structures solved by direct methods using SHELXS or SHELXT and refined by full 
matrix least-squares on F2 by SHELXL, interfaced through the programs X-Seed and/or 
Olex.58-61 In general, all non-hydrogen atoms were refined anisotropically, and hydrogen 
atoms were included as invariants at geometrically estimated positions. Details of data 
collection and structure refinement are given in Appendix 4.8.1.  
 
Synthesis of linkers 
Diethyl 2,5-bis(dimethylthiocarbamoyloxy)benzene 
dicarboxylate.62 To a solution of diethyl 2,5-dihydroxyl 
benzene dicarboxylate (2.04 g, 8.01 mmol) in DMF 
(100 mL) was added DABCO (3.71 g, 32.04 mmol) and 
the solution allowed to stir for several minutes. 
Dimethylthiocarbamoyl chloride (3.98 g, 32.04 mmol) was then added, the reaction 
mixture allowed to warm to room temperature and left to react for 6 h. The resultant 
suspension was poured over water (500 mL), filtered under reduced pressure and washed 
extensively with water to give diethyl 2,5-bis(dimethylthiocarbamoyloxy)benzene 
dicarboxylate as a fluffy white solid (3.41 g, 99%). 1H NMR (500 MHz, CDCl3): δ 7.73 (s, 






benzene dicarboxylate.62 Diethyl 2,5-
bis(dimethylthiocarbamoyloxy)benzene carboxylate 
(1.01 g, 2.40 mmol) was heated to 220ºC for 1 h under 
nitrogen protection. The crude product was cooled 
slowly to room temperature and recrystallised from ethanol to give diethyl 2,5-
bis(dimethylthiocarbamoylsulfanyl) benzene carboxylate as pale brown plate-like crystals 
(0.93 g, 92%). 1H NMR (500 MHz, CDCl3): δ 8.11 (s, 2H), 4.34 (q, J = 7.1 Hz, 4H), 3.17 
(s, 6H), 3.02 (s, 6H), 1.35 (t, 6H); consistent with literature. 
 
2,5-Dimercaptobenzene dicarboxylic acid (DMBDC).62 Diethyl 2,5-
bis(dimethylthiocarbamoylsulfanyl)benzene dicarboxylate (2.79 g, 6.51 
mmol) was added to a degassed solution of potassium hydroxide (1.3 M) 
in 1:1 ethanol/water (150 mL). The mixture was degassed for a further 
15 min and heated at reflux for 1 h under nitrogen protection. The 
solution was cooled to RT and acidified using hydrochloric acid (32%), the precipitate 
collected via vacuum filtration, washed extensively with degassed water and dried under 
nitrogen to give 2,5-dimercaptobenzene dicarboxylic acid as a bright yellow solid (1.46 g, 
98%). 1H NMR (500 MHz, DMSO-d6): δ 8.03 (s, 2H); consistent with literature. 
 
Dimethyl 2,5-dimercaptobenzene dicarboxylate.17 A yellow 
suspension of 2,5-dimercaptobenzene dicarboxylic acid (1.00 g, 4.34 
mmol) in methanol (30 mL) was degassed with nitrogen for 15 min. 
Sulfuric acid (98%, 1 mL) was added and the mixture heated at reflux 
for 4.5 h. The clear yellow solution was poured over a large amount of 
water, the product was collected by vacuum filtration and washed with water to give 
dimethyl 2,5-dimercaptobenzene dicarboxylic acid as a pale-yellow solid (1.10 g, 99%). 1H 





Dimethyl 2,5-bis(allylsulfanyl)benzene dicarboxylate.17 To a 
suspension of dimethyl 2,5-dimercaptobenzene dicarboxylate (53 
mg, 0.20 mmol) in acetone (10 mL) was added, under nitrogen 
protection, potassium carbonate (0.13 g) and potassium iodide (0.10 
g, 0.61 mmol). A solution of allyl bromide (0.052 mL, 0.58 mmol) in 
acetone (5 mL) was added dropwise to the reaction vessel via a cannula. Upon complete 
addition of the allyl bromide, the reaction mixture was left to stir at room temperature for 3 
h. The solvent was removed in vacuo and the crude product purified via a silica gel plug 
(1:2 hexane/dichloromethane) to give a dimethyl 2,5-bis(allylsulfanyl)benzene 
dicarboxylate as a bright yellow solid (64 mg, 92%). 1H NMR (500 MHz, CDCl3): δ 7.90 
(s, 2H), 5.88 (ddt, J = 16.9, 10.1, 6.8 Hz, 2H), 5.32 (d, J = 17.0 Hz, 4H), 5.19 (d, J = 10.1 
Hz, 4H), 3.94 (s, 6H), 3.62 (d, J = 6.8 Hz, 4H); consistent with literature. 
 
2,5-Bis(allylsulfanyl)benzene dicarboxylic acid (ASBDC).17 
Dimethyl 2,5-bis(allylsulfanyl)benzene dicarboxylate (0.36 g, 1.58 
mmol) was added to a solution of potassium hydroxide in methanol 
(3 M, 90 mL) and the suspension was stirred overnight at room 
temperature. Water (20 mL) was added to the cloudy, white 
suspension, acidified with hydrochloric acid (32%) and the product isolated via vacuum 
filtration to give 2,5-bis(allylsulfanyl)benzenedicarboxylic acid as a bright yellow solid 
(0.28 g, 78%). 1H NMR (500 MHz, DMSO-d6): δ 13.43 (s, 2H), 7.80 (s, 2H), 5.84 (ddt, J = 
16.6, 6.8 Hz, 2H), 5.29 (d, J = 17.0 Hz, 4H), 5.15 (d, J = 10.0 Hz, 4H), 3.65 (d, J = 6.2 Hz, 
4H); consistent with literature. 
 
Dimethyl 2,5-bis(propylsulfanyl)benzene dicarboxylate. A 
suspension of dimethyl 2,5-dimercaptobenzene dicarboxylate (0.52 
g, 2.01 mmol) in acetone (40 mL) was degassed for ~15 min. 
Potassium carbonate (1.14 g, 8.04 mmol) and sodium iodide (1.22 g, 
8.04 mmol) were then added to the suspension under nitrogen 
protection and allowed to stir for 30 min. A mixture of 1-bromopropane (0.75 mL, 8.04 
mmol) and acetone (5 mL) was injected via a cannula under N2, the resultant mixture was 
left to stir at room temperature for 3 hours and monitored via TLC (2:1 CH2Cl2/Pet. Spirit). 
The mixture was gravity filtered, the solvent removed in vacuo, and the yellow oil purified 
via silica plug (silica gel, 2:1 CH2Cl2/Pet. Spirit) to give dimethyl 2,5-
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bis(propylsulfanyl)benzene dicarboxylate as a bright yellow solid (0.50 g, 72%). 1H NMR 
(500 MHz, CDCl3): δ 7.84 (s, 2H), 3.95 (s, 6H), 2.92 (t, J = 7.3 Hz, 4H), 1.75 (sx, J = 7.3, 
7.3 Hz, 4H), 1.09 (t, J = 7.3 Hz, 6H). 
 
2,5-Bis(propylsulfanyl)benzene dicarboxylic acid (PSBDC). 
Dimethyl 2,5-bis(propylsulfanyl)benzene dicarboxylate (100 mg, 
0.32 mmol) was added to a solution of potassium hydroxide in 
methanol (3 M, 5 mL) and the suspension was stirred overnight at 
room temperature. Water (20 mL) was added to the cloudy, white 
suspension, the mixture acidified with hydrochloric acid (32%) and the product isolated via 
vacuum filtration to give 2,5-bis(propylsulfanyl)benzene dicarboxylate acid as a bright 
yellow solid (65 mg, 70%). 1H NMR (500 MHz, DMSO-d6): δ 7.75 (s, 1H), 2.90 (t, J = 7.2 
Hz, 2H), 2.55 – 2.45 (m, 1H), 1.69 – 1.52 (sx, 4H), 1.00 (t, J = 7.3 Hz, 6H). 
 
Synthesis of materials 
 UiO-66. Procedure followed as reported by Katz et al.43 ZrCl4 (125.8 mg, 0.54 
mmol) was dissolved in DMF (7.5 mL), benzene-1,4-dicarboxylic acid (BDC) (124.6 mg, 
0.75 mmol) was dissolved in DMF (7.5 mL) and both solutions sonicated for 10 min. Upon 
dissolution, the two solutions were combined and concentrated hydrochloric acid (1 mL) 
was added and the resultant mixture sonicated for a further 10 min. The solution was 
heated at 85°C overnight, cooled to room temperature, the solid isolated by centrifugation 
(10,000 rpm, RT, 5 min), washed with DMF (2 x 5 mL), and CH2Cl2 (2 x 5 mL), and dried 
under vacuum overnight. This yielded UiO-66 as a white microcrystalline powder. 
 
 ASUiO-66. ZrCl4 (100.1 mg, 0.43 mmol) was dissolved in DMF (10 mL), ASBDC 
(200 mg, 0.64 mmol) was dissolved in DMF (10 mL) and both solutions sonicated for 10 
min. Upon dissolution, the two solutions were combined and formic acid (661 µL) was 
added and the resultant mixture sonicated for a further 10 min. The solution was heated at 
120°C overnight, cooled to room temperature, the solid isolated by centrifugation (10,000 
rpm, RT, 5 min), washed with DMF (2 x 5 mL), and CH2Cl2 (2 x 5 mL), and dried under 
vacuum overnight. This yielded ASUiO-66 as a yellow microcrystalline powder. 
 
 PSUiO-66. ZrCl4 (98.8 mg, 0.42 mmol) was dissolved in DMF (10 mL), ASBDC 
(200 mg, 0.64 mmol) was dissolved in DMF (10 mL) and both solutions sonicated for 10 
min. Upon dissolution, the two solutions were combined and formic acid (653 µL) was 
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added and the resultant mixture sonicated for a further 10 min. The solution was heated at 
85°C overnight, cooled to room temperature, the solid isolated by centrifugation (10,000 
rpm, RT, 5 min), washed with DMF (2 x 5 mL), and CH2Cl2 (2 x 5 mL), and dried under 
vacuum overnight. This yielded PSUiO-66 as a yellow microcrystalline powder. 
 
 AgMOF-3 (single crystal). ASBDC (42.6 mg, 0.14 mmol) and silver 
trifluoroacetate (8.52 mg, 0.036 mmol) were separately dissolved in DMSO (2 x 2 mL). 
The two solutions were combined, and ethyl acetate diffused into the mixture over ~2 
weeks to produce colourless needle-like crystals.  
 
 AgMOF-3 (microcrystalline powder). ASBDC (42 mg, 0.14 mmol) and silver 
trifluoroacetate (8.49 mg, 0.035 mmol) were separately dissolved in DMF (2 x 2 mL). The 
solution of ligand was added, dropwise, to that of the stirred solution of the silver salt and 
the mixture allowed to stir for a further 15 min after addition. The resultant beige 
suspension was isolated by centrifugation (10,000 rpm, 5 min), washed with DMF (3 x 1 
mL), and acetone (3 x 1 mL) and dried under vacuum at 50°C. 
 
 2D [Zn(ox)2BDC-(SO3)2] material. DMBDC (12.5 mg, 0.040 mmol) and 
Zn(NO3)2.6H2O (36.2 mg, 0.122 mmol) were dissolved in DEF (2 mL). To the solution 
was added HNO3 (70%, 1-2 drops). The solution was split between multiple vials which 
were flame sealed. The solution was heated at 120°C for 3 days followed by a cooling rate 
of 6°C/h to room temperature to yield clear, colourless plate crystals. 
 
Impregnating materials with silver 
 Ionic silver: Ag(I)-MOF. Dried MOF was soaked in a solution of silver nitrate in 
acetonitrile (100 mM) at a ratio of 0.25 mL/mg MOF overnight in the dark. The solid was 
isolated by centrifugation (10,000 rpm, RT, 10 min) washed briefly with acetonitrile (5 
mL), centrifuged immediately - as above - and dried under vacuum overnight. 
 
 Mixed oxidation state silver: Ag(I/0)-MOF. Procedure adapted from Plesser, et 
al.63 Dried MOF was soaked in a solution of silver nitrate in water/ethanol (100 mM, 1:5 
v/v) at a ratio of 0.25 mL/mg MOF under a nitrogen atmosphere, overnight in the dark. 
The solid was isolated by centrifugation (10,000 rpm, RT, 10 min) washed briefly with 1:5 
v/v water/ethanol (5 mL), centrifuged immediately - as previous – washed with CH2Cl2 (2 
x 5 mL) and dried under vacuum, in the dark, overnight. 
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 Nanoparticulate silver loading: Ag(0)-MOF. The material was prepared as 
above, however, the solid was isolated by centrifugation (10,000 rpm, RT, 10 min) and 
washed thoroughly over 1 h with water/ethanol (6 x 5 mL, 1:5 v/v). After which time no - 
or minimal - silver chloride precipitate was observed when the supernatant of the wash was 
treated with a saturated sodium chloride solution. The material was then washed with 
CH2Cl2 (2 x 5 mL) and dried under vacuum, in the dark, overnight. 
 
Embedding materials in a polycaprolactone (PCL) matrix 
 Dried silver-loaded MOF (20 mg) was suspended in CH2Cl2 (2 mL) with sonication 
and, separately, PCL (60 mg) was dissolved in CH2Cl2 (2 mL). Upon dissolution of the 
polymer, the two components were combined and sonicated for a further 10 min. The 
suspended mixture was transferred to a glass petri dish (6 cm) and the solvent allowed to 
evaporate in the dark overnight. 
 
Silver leaching studies 
 To ultrapure water or Luria-Bertani (LB) broth (10 mL) was added shredded MOF-
PCL composite material (80 mg). The mixture was stirred for 24 h and aliquots (0.5 mL) 
were removed at 1, 2, 4, 8, and 24 h intervals. The aliquots were analysed by AAS by 
comparison of absorbance relative to known silver standards. At least three technical 
replicates of the leaching profile of each material were recorded and averaged. 
 
Microbiological studies 
 The antibacterial properties of the silver-loaded materials were tested against 
Escherichia coli (E. coli) MG1655 and Staphylococcus aureus (S. aureus) Newman 
strains. All assays were performed in technical and biological triplicate and averaged. 
Positive and negative controls were performed by using AgNO3 embedded PCL, and PCL, 
respectively. Antibacterial tests was carried out as per the procedure outlined by Young et 
al.64 LB broth (20 mL) was inoculated with S. aureus or E. coli to an OD600 of 0.05 and 
incubated at 37°C with shaking (200 rpm) for 6 h. The cultures were then diluted to an 
OD600 of 0.8 in LB broth and 100 µL spread onto LB + 1.5% (w/v) agar plates. The 
embedded disks were placed on the plates and inhibition zone measured after incubation 
overnight at 37°C by visual inspection.  
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X-ray absorption spectroscopy 
Powders. Materials were mixed with polyethylene (3:1 w/w) and compressed into disks 
with a hand press. The disks were then sandwiched between Kapton tape in an XAS 
sample holder and presented to the beamline. 
 
MOF-PCL composite materials. PCL/MOF thin films were folded upon themselves until 




 As-synthesised UiO-66 was soaked in a solution of benzoic acid in DMF (8%) 
overnight at 85°C. Each material (1-2 mg) was digested in DMSO-d6 (700 µL), and D2SO4 
(5 drops) at 80°C for 2 h to give a clear solution. The integration of the 1H NMR peaks 
corresponding to the formic or benzoic acid modulator (A) were compared to that of the 





(1 + 0.5)𝐴: 𝐿 
 
See Appendix 4.8.2 for details. 
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4.4 Results and Discussion 
4.4.1 Synthesis of organic linkers 
 According to a literature procedure, 2,5-dimercaptobenzene dicarboxylic acid 
(DMBDC) (Figure 3) was successfully synthesised from diethyl 2,5-dihydroxybenzene 
dicarboxylate and dimethyl thiocarbamoyl chloride via a Newman Kwart rearrangement.62 
Thioetherification of DMBDC with allyl or propyl bromide produced 2,5-
bis(allylsulfanyl)benzene dicarboxylic acid (ASBDC) or 2,5-bis(propylsulfanyl)benzene 
dicarboxylic acid (PSBDC), respectively; ASBDC has previously been reported16 while 





Figure 3: Structures of the organic linkers synthesised in this project: (a) 2,5-dimercaptobenzene 
dicarboxylic acid (DMBDC); (b) 2,5-bis(propylsulfanyl)benzene dicarboxylic acid (PSBDC); (c) 2,5-
bis(allylsulfanyl)benzene dicarboxylic acid (ASBDC). 
 
4.4.2 Synthesis of metal-organic frameworks (MOFs) 
 Synthesis of an ASBDC analogue of UiO-66 (ASUiO-66) has previously been 
reported.17 The procedure included 30 equivalents of acetic acid (relative to ZrCl4) as a 
modulator and heating at 120°C for 24 hours; however, when repeated in this work it was 
found that only amorphous yellow solid was formed under these conditions (or with any 
ratio of acetic acid to metal salt). However, substitution of acetic acid with formic acid 
yielded ASUiO-66 as a yellow, microcrystalline powder. Any ratio of formic acid to 
zirconium chloride used – except zero – produced ASUiO-66, and for all subsequent 
studies 40 equivalents were used as this was the lowest ratio that produced highly 
crystalline material (data not shown). The same conditions used to synthesise ASUiO-66 
were successfully applied to the synthesis of the PSBDC analogue of UiO-66 (PSUiO-
66).The solvothermal synthesis of unfunctionalized UiO-66 was adapted from work by 
Katz, et al.43 
 
 In addition to the three materials mentioned above, a dimercapto analogue of UiO-
66 (DMUiO-66) was synthesised using DMBDC, as per literature conditions.65 When 
(a) (b) (c) 
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treated with aqueous hydrogen peroxide, the thiolates of DMUiO-66 could be post-
synthetically oxidised to produce a disulfonate-functionalised UiO-66 analogue (DSUiO-
66)66 further extending the library of isoreticular materials (Figure 4). DM- and DSUiO-66 
were included as materials to investigate the effect of soft, and hard, negatively charged 




Figure 4: Schematic of the post synthetic modification of dimercapto UiO-66 (DMUiO-66) to disulfonate 
UiO-66 (DSUiO-66) using hydrogen peroxide. Only the octahedral UiO-66 pores are shown for clarity. 
 
 Powder X-ray diffraction (PXRD) patterns of all as-synthesised functionalised and 
unfunctionalized UiO-66 materials (Figures 5b, 6b, 7b, 8b, 9b) matched the powder 
pattern of UiO-66 simulated from single crystal data.67 The PXRD data indicated that the 
materials were isostructural to that of the unfunctionalized material, with Zr6O4(OH)4 
secondary building units (SBUs) connected by twelve 1,4-benzenedicarboxylic acid (BDC) 
linkers in the absence of defects. As noted, this connectivity has been shown to produce 
two types of pore environments; an octahedral cage, and a tetrahedral cage with diameters 
of ~9 and ~7 Å, respectively.68  
 
4.4.3 Synthesis and characterisation of silver-loaded MOFs 
 Silver nitrate was loaded into the dried materials by soaking them in an acetonitrile 
solution of the metal salt in the dark for ~16 h. The solids were isolated, washed briefly 
with fresh acetonitrile (to remove surface-bound silver) and dried under vacuum. Any 
materials treated in such a way were assigned the prefix of ‘Ag(I)-’ e.g. Ag(I)ASUiO-66.  
 Upon addition of silver nitrate solution (clear) to UiO-66 (white), the material 
immediately turned brown; an indication that the Ag(I) may have been reduced to Ag(0). 
AS/PS/DSUiO-66 did not undergo any colour change upon treatment of silver ions; 
however, despite already being bright yellow in colour, DMUiO-66 appeared to become an 
even more intense shade of yellow upon exposure to AgNO3. 
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 To further expand the library of silver-containing materials investigated, the in-situ 
reduction of silver ions to nanoparticles was carried out. Ethanol has previously been used 
as a mild reductant which allows silver ions to diffuse into the material and, over time, be 
reduced to nanoparticles.69 AS-, PS-, and unfunctionalized UiO-66 were soaked in aqueous 
ethanol solutions of silver nitrate in the dark, under nitrogen protection for ~16 h; DMUiO-
66 and DSUiO-66 were not included in these treatments. The batches of materials were 
then split in half and either washed extensively with fresh ethanol/water to remove 
unreacted Ag(I) (monitored visually by precipitation of AgCl when wash supernatant 
liquid was added to a saturated solution of NaCl in EtOH/H2O) or washed briefly to 
removed surface-bound silver. Materials that were washed thoroughly to remove ionic 
silver were given the prefix ‘Ag(0)-’ denoting that only reduced silver was proposed to 
remain in the material. Materials that were briefly washed were given the prefix ‘Ag(I/0)-’ 
to show that a mixture of silver oxidation states were likely present in the structure. 
PXRDs were recorded for all silver-loaded materials showing that crystallinity was 
retained during the loading process (Figure 5 to 9). No PXRD patterns recorded for the 
silver-treated materials differed significantly from the as-synthesised patterns suggesting 
that loading silver into the materials did not change the structure of the material and were 




Figure 5: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418Å) of UiO-66: (a) simulated pattern from 
single crystal structure of UiO-66; (b) as-synthesised; (c) treated with 100 mM solution of AgNO3 in 
acetonitrile; (d) treated with 100 mM solution of AgNO3 in 5:1 ethanol/water; (e) treated as per sample (d) 
but extensively washed with 5:1 ethanol/water to remove traces of ionic silver. Red stars highlight peaks 





Figure 6: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418Å) of PSUiO-66: (a) calculated pattern from 
single crystal structure of UiO-66; (b) as-synthesised; (c) treated with 100 mM solution of AgNO3 in 
acetonitrile; (d) treated with 100 mM solution of AgNO3 in 5:1 ethanol/water; (e) treated as per sample (d) 
but extensively washed with 5:1 ethanol/water to remove traces of ionic silver. Red stars highlight peaks 




Figure 7: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418Å) of ASUiO-66: (a) calculated pattern from 
single crystal structure of UiO-66; (b) as-synthesised; (c) treated with 100 mM solution of AgNO3 in 
acetonitrile; (d) treated with 100 mM solution of AgNO3 in 5:1 ethanol/water; (e) treated as per sample (d) 





Figure 8: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418Å) of DMUiO-66: (a) calculated pattern 





Figure 9: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418Å) of DSUiO-66: (a) calculated pattern from 
single crystal structure of UiO-66; (b) as-synthesised; (c) treated with 100 mM solution of AgNO3 in 
acetonitrile. 
 
 Crystalline silver nanoparticles have been shown to diffract X-rays at large 2q 
values, however, the absence of such peaks do not preclude the presence of nanoparticles 
as they can be amorphous or two small to diffract. Peaks inconsistent with those of the ‘as-
synthesised’ MOF materials were observed at 27.8°, 37.4°, and 46.3° in the PXRD patterns 
of UiO-66 and PSUiO-66 treated with silver (Figure 5 and 6, annotated with stars). These 
peaks may have been the result of diffraction by crystalline silver/silver oxide 
nanoparticles as the [110] plane of Ag2O NPs have been shown to diffract at 27.84°.70 
Similarly, the [111] and [211] planes of fcc Ag NPs have been shown to diffract at 38.3°, 
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and 46.34, respectively;71 the presence of diffraction from the AgNP [111] plane is often 
attributed to aggregation of NPs with diameters >10 nm. In phase-pure UiO-66, with no 
defects, any pore-contained nanoparticles would be restricted to diameters <9 Å due to the 
materials pore size distribution. Thus, the presence of these reflections would indicate that 
not all silver was confined to the pores of PSUiO-66 and UiO-66 and could have been 
located in the interstitial spaces between crystallites, or in larger pore regions associated 
with defect sites in the MOF. To determine whether the latter scenario might have been the 
case, defect analysis was carried out to determine the number of defects in the MOF 
samples. 
 
4.4.4 Defect analysis 
 Defect analysis of dried as-synthesised, Ag(I)-, Ag(I/0)-, and Ag(0)-treated PS- and 
ASUiO-66 materials was carried out. After heating samples at 85°C in DMSO-d6 and 
D2SO4, clear, yellow solutions were obtained and 1H NMR spectra recorded (Appendix 
4.8.2). The thioether-functionalised materials were all synthesised in the presence of 
formic acid modulator, which introduces defect sites into the structure, replacing, or 
binding in preference to the organic linker to the zirconium-oxo SBU. Integration and 
comparison of the formic acid 1H NMR peak relative to the aryl MOF linker signal enabled 
calculation of the number of defects per node in the material. Figure 10 summarises the 




Figure 10: Number of defects of formic acid modulated PS- and ASUiO-66 materials. See Appendix 4.8.2 
for calculations. 
 
 The number of defects per node for ‘as-synthesised’ PS- and ASUiO-66 were ~1.75 
and 2.6, respectively. Relative to ‘as-synthesised’ ASUiO-66, all silver treatments resulted 
in a decrease in the number of defects per metal node, with the largest decrease being for 
the Ag(0)ASUiO-66 materials (~1.0 defects per node). However, for the PSUiO-66 
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materials, the number of defects only decreased in the Ag(I/0)- and Ag(0)-treatments. 
Decreases in the defects indicated that the ratio of formic acid to organic linker decreased 
during the silver treatments or washing procedures. Given the way in which the Ag(0) 
materials were prepared, i.e. extensive washing to remove silver ions, the hydrolysis of 
defect acid site was not surprising; this does not mean that defects were removed or healed 
but that the measure of defects in the MOF (i.e. formic acid) was removed. If equal 
amounts of formic acid modulator and organic linker were leached from the materials, the 
number of defects per node would appear to remain constant, however, this would not 
preclude the assumption that the material was degraded by extensive washing, it merely 
suggested that unequal amounts of formic acid and organic linker were leached. 
 Defect analysis was not conducted for UiO-66 as hydrochloric acid was used as the 
modulator as per literature procedure.43 
 
Determination of silver-loading 
 Samples of all dried UiO-66 analogues soaked in 100 mM AgNO3 in acetonitrile 
were acid digested and the ratio of zirconium to silver quantified by ICP-MS. As the 
number of zirconium atoms per unit cell of UiO-66 is known, and the functionalised 
materials were known to be isostructural with UiO-66, the amount of silver per unit cell 
could be calculated. Table 1 summarises the mole percent of silver in the unit cell of the 
material as loaded in by each silver treatment. 
 
Table 1: Mole percent of silver per unit cell of UiO-66 and derivatives thereof soaked in solutions of AgNO3 
in acetonitrile, as determined by ICP-MS. 







 Of the five materials investigated, unfunctionalised UiO-66 had the lowest uptake 
of silver ions from a solution of AgNO3, while DMUiO-66 had the highest (Table 1). A 
high uptake of silver by DMUiO-66 was likely due to the strong affinity soft thiolate 
donors have for silver, as well as electrostatic attraction between the negative sulfur and 
positive silver ions. Conversely, DSUiO-66 had a moderate uptake of silver, likely due to 
the electrostatic attraction between the silver cations and the negative sulfonates. However, 
sulfonates are not known to have strong affinity for Ag(I) like thiolates. Of the two 
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thioether-containing materials, ASUiO-66 had a greater uptake of Ag(I) than did PSUiO-
66, possibly due to the inclusion of the allyl functionality in the structure of the former, 
which has been reported to have an affinity for noble metals.16 
 
 The leaching profiles of DM- and DSUiO-66 (Figure 11, page 173) revealed that a 
strong affinity for the metal ions, as well as electrostatic forces, significantly limited the 
release of silver from the materials. Thus, only UiO-66, PS- and ASUiO-66 were used in 
subsequent studies where in-situ reduction of silver ions by ethanol was investigated. 
Similar to the Ag(I) treated materials, the silver loading of Ag(I/0) and Ag(0) treated 
materials was determined by acid digestion and analysis of Zr/Ag ratios by ICP-MS (Table 
2). 
 
 Of the three silver treatments the mixed oxidation state Ag(I/0) treatment resulted 
in the highest uptake of silver of each of the three materials. The increase in silver loading 
may be attributed to the close packing of reduced silver in the materials relative to Ag(I), 
allowing a greater uptake of the metal. The uptake of silver in the Ag(I/0)UiO-66 only 
increased by ~1% which was likely due to the fact that, when exposed to Ag(I) in the 
absence of a reducing agent, the material already appeared to reduce the ions (observable 
as a colour change from white to brown). 
 
Table 2: Mole percent of silver calculated for UiO-66, PSUiO-66, and ASUiO-66 for three silver treatments, 
as determined by ICP-MS. 
 mol % Ag 
Material Ag(I) Ag(I/0) Ag(0) 
UiO-66 9.1(1) 10.9 6.0 
PSUiO-66 13.2(1) 17.1 16.5 
ASUiO-66 18.4(8) 23.4 15.6 
Values in brackets represent the standard error. Ag(I/0) and Ag(0) values  
 
 The Ag(0) treated materials were washed thoroughly with ethanolic water to 
remove residual silver ions (ideally leaving only silver in the zero oxidation state). Thus it 
was unsurprising that the percentage of silver in all three Ag(0) materials was lower 
relative to Ag(I/0). Six washes per material were carried out over the course of 1 hr with 
the MOF suspended in EtOH/H2O in the dark for 10 min between centrifugation and 
replacement of the supernatant liquid. Six washes were deemed sufficient since addition of 
the supernatant liquid from the sixth wash to a saturated solution of sodium chloride did 
not result in precipitation of AgCl. The fresh ethanolic water used to wash the materials 
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was deaerated by sonication prior to use, however, all washings were carried out under 
atmospheric conditions and may have contributed to the formation of Ag2O NPs, the 
diffraction from which was possibly observed in the PXRD patterns for UiO-66 and 
PSUiO-66 (Figures 5 and 6). The speed of washing meant that oxidative dissolution of the 
silver nanoparticles in the materials was likely to be minimal. 
 During washing, the supernatant liquid of ASUiO-66 became faintly yellow in 
colour. Suspensions of silver nanoparticles have been reported to have colours ranging 
from yellow to brown due to surface plasmon resonance of the NPs.72 To investigate the 
source of the colour of the supernatant liquid, a UV-Vis spectrum was recorded for the 
supernatant liquid as well as a solution of ASBDC (in the same solvent system – 5:1 
EtOH/H2O). A lmax of 385 nm was recorded for the supernatant liquid, as well as the 
solution of ASBDC, thus the colour was attributed to degradation of ASUiO-66 and 
liberation of the organic linker into solution (rather than leaching of silver nanoparticles) – 
data not shown. 
 
4.4.5 Leaching profiles of silver-loaded metal-organic frameworks 
 The silver leaching profiles of the five Ag(I)-loaded, powdered materials into ultra-
pure water were measured by stirring suspensions of the dried material in water (in the 
dark) for 24 hours. At each time point all supernatant liquid was removed and replaced 
(Figure 11). For all frameworks the greatest percentage of silver was released within the 
first hour of the study. Despite a higher loading of silver ions into the allylsulfanyl 
(ASUiO-66) material relative to the propylsulfanyl (PSUiO-66) derivative, PSUiO-66 
released a larger percentage of total loaded silver within the first hour than did ASUiO-66 
(~55% vs. ~40%, respectively, Table 3); over 24 hours ASUiO-66 released 56% of total 
silver compared to 77% for PSUiO-66. This observation added weight to the hypothesis 
that addition of an alkene group in the thioether unit of the organic linker (the major 
difference between AS and PSUiO-66) could influence the uptake, and retention, of silver 
ions. Control over the uptake and release of biologically relevant molecules (like silver) by 
tailoring the MOF pore environment is a favourable property in materials to be used in 





Figure 11: Silver leaching profiles of powdered: Ag(I)PSUiO-66 (red); Ag(I)ASUiO-66 (yellow); 
Ag(I)UiO-66 (green); Ag(I)DMUiO-66 (blue); and Ag(I)DSUiO-66 (purple) stirred in MilliQ water in the 
dark for 24 h. Supernatant liquid was removed and replaced with fresh water at 1, 2, 5, 8, and 24 h and 
analysed by ICP-MS. Lines are direct connection between adjacent measured points. Point markers were not 
included due to the closeness of measurement at larger time. 
 
 The two materials with negatively charged linkers (DM and DSUiO-66) released 
the lowest percentage of total loaded silver over 24 hours; 15%, and 2%, respectively. 
Sulfonic acids are highly acidic (pKa ~ -7),73 thus, at the pH of ultra-pure water (pH 6 to 
7), all of the sulfonic acid groups in the material would be expected to be deprotonated. 
Electrostatic forces between the silver cations and the anionic sulfonate functional groups 
would be expected to be the dominant interaction as oxygen is considered a ‘hard’ Lewis 
base with low affinity for soft metals like silver.74 Conversely, the pKa of thiophenol,75 
which is analogous to the mercapto linker in DMUiO-66, is only 6.6 in water. Thus, at pH 
6-7, only ~50% of the thiol groups in the material may be deprotonated.  
 
Table 3: Percentage of silver released from UiO-66 and derivatives thereof after 1 hour of stirring in MilliQ 
water and the total percentage released over the duration of the experiment (24 h). 
Silver loaded 
material 
Silver released at T = 1 hr 
(%) 




UiO-66 26.9 32.2 9.07 
PSUiO-66 54.3 76.9 13.2 
ASUiO-66 39.1 56.2 18.4 
DMUiO-66 11.6 15.1 37.7 
DSUiO-66 0.73 2.4 17.7 
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4.4.6 Embedding silver-loaded metal-organic frameworks into polymer matrices 
 Powdered, crystalline solids serve little use in medical settings; thus, to extend the 
application of these materials they were embedded into polycaprolactone (PCL) polymer 
matrices. PCL is a polymer approved for use by the United States Food and Drug 
Administration (FDA) and offers ease of processing as the polymer can be solution cast 
from volatile solvents.76 A maximum loading of 25% w/w MOF in PCL was achievable 
before the structural integrity of the polymer was visually compromised (data not shown). 
All materials were embedded into the polymer at 25 wt% and retained their crystallinity 
(Appendix 4.8.3). All MOF-derived peaks in the PXRD were significantly reduced in 
intensity and broadened as a result of the reduced amount of crystalline material presented 
to the X-ray beam. All peaks not associated with the PCL matrix were in good agreement 
with the UiO-66 materials, suggesting no significant change in the morphology of the 
microcrystalline powders occurred during solvent casting of the films. 
 
4.4.7 X-ray absorption spectroscopy 
 Single crystal X-ray diffraction (SCXRD) is a powerful technique to study 
crystalline materials but is limited by the ability to grow suitable crystals and the necessity 
of a well-ordered structure to provide useful information. The UiO-66 family of materials 
often form as microcrystalline powder, the crystals of which are too small for synchrotron 
or home-lab SCXRD experiments. Single crystal structures of UiO-66 have been reported 
in literature,67 however, the conditions for growth are not universally applicable between 
analogous materials. Additionally, the presence of poorly ordered thioether units in the 
materials, as well as variability in the orientation of a 2,5-substituted BDC linker, results in 
a high degree of disorder in the materials, frustrating data collection and analysis. Finally, 
a lack of well-defined binding sites for silver cations in the pores of the (un)functionalised 
UiO-66 derivatives provided yet another layer of difficulty in determining the structure of 
the silver-impregnated materials. X-ray absorption spectroscopy (XAS) is an element 
specific technique that has previously been used to study speciation of heavy elements 
loaded into crystalline materials.77 Both X-ray absorption near edge structure (XANES) 
and extended X-ray absorption fine structure (EXAFS) were recorded for all 
microcrystalline powders as well as select PCL-MOF films. 
 
XANES of silver-loaded metal-organic frameworks 
 Silver K-edge XANES spectra of silver-loaded UiO-66, PSUiO-66, and ASUiO-66 
are presented in Figures 12 and 14, respectively. Principal component analysis (PCA) of 
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the MOF XANES dataset indicated that three spectral components were required to 
describe these data (not shown). Target transformation against a library of Ag K-edge 
XANES model spectra allowed visual identification of similarities between the 
experimental, and model spectra. Bulk silver metal, aqueous silver nitrate, and a buffered 
solution of the thioether-containing amino acid methionine with silver were identified as 
possible spectral components of the experimental spectra. The relative proportions of each 
model spectrum required to describe the experimental data were calculated by linear 
combination fitting (LCF) (Figures 13/15, and Table 4). 
 
 Figure 12 shows the XANES spectra for the three silver treatments of UiO-66 (a to 
c), PCL embedded Ag(0)UiO-66 (d), and bulk elemental silver (e). The three peaks of the 
elemental silver spectrum annotated with red stars were prominent features of each of the 
four UiO-66 spectra; only the relative intensities of these peaks changed between samples. 
A point of differentiation in the experimental spectra was between the Ag(I/0) and Ag(0) 
materials (b and c, respectively). The post-edge oscillations of samples (a) and (b) (Ag(I)-, 
and Ag(I/0)UiO-66), while bearing similarities to the spectrum of bulk silver, were 
reduced in intensity relative to the Ag(0)-containing samples, which may have been due to 
the inclusion of Ag+ in the structure. The spectrum of bulk silver metal was not a perfect 
model for the speciation of silver in the Ag(0)UiO-66 samples (c and d) as the post-edge 
oscillations were more intense for the bulk metal than for the materials. Additionally, the 
edge position of the silver metal was higher in energy than all of the experimental spectra.  
 
 The LCF results of the UiO-66 XANES spectra are shown in Figure 13 and Table 
4. The silver methionine model spectrum was included for the UiO-66 dataset despite the 
absence of thioether units in the unfunctionalized material, as, when the data were fit, the 
features of the methionine spectrum were so obscured that the contribution from the 
methionine spectrum appeared to be to ‘bulk up’ the other spectral components 
(particularly silver metal). I.e. the bulk silver model spectrum was fit at a ratio where the 
intensity of the oscillations of the model matched the intensity of the oscillations of the 
experimental spectra (Figure 13A, C and D). It has been observed that the XANES spectra 
of nanoparticles share similar but dampened post-edge features with that of the bulk 
element.78-79 The reason for this is unclear, but may be due to the reduction in long-range 
order when transitioning from a bulk material to nanoparticles. Hence, the resemblance of 
the Ag(0) treated materials to that of bulk silver does not preclude the presence of silver 
nanoparticles in the material. While an imperfect model, the spectrum of bulk silver 
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provided a better fit to the experimental data than did PVP-capped silver nanoparticles. 
Better quality XANES data of a suspension of small-diameter (<10 nm), unfunctionalized 
silver nanoparticles could act as a better model but is not available in the current Ag K-




Figure 12: Ag K-edge X-ray absorption near-edge spectra of UiO-66 treated with: (a) 100 mM solution of 
AgNO3 in acetonitrile; (b) 100 mM solution of AgNO3 in 5:1 ethanol/water; (c) as per (b), but extensively 
washed with 5:1 ethanol/water to remove ionic Ag; (d) as per (c) but embedded in a polycaprolactone matrix; 
(e) bulk silver metal. Some of the loose, powdered MOF was combined with granulated polyethylene (~3:1 
w/w) and compressed into a pellet prior to presentation to the beamline; the MOF/polymer composite (d) was 
secured in a Lucite holder by Kapton tape. All spectra were measured in transmission. PXRD patterns of the 
samples were recorded pre and post XAS analysis (Appendix 4.9.4). 
 
 The Ag K-edge XANES of Ag(0)UiO-66 (Figure 13C) and Ag(0)UiO-66 in 
polycaprolactone (D) revealed that no significant change in the speciation of silver 
occurred when the MOF was embedded in the polymer matrix. The polymers were cast by 
suspending the silver-loaded framework in a solution of polymer followed by evaporation 
of solvent overnight (in the dark). A visible difference between the two spectra was the 
diminution of the intensities of the post-edge peaks in the polymer-embedded sample, 
which may have resulted in the difference in the ratio of model components fit by LCF. 
The reduction in intensity was most likely due to the amount of sample presented to the 
beamline. The films were <100 µm thick and simply folded on themselves until an 
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appropriate size to fit into the sample holder used. At 25% w/w loading, a significantly 
lower amount of silver-loaded MOF was present than for the loose, powdered material 
(Figure 13C) which was compressed into a pellet of ~0.5 cm thickness. 
 
 
Figure 13: Linear combination fits of Ag K-edge XANES of UiO-66 treated with: (A) 100 mM solution of 
AgNO3 in acetonitrile; (B) 100 mM solution of AgNO3 in 5:1 ethanol/water; (C) as per (B), but extensively 
washed with 5:1 ethanol/water to remove ionic Ag; (D) as per (C) but embedded in a polycaprolactone 
matrix. The experimental spectra (black) were fit with a linear combination fit (green) comprised of model 
XANES spectra of solid bulk silver metal (light blue); aqueous silver nitrate (purple); a buffered solution of 
the thioether-containing amino acid methionine with silver (orange) with the residual (red) shown offset. 
Results of linear combination analysis are shown in Table 4. 
 
 The post edge XANES oscillations of the thioether-containing materials (Figure 
14) were significantly different from those of the unfunctionalized MOF with the most 
intense peak atop the rising edge and lower intensity oscillations occurring at higher 
energy. For both PS- and ASUiO-66 treated with Ag(I) (Figure 14a) the post-edge 
features were almost identical, which suggested that the speciation of silver in both 
materials was similar. This similarity was reflected in the LCF results shown in Figure 15 
and Table 4.  
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 In contrast to the UiO-66 LCF data (Figure 13), similarities between the silver-
methionine model spectrum and the experimental PS/ASUiO-66 spectra were visually 
present (Figure 15, orange), e.g. the broad peaks at ~25,540 eV and ~25,575 eV. 
Similarly, features of the aqueous silver nitrate XANES spectrum (Figure 15, purple) 
could be identified in the experimental data such as the peak atop the rising edge and the 





Figure 14: Ag K-edge X-ray absorption spectra of PSUiO-66 (left), and ASUiO-66 (right) treated with: (a) 
100 mM solution of AgNO3 in acetonitrile; (b) 100 mM solution of AgNO3 in 5:1 ethanol/water; (c) as per 
(b), but extensively washed with 5:1 ethanol/water to remove ionic Ag; (d) as per (c) but embedded in a 
polycaprolactone matrix. Some of the loose, powdered MOF was combined with granulated polyethylene 
(~3:1 w/w) and compressed into a pellet prior to presentation to the beamline; the MOF/polymer composite 
(d) was secured in a Lucite holder by Kapton tape. All spectra were measured in transmission. PXRD 
patterns of the samples were recorded pre and post XAS analysis (Appendix 4.9.4). 
 
 The XANES spectra of Ag(0)ASUiO-66 and the PCL-embedded equivalent 
(Figure 14c and d) displayed different post-edge features which suggested that the 
speciation of silver in the material may have been perturbed by the evaporation of solvent 
when casting the Ag(0)ASUiO-66/PCL composite material. The LCF results showed an 
increase in the bulk silver metal contribution (2.5% to 39%) and a reduction in the 
methionine component (61% to 39%) which could indicate aggregation of nanoparticulate 




 When ethanol was included as a reductant, a colour change from yellow to brown 
was observed for both PS- and ASUiO-66 after soaking for ~16 h. Despite this observation 
silver-methionine was the dominant component fit to almost all thioether-containing 
materials. The absence of metallic or nanoparticulate character in the XANES spectra of 
Ag(I/0) and Ag(0) treated PS/ASUiO-66 could indicate that the silver was largely located 
within the pores of the materials and interacted strongly with the pendant thioether units. 
Any silver located outside of the pores would likely have been reduced to metallic silver in 




Figure 15: Linear combination fits of Ag K-edge XANES of PSUiO-66 treated with: (A) 100 mM solution 
of AgNO3 in acetonitrile; (B) 100 mM solution of AgNO3 in 5:1 ethanol/water; (C) as per (B), but 
extensively washed with 5:1 ethanol/water to remove ionic Ag; (D) as per (C) but embedded in a 
polycaprolactone matrix. The experimental spectra (black) were fit with a linear combination fit (green) 
comprised of model XANES spectra of solid bulk silver metal (light blue); aqueous silver nitrate (purple); a 
buffered solution of the thioether-containing amino acid methionine with silver (orange) with the residual 
(red) shown offset. Results of linear combination analysis are shown in Table 4. 
 
 182
Table 4: Calculated ratios of Ag species in UiO-66, PSUiO-66, and ASUiO-66 treated with silver, as 
estimated by linear combination of model XANES spectra. 
 Ratio of component fitteda   
Sample Silver nitrate Bulk silver Methionine Ntotb Residual 
Ag(I)UiO-66  0.50(2) 0.168(9) 0.36(2) 1.02 0.41 
Ag(I/0)UiO-66 0.34(2) - 0.67(1) 1.00 0.54 
Ag(0)UiO-66 - 0.52(1) 0.49(1) 1.01 0.75 
Ag(0)UiO-66/PCL 0.23(2) 0.391(7) 0.39(2) 1.01 0.19 
Ag(I)PSUiO-66 0.41(2) - 0.59(2) 1.00 0.30 
Ag(I/0)PSUiO-66 0.39(1) 0.077(5) 0.53(1) 1.00 0.11 
Ag(0)PSUiO-66 0.24(1) 0.095(6) 0.67(1) 1.00 0.14 
Ag(I)ASUiO-66 0.38(2) - 0.61(2) 1.00 0.30 
Ag(I/0)ASUiO-66 0.53(2) - 0.47(2) 1.00 0.26 
Ag(0)ASUiO-66 0.365(9) 0.025(4) 0.61(1) 1.00 0.08 
Ag(0)ASUiO-66/PCL 0.23(2) 0.391(7) 0.39(2) 1.01 0.19 
aValues in parentheses are the estimated standard deviation derived from the diagonal elements of the 




EXAFS of silver-loaded metal-organic frameworks 
 Figures 16 and 17 show the EXAFS oscillations (left panel) and phase-corrected 
Fourier Transforms (FTs) (right panel) of all powdered materials. The oscillations of the 
UiO-66 materials (all treatments) were dampened until ~4 Å-1 at which point the amplitude 
of the oscillations increased and continued until the cessation of data collection at 14 Å-1, 
suggesting a high degree of interaction between the absorbing Ag atoms and other heavy 
elements. The maximum amplitudes of the oscillations shifted to larger k from Ag(I) ~8.5 
Å-1 to Ag(0) >14 Å-1 which indicated an increase in heavy element interactions in the 
absorbing Ag coordination sphere, consistent with the premise of AgNP formation and 
removal of Ag+ via thorough washing. The FTs of the EXAFS oscillations for all UiO-66 
materials displayed an intense peak at ~2.8 Å which, for the Ag(I) and Ag(I/0) materials 
was adequately described by single scattering silver and oxygen backscattering 
interactions. However, the EXAFS of Ag(0)UiO-66 and the PCL-embedded equivalent 
were successfully fitted with multiple scattering models calculated from a crystal structure 
of fcc silver metal80 (Table 5). When applied to the EXAFS recorded from Ag(0)UiO-66, 
the generated MS model required minimal relaxation as the model and the experimental 
spectrum were almost superimposable, suggesting coordination of silver in the material 
similar to that in the bulk metal. Such an observation brought into question the location of 
the silver in unfunctionalised UiO-66. In the absence of defects, the pores of UiO-66 are 7 
and 9 Å in diameter which could accommodate – assuming close-packed fcc geometry and 
a silver Van de Waals radius of 1.72 Å81 – between 7 and 14 atoms of silver; so few atoms 
are unlikely to result in the intense oscillations and similarities to the bulk metal. The 
similarity of the experimental spectrum with elemental silver may suggest that, for UiO-
66, the washing steps caused aggregation of silver.  
 
 Despite the absence of a reducing agent when a solution of silver nitrate in 
acetonitrile was diffused into UiO-66, the intensity of the EXAFS of Ag(I)UiO-66 
suggested that some of the silver was in the Ag(0) oxidation state, possibly reduced by the 
material itself; corroborated by the LCF analysis. This rendered the putative prefix of 
‘Ag(I)-’ not entirely correct for the unfunctionalised material, however, it was employed to 





Figure 16: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
UiO-66 treated with: 100 mM solution of AgNO3 in acetonitrile (black); 100 mM solution of AgNO3 in 5:1 
ethanol/water (blue); as per previous, but extensively washed with 5:1 ethanol/water to remove ionic Ag 




Table 5: Parameters fit to EXAFS spectra of Ag(I), Ag(I/0), Ag(0)UiO-66, and Ag(0)UiO-66/PCL, shown in 
Figure 16. See Appendix 4.8.5 for calculated fits.a 
Sample Scatterer CN Distance (Å) DWF (Å2) -E0 Fit error 
Ag(I)UiO-66 O 2 2.536(8) 0.0030(7) 19 0.42 
Ag 5 2.840(3) 0.0068(1)   
 Ag 2 3.913(5) 0.0046(3)   
Ag(I/0)UiO-66 O 2 2.219(5) 0.0032(5) 14 0.39 
Ag 3 2.881(2) 0.0041(1)   
Ag(0)UiO-66 010 12 2.896(2) 0.0036(1) 11 0.34 
 010 5 4.096 0.0051   
 010 24 5.017 0.0062   
 0110 96 5.405 0.0067   
 010 12 5.793 0.0072   
 0110 24 5.793 0.0072   
 01010 12 5.793 0.0072   
 01110 12 5.793 0.0072   
Ag(0)UiO-66/PCL 010 12 2.885(2) 0.0045(1) 13 0.35 
 010 5 4.080 0.0064   
 010 24 4.996 0.0078   
 0110 96 5.382 0.0084   
 010 12 5.769 0.0090   
 0110 24 5.769 0.0090   
 01010 12 5.769 0.0090   
 01110 12 5.769 0.0090   
ak-ranges used for fitting each spectrum were 1-14 Å with a scale factor (S02) of 0.9. DE0 = E0 – 25515 eV 
where E0 is the threshold energy. Values in parentheses are the estimated standard deviation derived from the 







Figure 17: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
PSUiO-66 (top) and ASUiO-66 (bottom) treated with: 100 mM solution of AgNO3 in acetonitrile (black); 
100 mM solution of AgNO3 in 5:1 ethanol/water (blue); as per previous sample, but extensively washed with 
5:1 ethanol/water to remove ionic Ag (red). EXAFS fits are shown in Appendix 4.8.5. 
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Table 6: Parameters fit to EXAFS spectra of Ag(I), Ag(I/0), Ag(0)PS and ASUiO-66, and Ag(0)ASUiO-
66/PCL, shown in Figure 17. See Appendix 4.8.5 for calculated fits.a 
Sample Scatterer CN Distance DWF -E0 Fit error 
Ag(I)PSUiO-66 S 1 2.506(8) 0.0025(4) 15(2) 0.84 
Ag(I/0)PSUiO-66 S 2 2.479(5) 0.0028(3) 18(1) 0.43 
Ag 6 2.854(3) 0.0071(3)   
Ag(0)PSUiO-66 O 1 2.30(1) 0.004(1) 16(1) 0.42 
 S 1 2.48(2) 0.009(1)   
 Ag 2 2.863(3) 0.0052(1)   
Ag(I)ASUiO-66 C/O 2 2.40(1) 0.014(3) 13(1) 0.55 
 S 1 2.502(4) 0.0038(3)   
 C/O 1 3.02(1) 0.0044(3)   
 Ag 1 3.939(8) 0.0066(4)   
Ag(I/0)ASUiO-66 S 1 2.496(4) 0.0024(3) 18(1) 0.51 
 S 1 2.67(1) 0.007(1)   
 Ag 1 2.852(5) 0.0062(3)   
Ag(0)ASUiO-66 C/O 2 2.30(1) 0.017(2) 19(1) 0.36 
 S 1 2.494(5) 0.0066(4)   
 Ag 1 2.824(3) 0.0070(1)   
ak-ranges used for fitting each spectrum were 1-14 Å with a scale factor (S02) of 0.9. DE0 = E0 – 25515 eV 
where E0 is the threshold energy. Values in parentheses are the estimated standard deviation derived from the 
diagonal elements of the covariance matric and are a measure of precision. The fit error is defined as 
[Sk6(cexp-ccalc)2/Sk6cexp2]½. 
 
 The phase-correct Fourier Transforms of the Ag(I)PS and ASUiO-66 (Figures 17, 
black) both displayed intense peaks at ~2.5 Å which were fit by sulfur backscattering 
interactions at distances of 2.5 Å, and 2.7 Å. A survey of the CSD indicated that bond 
lengths of ~2.5 Å are consistent with silver-thioether interactions, while the longer 
distances were likely due to bridging of the thioether units between multiple silver atoms. 
Carbon/nitrogen/oxygen backscattering interactions were fit to the low R peak in the FTs 
of Ag(I)PS and ASUiO-66 but resulted in physically unrealistic fit parameters. Silver-
silver interactions were successfully fit to both spectra but yielded very different distances. 
The allyl sulfanyl material was fit with an Ag-Ag distance of 3.9 Å while the same 
component fit to the propyl sulfanyl material resulted in a distance of 2.9 Å. The difference 
in distances could possibly be due to multiple scattering (e.g. Ag-S-Ag pathways). The 
orientations of the pi system in the pendant allyl sulfanyl groups in UiO-66 are not known, 
however, if they were to form pi-pi interactions with adjacent allyl groups or the benzene 
core of the ligand (see novel materials section) then the additional rigidity provided by this 
interaction may have facilitated multiple scattering. In contrast to the EXAFS oscillations 
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of Ag(I)UiO-66 the oscillations of the Ag(I)PS and ASUiO-66 materials (Figure 17, 
black) were reduced in intensity up to the end of data collection (14 Å-1), confirming the 
absence of elemental silver. 
 
 The Ag(I/0) and Ag(0) treatments of both PS- and ASUiO-66 displayed strong 
contributions from silver-silver backscattering interactions, evident from the emergence of 
a prominent peak at ~2.9 Å in the EXAFS FTs of the corresponding materials. While the 
Ag-Ag interaction became the dominant feature of the PSUiO-66 FTs, it did not for the 
ASUiO-66 with the peak at ~2.5 Å remaining the most intense feature.  
 
 Both Ag(0)PSUiO-66 and Ag(0)ASUiO-66 were fit with Ag-O interactions at 2.30 
Å. The emergence of PXRD peaks corresponding to the formation of Ag2O nanoparticles 
in the Ag(0)PSUiO-66 materials supported this fitting, however, it was unclear why the 
interaction was only seen in the Ag(0) material EXAFS. It was possible that the Ag(I/0), 
overall, contained less significant contribution of Ag-O interactions than did the Ag(0) 
materials, which had been washed extensively with water/ethanol in air.  
 
4.4.8 Silver leaching from MOF/polymer composite materials 
 Solid-state materials are unlikely to find application as consumable medicines to 
fight established bacterial infections, however, the premise of coating surfaces to prevent 
infection in clinical settings provides a wealth of opportunity. For example, coating 
prostheses, instruments, and components with antibacterial materials. Unlike some natural 
bactericidal materials82 metal-organic frameworks have not been shown to elicit an 
antibacterial response through the topology/morphology of the material and their brittle, 
powdered nature precludes them from such applications. Instead the medicinally relevant 
attribute of the materials is usually the release of a payload, degradation of the material 
itself to release molecular entities or generation by external stimuli.31, 83 If preventative 
action is required (i.e. preventing biofilms from forming at wound or implant) sites then a 
prolonged release of, in this case, silver would be desirable. Thus, an understanding of the 
kinetics of release of silver from the MOF/polymer composite materials is crucial. 
 
 To investigate the silver leaching profiles of all PCL-embedded materials they were 
stirred in water or Luria Bertani bacterial broth for 24 hours. Aliquots were removed at 1, 
2, 4, 8, and 24 hour and analysed by atomic absorption spectroscopy (AAS) by comparison 
to a silver calibration curve. The release of silver from the MOF/PCL films was 
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significantly reduced relative to release from the loose, powdered MOFs (Figure 11) due 
to the silver having to diffuse through the polymer matrix in addition to out of the material 
itself.  
 
 The leaching profile of the PSUiO-66 materials (Figure 18) did not follow the 
trend observed for the loading of silver into the material (Table 1, above). Ag(I)PSUiO-66 
had the lowest loading of silver (~13 mol%), but the greatest release of silver after 24 
hours (15.4% of total loaded silver), followed by Ag(I/0) and Ag(0). The lower release of 
silver from the materials in which reduced silver was present was possibly due to the mode 
of release from the materials. From the leaching profile it was clear that the silver 
nanoparticles (and elemental silver) in the materials were prevented from diffusing, out of 
the materials into the aqueous medium, likely limited by oxidative dissolution, an 
additional process on top of diffusion of Ag+ out of the MOF/polymer composite. 
Logarithmic release was observed for all PSUiO-66 materials with a plateau beginning to 
appear after 8 h that would likely have been reached if the studies were conducted for a 
longer period of time. The error bars displayed for all silver leaching profiles were 
representative of both technical and material batch replicates which suggested that the 
loading of silver into the PSUiO-66 materials was consistent for the Ag(I) and Ag(0) 





Figure 18: Percentage of total loaded silver in PSUiO-66/PCL composites released into MilliQ water over 
24 hours. Error bars are representative of the standard error calculated from multiple replicates. 
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 Similar to PSUiO-66 composite materials, the leaching profile of the ASUiO-
66/PCL materials into water did not adhere to the trend of loading reported in Table 1. 
Both the Ag(I) and Ag(I/0) materials released similar percentages of total loaded silver 
over 24 hours despite the latter having the highest loading of all ASUiO-66 materials (~23 
mol%). The standard error of the measurements of silver released from Ag(I/0)ASUiO-66 
was greater than that of Ag(I)ASUiO-66 which, again, suggested variable results when 
loading silver into the material in this way. Both the Ag(I) treated PS and ASUiO-66 
materials released similar percentages of total loaded silver into water after 24 hours (15.9 
vs. 14.3%, respectively). However, both the Ag(I/0) and Ag(0) treatments of ASUiO-66 
released approximately twice as much Ag than did the equivalent PSUiO-66 materials.  
 
 Silver-silver interactions were the dominant features of the Ag(I/0) and 
Ag(0)PSUiO-66 EXAFS FTs (Figure 17). Conversely, the EXAFS of the ASUiO-66 
materials maintained a strong contribution from the thioether sulfur in the coordination 
sphere of silver for both the Ag(I/0) and Ag(0) samples. An increased contribution could 
indicate a strong interaction between the pendant allyl thioether and the loaded silver. If 
this interaction increased the rate of oxidative dissolution of the reduced silver, it could 
help explain the increased release of Ag+ from ASUiO-66, relative to PSUiO-66. 
Alternatively, the silver ions may have been stabilised and prevented from being reduced 
to Ag(0) in the presence of ethanol. 
 
 The leaching profiles discussed thus far were carried out in ultra-pure MilliQ water, 
a poor comparison for a wound site. To better understand the kinetics of release into 
biological systems, leaching studies were carried out in Luria Bertani (LB) broth. LB broth 
is an ‘undefined’ media commonly used in microbiology to culture bacteria. It is 
considered undefined as it is composed of reconstituted water-soluble yeast extract (5 g/L), 
digested casein (tryptone) (10 g/L), and sodium chloride (5 g/L). The results of silver 
leaching from the ASUiO-66 family of materials into LB broth are displayed in Figure 19, 
bottom and key points summarised in Table 7. Overall the release of silver from all 
Ag-treatments of ASUiO-66 were reduced, relative to release into water. For all time 
points, the Ag(I/0)ASUiO-66 material released the greatest percentage of total loaded 
silver which was consistent with the mol% loading of silver discussed above. It was 
unclear why the trend of silver release changed between water and broth; however, it may 
have been that some of the solute dissolved in the broth (short chain peptides, amino acids, 
minerals, etc.) aided in the oxidative dissolution of the nanoparticles (or elemental silver) 
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in Ag(I/0)ASUiO-66. Similarly, the Ag(0)ASUiO-66 material (despite having the lowest 
loading of the three silver treatments – 15.6 mol%) released the second highest percentage 
of silver after 24 hours. Ag(I)ASUiO-66 released the lowest percentage of silver into broth 
of the three materials, which was possibly a result of impeded diffusion out of the 
MOF/PCL composite due the high ionic strength of the broth reducing the concentration 
and diffusion gradient from material to medium. Given the significantly reduced release of 
silver from the ASUiO-66 materials into broth (Figure 19, bottom), the same experiments 




Figure 16: Percentage of total loaded silver in ASUiO-66/PCL composites released into MilliQ water (top) 
and Luria Bertani broth (bottom) over 24 hours. Error bars are representative of the standard error calculated 
from multiple replicates. 
 
 For almost all silver treatments, measuring the leaching of silver from the 
unfunctionalised UiO-66 materials gave inconsistent results. A high degree of variability in 
the release of silver from the Ag(I/0) and Ag(0) materials was observed even within the 
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same batch of processed material; tables of UiO-66 leaching data are shown in Appendix 
4.8.6. The variability was likely a result of non-specific interactions between the silver and 
the material resulting in inhomogeneous distribution within the sample. Leaching from 
Ag(I)UiO-66, however, was consistent and the silver release profile into water and broth is 
shown in Figure 20. Similar to the ASUiO-66 materials, the overall release of silver into 
broth was reduced compared to release into water. After 24 hours, 15.4% of total loaded 





Figure 20: Percentage of total loaded silver in Ag(I)UiO-66/PCL composites released into MilliQ water 
(solid) and LB broth (dashed) over 24 hours. Error bars are representative of the standard error calculated 
from multiple replicates. 
 
Table 7: Concentrations and percentage of silver released into water or broth by MOF/PCL composite 
materials after 24 hours.a 
Material Medium [Ag] after 24 h [ppm] Released Ag after 24 h [%] 
Ag(I)UiO-66 Water 30.7 (2.5) 15.4 (1.5) 
Ag(I)UiO-66 Broth 3.0 (0.6) 0.7 (0.5) 
Ag(I)PSUiO-66 Water 44.1 (7.0) 15.9 (2.5) 
Ag(I/0)PSUiO-66 Water 32.7 (20.3) 8.1 (4.2) 
Ag(0)PSUiO-66 Water 13.0 (3.4) 3.4 (0.9) 
Ag(I)ASUiO-66 Water 42.2 (5.0) 14.3 (1.7) 
Ag(I/0)ASUiO-66 Water 72.3 (25.9) 14.2 (5.2) 
Ag(0)ASUiO-66 Water 27.9 (5.9) 6.7 (0.9) 
Ag(I)ASUiO-66 Broth 6.6 (1.1) 2.0 (0.4) 
Ag(I/0)ASUiO-66 Broth 24.9 (0.8) 3.0 (0.7) 
Ag(0)ASUiO-66 Broth 10.1 (1.7) 4.6 (0.1) 
aValues in parentheses are calculated standard errors of replicates 
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4.4.9 Antibacterial disk diffusion assays of silver-loaded MOF/PCL composites 
 The antibacterial activity of all materials was tested by disk diffusion assays on 
1.5% LB broth agar plates inoculated with cultures of Gram-negative (E. coli) and Gram-
positive (S. aureus) bacteria. Disks of polymer-embedded silver-loaded MOF (5 mm 
diameter) were cut from the bulk cast films and placed on the surface of the inoculated 
plates along with disks of PCL alone, and 25% w/w AgNO3 in PCL as negative and 
positive controls, respectively (Figure 21). For all silver-loaded MOF/PCL materials the 
antibacterial response was greater against the Gram-positive S. aureus compared to the 
Gram-negative E. coli, shown by larger zones of inhibited growth around the MOF-
polymer disks. It has been reported in literature that Gram-negative bacteria can be more 
tolerant of higher metal concentrations.84 The higher resistance of the E. coli to the leached 
silver could be due to a wealth of copper efflux genes in the bacterial strain used herein 
(MG1655). Due to similarities in chemistry, removal of Ag(I) from bacterial cells is often 
associated with Cu(I) transport and regulation.85 The proteome of the Newman strain of S. 
aureus only contains one known copper-efflux protein, while that of the strain of E. coli 
used (MG1655) contains up to 10 copper-efflux proteins. The ability for E. coli to efflux 
endogenous silver could have resulted in the overall reduced zones of inhibition (ZOIs) 




Figure 21: Measured zones of inhibited growth of S. aureus (red) and E. coli (blue) around 5 mm disks of 
PCL-embedded, silver-loaded UiO-66 materials (25 wt%). Disks of untreated PCL, and silver nitrate 
embedded in PCL (25 wt%) were used as negative and positive controls, respectively. Error bars are 
representative of biological and technical replicates. 
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 The ZOI for all silver treatments of unfunctionalised UiO-66, and ASUiO-66 
reflected the relative amounts of silver loaded into each material (Table 2). For example, 
the mixed oxidation state material (Ag(I/0)) had the highest loading of silver and the 
highest ZOI, followed by ionic silver (Ag(I)), and nanoparticulate silver (Ag(0)). However, 
the difference between the ZOIs of the Ag(I) and Ag(I/0)ASUiO-66 samples were within 
the margin of error for the measurements. The trend observed for the PSUiO-66 materials 
did not match the relative loadings of silver into each material, instead the ionic silver 
treated material had the greatest antibacterial response with the ZOI decreased for Ag(I/0), 
and Ag(0), respectively.  
 
 No materials had a greater antibacterial response than the positive control of silver 
nitrate in PCL, however, upon analysis of the relative amount of silver in each sample, the 
results of the disk diffusion assays changed significantly. The 5 mm disks punched from 
the bulk cast films for the disk diffusion assays had an average mass of 2.2 ± 0.3 mg. 
Knowing the mass of the disks used, weight loading of solid into the PCL, and percentage 
of silver per unit cell of MOF enabled the mass of silver in each disk to be calculated. 
Thus, the zone of inhibition data in Figure 21 could be weighted relative to the mass of 




Figure 22: Zone of inhibition distances – from Figure 21 – against S. aureus (green) and E. coli (purple) 
weighted by the mass of silver in each 5 mm disk of MOF/PCL composite. Error bars omitted for clarity; 
same as Figure 21. 
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 The weighted zone of inhibition data revealed that the positive control of 25% w/w 
AgNO3 in polycaprolactone had the lowest clearance zone per mg of silver against both S. 
aureus and E. coli. Additionally, it was found that for the PS- and ASUiO-66 materials the 
Ag(I) treatments had the highest ZOI per mg Ag and were the best performing materials of 
the same MOF type. By viewing the data in this way, it also highlighted that the amount of 
silver loaded into each framework was not the governing factor in the antibacterial 
properties of the composite materials. If this was the case, the Ag(I/0) material of each 
analogue would have had the greatest zone of clearance per mg of silver according to the 
silver-loading results in Table 2. Once weighted, unfunctionalised UiO-66/PCL samples 
were found to have the greatest antibacterial efficacy for each silver treatment. However, 
while the unfunctionalised materials may have been the best performing in the short term, 
the disk diffusion assays were only conducted over ~16 h and did not take into 
consideration the longevity of silver release from the materials. Conducting longer 
duration disk diffusion assays would likely have resulted in erroneous results due to the 
natural death of the microorganisms. 
 
4.4.10 Novel materials 
AgMOF-3 
 As has been detailed elsewhere, having a material loaded with an antibacterial 
agent and made from an antibacterial metal node (silver) could increase bactericidal 
efficacy (4.7 Future directions); either additive or synergistic. It was found that reaction 
of the ASBDC linker with silver trifluoroacetate, in a DMSO/ethyl acetate solvent mixture 
provided single crystals suitable for single crystal X-ray crystallography (parameters 
shown in Appendix 4.8.1). The structure of the material, [Ag2(ASBDC)], is a three-
dimensional framework comprised of silver ions and the ASBDC linker and reveals a 
rather unusual coordination environment for Ag ions comprising carboxylate and thioether 
donors. The asymmetric unit of AgMOF-3 comprises two silver ions chelated by sulfur 
and oxygen atoms from half an ASBDC linker (Ag2C7O2S1) (Figure 23). Pillars of silver 
atoms coordinated by both carboxylate oxygen and sulfur atoms from the ASBDC linkers 
project along the c axis (Figure 24). Two silver S2O4 coordination spheres are formed in 
the material, both with distorted octahedral geometry, with one located in the interior of 
the pillar and the second on the periphery. One distinction between the two silver 
coordination spheres is that in one the two sulfur donors coordinate in a linear fashion (S-
Ag-S angle: 169.4°) while the other has them arranged at right angles (S-Ag-S angle: 
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88.8°). The pillars are coordinated to three carboxylate linkers at each repeat giving rise to 




Figure 23: Asymmetric unit of the single crystal structure of AgMOF-3. 
 
 
Figure 24: AgMOF-3 has pillars of silver ions running along the c-axis of the structure. Two S2O4 
coordination spheres of the silver ions are formed, both with distorted octahedral geometries; one 
coordination sphere has the thioether sulfurs coordinating the Ag ion linearly (S-Ag-S angle: 169.4°) while 





Figure 25: Hexagonal pores that run along the c-axis of the framework with ~9 Å apertures. The allyl pi 
systems are projected into the pore space of the material. 
 
 The structure of [Ag2(ASBDC)] is further stabilised by pi stacking interactions.  
The benzene rings of the ASBDC linkers are separated by 4.054 Å, which is within the 
distance range normally ascribed to pi stacking interactions.86 When viewed down the c-
axis the hexagonal pores are lined by interdigitated allyl groups from the ASBDC linkers. 
The pendant allylsulfanyl ether units also appear to form intermolecular pi-pi contacts with 
nearby ASBDC thioether groups with a C-C distance of 4.054 Å (Figure 26, right). 
Furthermore, close contacts between the pendant allyl group and the linker benzene core 
are also formed with distances of 3.426 and 3.501 Å (Figure 26, left). 
  
 A simulated powder X-ray diffraction pattern was generated from the single crystal 
data presented here of AgMOF-3 and is shown in Figure 27a. Once grown by vapour 
diffusion, the single crystals of AgMOF-3 were crushed under solvent and wet-loaded into 
a capillary to obtain a powder diffraction pattern of the bulk material (Figure 27b). 
Additionally, room temperature conditions to synthesise the material were also identified 
(Figure 27c). As the simulated powder pattern accounts for all major peaks, and their 
relative intensities, it can be said that the single crystal structure presented here is 
representative of the bulk material generated from this experiment. No further 
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characterisation of this material was undertaken, but future work has been detailed 








Figure 27: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418Å) of AgMOF-3: (a) simulated pattern 
from single crystal structure; (b) bulk material (vapour diffusion); (c) bulk material (room temperature). 
 
 The hexagonal channels running through the structure of AgMOF-3 are similar to 
(albeit more hydrophobic than) those of M-MOF-74 (M = Zn, Ni, Co, Mg), a family of 
stable materials in which the organic linker is 2,5-dihydroxy BDC.87-88 Investigated uses of 
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MOF-74 include gas separation, proton mobility, sensing, catalysis, and drug delivery, 
although in the present case the permanent porosity of AgMOF-3 has not been established. 
The large channels running throughout the material could potentially facilitate flow-
through chemistry and reactions. Were the stability and porosity of AgMOF-3 to approach 
that of MOF-74, then it could present some interesting opportunities. Silver and the noble 
metals have been shown to have affinity for pi-systems and be potentially useful in 
alkene/alkane separation.26 The decoration of the hexagonal channels with the alkene of 
the allylthioether also presents opportunities for tailoring of the pore by Diels Alder 
chemistry, and substitution of different functional groups onto the alkene.89 MOF-74 
derivatives have also been prepared with longer linkers which suggests the intriguing 
possibility that AgMOF-3 may also be able to be prepared with an even larger pore 
aperture.90 
 
2D [Zn(ox)2BDC-(SO3)2] material 
 While no data is included in this thesis, an early stage focus of this project involved 
the synthesis of the archetypal MOF-5 materials, which were comprised of ZnO4 clusters 
and BDC linkers, the latter decorated with a range of sulfur-containing functional groups. 
This aspect of the project was eventually discarded due to the poor aqueous stability of the 
MOF-5 analogues which arises from easily hydrolysed Zn-O bonds.91 However, while still 
in consideration, a thiol-functionalised MOF-5 analogue was pursued. One attempt to form 
this material, involving reaction of zinc nitrate hexahydrate and 2,5-dimercapto benzene 
dicarboxylic acid in N,N-diethyl formamide and nitric acid, yielded clear colourless 
crystals suitable for analysis by SCXRD (parameters in Appendix 4.8.1). The structure of 
the resulting material turned out to be a 2D layered structure (H2NEt2)2[Zn(ox)2BDC-
(SO3)2] comprising five-coordinate zinc cations with distorted square pyramidal geometry 
coordinated by oxalate (ox) ligands and the oxidised ligand, disulfonate BDC (BDC-
(SO3)2).  These zinc centres form a strand down the b axis with oxalate ligands chelating 
the metal in the four basal positions; the direction of the apices of these polyhedra alternate 
at each zinc centre (ca. 5.33 Å) which causes the strand to zig-zag (Figure 28). The apices 
of the polyhedra were occupied by one of the oxygen atoms from the carboxylic acid group 
of the disulfonate BDC (DSBDC) linker which bridged between the zinc-oxalate strands 
and forms anionic sheets which propagate in the bc plane. The crystal packing was 
completed by well-ordered molecules of protonated diethylamine (DEA) which lie 
between the zinc-oxalate-DSBDC sheets and are associated with the sheets through 
hydrogen bonding interactions. Both the oxalate and the diethylamine were likely 
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degradation products of the N,N-diethylformamide; upon heating, DEF/DMF are well 
known to degrade to di(m)ethylamine and formic acid, however, the formation of oxalate 
from the formic acid was less clear. It is possible that the highly acidic reaction medium 
and high heat (100°C) enabled conversion of formic acid to oxalic acid which can usually 
only be achieved at ~400°C or with a catalyst.92 The flame-sealed glass vials in which the 
crystals were grown popped and bubbled when broken open, an indication that a gas had 
formed during the synthesis (possibly H2). The ordering of the DEA molecules between 
the layers was due to hydrogen bonding between a sulfonate oxygen on the organic linker 
and the secondary amine as well as an oxygen from an oxalate linker secondary amine 
(Figure 29, left & Table 8). The diethylamine counterions within the cavities of the 
anionic 2D sheets of the material have their orientation fixed by hydrogen bonding 
interactions from the sulfonate oxygens of two adjacent DSBDC linkers as well as one of 




Figure 28: A view of the 2D layered structure of (H2NEt2)2[Zn(ox)2BDC-(SO3)2] showing the 1D Zn-oxalate 
chains which are bridged to form the 2D structure.  Localisation of diethyl ammonium cations is highlighted 
in purple and green (within and between the layers, respectively). 
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Table 8: Summary of hydrogen bonding interactions in 2D layered (H2NEt2)2[Zn(ox)2BDC-(SO3)2] in 
Figure 29. 
DEAa Interaction D⋯A (Å) DH⋯A (Å) DH⋯A angle (°) 
Purple OSO3 ⋯NDEA 2.826 1.900 173.02 
 Oox⋯NDEA 2.864 1.942 169.74 
Green OCOOH⋯NDEA 2.842 2.079 138.31 
 OSO3⋯NDEA 2.844 2.229 122.88 
 OSO3⋯NDEA 2.874 1.963 168.71 




Figure 29: Hydrogen bonding interactions between diethyl ammonium molecules and sulfonates/oxalates 




Figure 30: Diethyl ammonium solvent molecules held in place between layered sheets of material (green) 
due to hydrogen bonding (Table 8). 
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4.5 Conclusions 
 This chapter described the effect of the inclusion of a range of sulfur-containing 
organic linkers on the uptake and release kinetics of silver in UiO-66 and its analogues. It 
was found that, overall, incorporation of sulfur-containing functionality in the material 
resulted in a higher uptake of silver ions relative to unmodified UiO-66. A thiolate-
containing MOF (DMUiO-66) had the highest uptake of silver ions from solution, 
however, the material had poor release properties. Inclusion of thioether units greatly 
decreased the uptake of silver relative to DMUiO-66, but the release of silver from these 
materials were greatly improved, likely due to the absence of electrostatic forces. The allyl 
thioether-containing material (ASUiO-66) had a higher uptake of silver relative to the alkyl 
thioether derivative (PSUiO-66), possibly highlighting an affinity between the pi-system 
and the silver ions. When silver ions were diffused into each material and reduced in situ to 
give nanoparticle or mixed oxidation state materials the relative trend in uptake of silver 
between the materials remained unchanged. 
 Ag XAS revealed that silver ions loaded into unfunctionalised UiO-66 were 
partially reduced to Ag(0), possibly by the framework itself. The interactions of the added 
metal in UiO-66 were almost exclusively with other silver atoms (resembling the spectrum 
of metallic silver), with some small contribution from oxygen. Conversely, XAS of the 
thioether-containing materials showed strong interaction between the silver ions and the 
thioether sulfur. Interestingly, the ASUiO-66 material appeared to stabilise the silver ions 
in the presence of a reductant, as silver-sulfur interactions were the dominant interaction 
observed in the EXAFS FT for all silver treatments of ASUiO-66; a feature not observed 
for the propyl thioether derivative.  
 Composites of all silver-loaded materials were successfully prepared by embedding 
them into a polycaprolactone matrix. Incorporation into the polymer further slowed silver 
release from the materials and release kinetics were determined for all composites. 
Ag(I)AS/PS/UiO-66-PCL composites all released ~15% of total loaded silver into ultra-
pure water after 24 hours. Release of silver into a more biologically relevant medium, such 
as bacterial broth, resulted in a 5 to 10-fold decrease in the amount of total bound silver 
released from the materials tested suggesting that ionic strength of the solution could play 
a role in material release kinetics.  
 All silver-loaded UiO-66 derivatives embedded in a PCL matrix were shown to 
have antibacterial activity against both S. aureus and E. coli. Overall, the materials were 
more effective against the Gram-positive S. aureus with Ag(I/0)ASUiO-66 having the 
greatest antibacterial effect, based on disk diffusion assays. The positive control of silver 
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nitrate embedded in PCL (25 wt. %) had greater antibacterial efficacy than all tested 
materials, however, weighting the results of the disk diffusion assay based on the mass of 
silver in each sample revealed that with less silver content, the MOF-containing species 
(i.e. not the positive control) produced a greater antibacterial response. Whether the 
increased response was due to the controlled release of the silver from the materials or 
possibly leaching of other material components having an additive effect is unclear but 
could be clarified by testing the antibacterial activity of all components of the material 
individually.  
 
4.6 Future directions 
 Loading a bioactive payload into a framework is only one way of delivering 
medicinally relevant species to a wound site. Copper and zinc have been shown to have 
antibacterial properties and are also common metal nodes in MOF chemistry.93 Examples 
of such frameworks are MOF-5, composed of Zn4O clusters joined by BDC linkers or the 
copper-based HKUST-1 which used benzene tricarboxylic acid.40, 94 Both materials are 
known to degrade in aqueous media through hydrolysis of the Zn/Cu-Ocarboxylate bonds, 
liberating zinc and copper ions.91, 95 Were such a framework loaded with silver to be 
released by material degradation then two bioactive metals would be released into solution 
possibly having an additive or synergistic effect. Design of an antibacterial linker could 
provide a third prong of attack in the degradation of the material; sulfonamides, camphor, 
and beta lactams are all known to be potent antibacterial functional groups.96-97 Finally, 
embedding of a material comprising an antibacterial metal, linker, and payload into an 
antibacterial polymer, such as chitosan,98 could provide yet another layer of efficacy as 
well as extending the applicability of the material for medical use. Such experiments were 
attempted here with MOF-5 and the thioether-containing linkers, however, the degradation 
of the material complicated characterisation, handling, and processing. 
 
 Permanently porous silver-based MOFs or coordination polymers are a class of 
materials for which there are only limited reports.99 As such, the discovery of AgMOF-3 
which has large, hexagonal channels running throughout it could provide an interesting 
material to further investigate, especially as both single crystal and room temperature 
syntheses have been identified. To test the stability and porosity of the new framework 
thermogravimetric analysis, and gas adsorption isotherms would need to be carried out.  
 The channels decorated with well-ordered allyl thioether units provides an 
opportunity for saturation of the double bond with other functionality, and Diels Alder 
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chemistry. Additionally, rearrangement reactions of allyl ethers have been reported 
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Appendix 4.8.1 Single crystal X-ray experimental data 
Table 9: X-ray experimental data for Ag2ASBDC 
Compound AgMOF-3 
Identification code AgMOF-3 
Empirical formula C7H6AgO2S 
Formula weight 309.31 
Crystal system trigonal 












Radiation Synchrotron (λ = 0.71073) 
2Θ range for data collection/° 5.008 to 64.636 
Reflections collected 42024 
Independent reflections 2712 [Rint = 0.7445, Rsigma = 0.5168] 
Data/restraints/parameters 2712/0/101 
Goodness-of-fit on F2 0.945 
Final R indexes [I>=2σ (I)] R1 = 0.1466, wR2 = 0.3264 
Final R indexes [all data] R1 = 0.2821, wR2 = 0.4180 
Largest diff. peak/hole / e Å-3 2.20/-10.08 
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Table 10: X-ray experimental data for [Zn(ox)2BDC-(SO3)2] 
Compound 2D [Zn(ox)2BDC-(SO3)2] material 
Identificantion code [Zn(ox)2BDC-(SO3)2] 
Empirical formula C14H25N2O9SZn 
Formula weight 462.79 
Temperature/K 100.15 
Crystal system triclinic 












Crystal size/mm3 0.2 × 0.2 × 0.2 
Radiation Synchrotron (λ = 0.71073) 
2Θ range for data collection/° 4.348 to 66.188 
Index ranges -13 ≤ h ≤ 13, -12 ≤ k ≤ 14, -19 ≤ l ≤ 19 
Reflections collected 17721 
Independent reflections 5871 [Rint = 0.1106, Rsigma = 0.1178] 
Data/restraints/parameters 5871/4/248 
Goodness-of-fit on F2 1.176 
Final R indexes [I>=2σ (I)] R1 = 0.0783, wR2 = 0.2304 
Final R indexes [all data] R1 = 0.0888, wR2 = 0.2479 




Appendix 4.8.2 Defect calculations of PS- and ASUiO-66 materials 
MOF formulas Zr6O4(OH)4L(6-0.5X)AX, where L is the linker, and A the acid modulator, 
were obtained from 1H NMR spectra using the following equation: 
X = 6R/(1+0.5R) 
where R is the ratio of A to L determined from the integration of the formic acid and 
aromatic linker signals in the 1H NMR spectrum of digested MOF (obtained from the 
figures below). 
 
Table 11: Calculated number of defects per node of PS and ASUiO-66 derivatives for all silver treatments 







PSUiO-66 0.31 2 0.24 5.37 1.27 
Ag(I)PSUiO-66 0.34 2 0.25 5.32 1.35 
Ag(I/0)PSUiO-66 0.22 2 0.18 5.50 0.99 
Ag(0)PSUiO-66 0.15 2 0.13 5.63 0.73 
ASUiO-66 0.58 2 0.37 5.07 1.86 
Ag(I)ASUiO-66 0.35 2 0.26 5.31 1.38 
Ag(I/0)ASUiO-66 0.28 2 0.22 5.41 1.18 





Figure 7: 1H NMR spectrum of digested untreated PSUiO-66 synthesised using 30 equivalents of formic 
acid. Integration of PSBDC linker aromatic signal (7.65 ppm, 1.40 integration) and acid modulator (8.07 





Figure 32: 1H NMR spectrum of digested Ag(I)PSUiO-66 synthesised using 30 equivalents of formic acid. 
Integration of PSBDC linker aromatic signal (7.65 ppm, 2.00 integration) and acid modulator (8.07 ppm, 




Figure 33: 1H NMR spectrum of digested Ag(I/0)PSUiO-66 synthesised using 30 equivalents of formic acid. 
Integration of PSBDC linker aromatic signal (7.69 ppm, 2.00 integration) and acid modulator (8.10 ppm, 





Figure 34: 1H NMR spectrum of digested Ag(0)PSUiO-66 synthesised using 30 equivalents of formic acid. 
Integration of PSBDC linker aromatic signal (7.66 ppm, 2.00 integration) and acid modulator (8.08 ppm, 




Figure 35: 1H NMR spectrum of digested untreated ASUiO-66 synthesised using 30 equivalents of formic 
acid. Integration of ASBDC linker aromatic signal (7.75 ppm, 2.00 integration) and acid modulator (8.04 




Figure 36: 1H NMR spectrum of digested Ag(I)PSUiO-66 synthesised using 30 equivalents of formic acid. 
Integration of ASBDC linker aromatic signal (7.70 ppm, 2.00 integration) and acid modulator (8.07 ppm, 




Figure 37: 1H NMR spectrum of digested Ag(I/0)ASUiO-66 synthesised using 30 equivalents of formic acid. 





Figure 38: 1H NMR spectrum of digested Ag(0)ASUiO-66 synthesised using 30 equivalents of formic acid. 
Integration of ASBDC linker aromatic signal (7.65 ppm, 2.00 integration) and acid modulator (8.07 ppm, 
0.14 integration) shown. 
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Figure 39: Baseline-corrected powder X-ray diffraction patterns (Co Ka, l = 1.789 Å) of UiO-66 embedded 
in a polycaprolactone matrix: (a) treated with 100 mM solution of AgNO3 in acetonitrile; (b) treated with 100 
mM solution of AgNO3 in 5:1 ethanol/water; (c) treated as per sample (b) but extensively washed with 5:1 




Figure 40: Baseline-corrected powder X-ray diffraction patterns (Co Ka, l = 1.789 Å) of PSUiO-66 
embedded in a polycaprolactone matrix: (a) treated with 100 mM solution of AgNO3 in acetonitrile; (b) 
treated with 100 mM solution of AgNO3 in 5:1 ethanol/water; (c) treated as per sample (b) but extensively 





Figure 41: Baseline-corrected powder X-ray diffraction patterns (Co Ka, l = 1.789 Å) of ASUiO-66 
embedded in a polycaprolactone matrix: (a) treated with 100 mM solution of AgNO3 in acetonitrile; (b) 
treated with 100 mM solution of AgNO3 in 5:1 ethanol/water; (c) treated as per sample (b) but extensively 
washed with 5:1 ethanol/water to remove traces of ionic silver, and (d) polycaprolactone alone. 
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Figure 42: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418 Å) of silver-treated UiO-66 pre and post 
XAS experiments. Some of the powdered materials were compressed into a pellet with granulate 
polyethylene before being presented to the beam which led to the appearance of the broad peaks starting at 




Figure 43: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418 Å) of silver-treated PSUiO-66 pre and post 
XAS experiments. Some of the powdered materials were compressed into a pellet with granulate 
polyethylene before being presented to the beam which led to the appearance of the broad peaks starting at 





Figure 44: Powder X-ray diffraction patterns (Cu Ka, l = 1.5418 Å) of silver-treated ASUiO-66 pre and 
post XAS experiments. Some of the powdered materials were compressed into a pellet with granulate 
polyethylene (PE) before being presented to the beam which led to the appearance of the broad peaks starting 
at ~25°. The peaks were cross referenced with an XRD of PE alone (not shown). 
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Appendix 4.8.5 MOF EXAFS fits 
 
Figure 45: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
UiO-66: (A) treated with 100 mM solution of AgNO3 in acetonitrile; (B) treated with 100 mM solution of 
AgNO3 in 5:1 ethanol/water; (C) treated as per sample (B) but extensively washed with 5:1 ethanol/water to 
remove traces of ionic silver, and (D) sample (C) embedded in a polycaprolactone matrix. Experimental 
(black) and calculated (green) data with the residual (red) shown offset. Fit parameters are shown in Table 5. 
 
 
Figure 46: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
PSUiO-66: (A) treated with 100 mM solution of AgNO3 in acetonitrile; (B) treated with 100 mM solution of 
AgNO3 in 5:1 ethanol/water; (C) treated as per sample (B) but extensively washed with 5:1 ethanol/water to 
remove traces of ionic silver. Experimental (black) and calculated (green) data with the residual (red) shown 
offset. Fit parameters are shown in Table 6. 
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Figure 47: Ag K-edge EXAFS spectra (left panel) and corresponding Fourier Transform (right panel) of 
ASUiO-66: (A) treated with 100 mM solution of AgNO3 in acetonitrile; (B) treated with 100 mM solution of 
AgNO3 in 5:1 ethanol/water; (C) treated as per sample (B) but extensively washed with 5:1 ethanol/water to 
remove traces of ionic silver, and (D) sample (C) embedded in a polycaprolactone matrix. Experimental 
(black) and calculated (green) data with the residual (red) shown offset. Fit parameters are shown in Table 6. 
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Appendix 4.8.6 Silver leaching results for UiO-66 treated with Ag(I/0) and Ag(0) 
Table 12: Ag(I/0)UiO-66/PCL in water 
 Conc. of Ag [ppm] & replicate 
Time 1 2 3 4 
1 45.9 1.7 115.1 14.6 
2 64.7 4.2 126.1 26.8 
4 84.0 7.2 134.0 81.7 
8 98.7 9.6 138.1 54.8 
24 115.0 15.6 149.3 84.4 
 
Table 13: Ag(0)UiO-66/PCL in water 
 Conc. of Ag [ppm] & replicate 
Time 1 2 3 4 
1 1.04 0.60 0.26 1.50 
2 1.44 0.93 0.66 2.01 
4 1.26 1.43 1.10 2.36 
8 4.19 1.46 1.68 2.37 






Chapter Five: Conclusions and future work 
5.1 Conclusions and future work 
 Presented herein was an in-depth analysis of the biochemical fate of silver ions in 
bacterial and mammalian systems by metallomics techniques: X-ray absorption 
spectroscopy, and size exclusion chromatography hyphenated with inductively coupled 
plasma mass spectrometry. In addition, silver-loaded metal-organic frameworks with 
chemically-programmed pore enviornments were synthesised, characterised and tested for 
antibacterial efficacy. 
 
 At sublethal concentrations, silver ions in Luria Bertani broth were determined to 
be predominantly bound by cysteine, or thiolate-containing low to medium molecular 
weight species, likely partially degraded protein species or agglomerations of short-chain 
peptides. Interestingly, no silver chloride was identified in the XAS data of silver in broth, 
despite the medium containing ~5 g/L NaCl. This would suggest that the silver species in 
solution is highly stable against precipitation as AgCl but was still bioavailable to the 
bacteria grown in the broth. Such a silver-species could potentially be an antibiotic drug 
candidate if successfully isolated and characterised further. The speciation of the silver 
ions was found to be concentration dependent, with a twenty-fold increase in [AgNO3] 
resulting in formation of distinct, new complexes, possibly due to aggregation of smaller 
molecular weight species peptides. At such a concentration, AgNO3 would be well above 
the MIC of both strains of bacteria used. 
 Analysis of post bacterial growth silver-treated broth found that no detectable silver 
remained in the S. aureus depleted broth, and a significantly reduced silver signal was 
detected from the E. coli depleted broth. Interestingly, the post growth broth SEC traces 
did not differ significantly from that of the pre growth broth. From this it could be 
concluded that the silver concentration was indeed ‘sublethal’ as, if cell death had occurred 
due to the presence of silver ion, the post growth chromatogram would be expected to be 
significantly altered as a result of cell lysis. Additionally, the complete uptake of silver 
ions by S. aureus from the broth indicated that efflux from the organism was not occurring. 
Taking these observations into consideration it could be concluded that the bacteria were 
taking up the silver containing molecules and not identifying them as a toxicant to be 
effluxed from the cell.  
 Intracellular silver was also found to be coordinated by sulfurous donors like 
cysteine. However, SEC-ICP-MS of the bacterial lysates indicated that intracellular silver 
ions were associated with high molecular weight species. Comparison of the S. aureus and 
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E. coli 107Ag and 65Cu traces revealed the silver ions were nonuniformly colocalised with 
copper ions. Such confluence of the two elements could suggest that the cells were 
processing the endogenous Ag+ ions as if they were nutrient copper ions. For this to have 
occurred, the short-chain peptide-bound silver ions would have to have been stripped of 
their exogenous ligands (e.g. peptide or partially digested protein), transported by a 
chaperone through the cell to metallate a cuproenzyme or homeostatic copper protein. 
Extension of the Irving-Williams series would suggest that the silver ions would form 
more stable complexes with cuproenzymes than their native copper cofactors. Silver’s lack 
of accessible oxidation states would likely result in inhibition of redox-active species. 
Thus, it is possible that in the initial stages of bacterial cell death, silver is incorporated 
into copper metabolic pathways which would be overwhelmed as the concentration rose.  
 While ~20 copper-binding proteins have been identified in the proteome of E. coli 
MG1655, only two have been identified in the proteome of S. aureus Newman. However, 
the 65Cu trace of S. aureus lysate revealed many more than two copper-binding proteins. 
Isolation, purification and characterisation of these species by techniques like anion 
exchange chromatography and mass spectrometry could provide great insight into the 
copper homeostatic pathways of bacteria. Following the fate of silver through these 
additional proteomics techniques would also yield more information about the molecular 
mechanisms through which silver ions elicit their antibacterial response.  
 Given the close association between silver and copper reported here, it would be 
informative to carry out transcriptomics analysis of the organisms at concentrations of 
AgNO3 approaching the MIC with particular attention paid to the scores associated with 
copper-binding protein expression. However, for this to be useful, greater knowledge about 
the copper-binding proteins in the organisms would be required. 
 
 In human whole blood, silver nitrate was found to rapidly associate with the red 
blood cell fraction where ~90% of Ag+ was localised, 5 minutes post exposure. Significant 
lysis of the RBCs was also observed to occur in the presence of 2 mM AgNO3, which was 
consistent with previously reported observations. Within the red blood cells, silver was 
predominantly associated with haemoglobin and bound by cysteine residues present in the 
protein, a small portion of the silver was also found to be associated with carbonic 
anhydrase. 
 Due to haemolysis, the plasma fraction of whole blood treated with 2 mM silver 
nitrate was contaminated with RBC cellular contents. SEC-ICP-MS of the plasma fraction 
revealed that the greatest proportion of Ag+ was associated with contaminant haemoglobin. 
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After Hb, human serum albumin was found to be the dominant silver-binding species, as 
well as a range of higher molecular weight protein species. Interestingly, in isolated plasma 
the speciation of silver nitrate was found to be predominantly silver chloride, which was 
suspected to be present as a colloidal suspension. Conversely, in a sample of plasma 
fractionated from whole blood treated with silver nitrate, no silver chloride was determined 
to be present. This would suggest that studies carried out elsewhere in isolated plasma or 
serum are correct in conclusion that the antibacterial properties of silver are reduced in 
such systems due to sequestration as silver chloride, however, that appears to not be 
representative of ‘true’ or ‘complete’ biological fluids as reported here. At a lower 
concentration of silver nitrate (0.1 mM) lysis of RBCs did not visibly occur, as validated 
by the absence of a haemoglobin peak in the SEC-ICP-MS plasma chromatogram. 
However, this could merely indicate that the degree of lysis that did occur was successfully 
managed by the haemoglobin scavenging protein, haptoglobin.  
 A second dimension of separation and purification of the size exclusion 
chromatograms by anion exchange chromatography would possibly allow more precise 
identification of silver-binding protein species in plasma and red blood cells. To do this, 
the buffer system would need to be changed to one that is not anionic at physiological pH, 
like Tris or bis-Tris. Isolation of protein samples could enable testing for enzymatic 
activity for validation of plasma proteins that may bind silver.  
 
 Finally, the pore environment of UiO-66 was successfully modified and tailored for 
increased uptake and prolonged release of silver ions. This was acheived through synthesis 
of alkyl thioether- and allyl thioether-functionalised analogues of the parent material. 
Soaking of the materials in solutions of silver nitrate enabled loading of the materials with 
silver ions and, depending on the solvent system used, silver could be loaded in as Ag+, 
Ag(I)/Ag(0) or Ag(0) with slow in situ reduction. Embedding the silver loaded MOFs into 
a polymer matrix slowed the release of silver from all MOF/polymer composites relative to 
the free MOF as well as extending the applicability of the material for use in clinical 
settings as an antibacterial coating. Comparison of the leaching of silver from the polymer-
embedded materials into water and into bacterial broth revealed that release into broth was 
significantly suppressed. Reduced release of silver was likely due to the high ionic strength 
of the medium which provides useful information regarding the behaviour of the materials 
in biological settings. Additionally, it was found that release of silver from the 
unfunctionalised UiO-66 was highly variable for all silver treatments which could have 
been due to heterogenous distribution of the silver in the framework given that this 
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variability was even observed within a single batch of the material. Antibacterial testing of 
the silver-loaded, polymer-embedded materials revealed that all silver-containing material 
had antibacterial properties against Gram-positive and Gram-negative bacteria. Comparing 
raw bacterial growth inhibition zones between the silver-loaded materials and silver nitrate 
in the polymer at an equivalent weight loading, none of the materials performed better than 
the AgNO3/PCL sample. However, weighting the inhibition zones by the mass of silver in 
each sample, it was revealed that almost all materials outperformed the positive control 
(based on mm of inhibited growth per mg of silver). The material with the greatest zone of 
inhibition per mg of silver was the unfunctionalised UiO-66; however, the disk diffusion 
assays did not take into account the longevity of the materials. 
 The only known antibacterial component of the UiO-66 analogues presented herein 
was the loaded silver. The antibacterial properties of the materials could be further 
optimised by using of a framework which comprises another antibacterial metal (like Cu or 
Zn) and/or inclusion of a linker with antibacterial properties, possibly a sulfonamide 
derivative. Coupled with embedding into an antibacterial polymer matrix like chitosan and 
loaded with silver ions or another antibiotic, a material entirely comprised of antibacterial 
components could be produced.  
